,Unnamed: 0,manuscript_title,team,doi_pre,doi_pub,original_research,OpenAlex_ID,ListofAlexIds,ListofNames,ListofOrcids,Role,Team,FirstLastName
0,0.0,LRRK2 phosphorylation of Rab GTPases in Parkinson’s disease,Alessi,review,10.1002/1873-3468.14492,0.0,W4296162466,A5033452410,Suzanne R. Pfeffer,0000-0002-6462-984X,Co-PI,Team Alessi,Suzanne Pfeffer
2,2.0,PTEN-induced kinase 1 (PINK1) and Parkin: Unlocking a mitochondrial quality control pathway linked to Parkinson's disease,Alessi,review,10.1016/j.conb.2021.09.005,0.0,W3209929601,A5084528692,Miratul M. K. Muqit,0000-0001-9733-2404,Co-PI,Team Alessi,Miratul Muqit
6,6.0,Isotope tracing in health and disease,Alessi,review,10.1016/j.copbio.2022.102739,0.0,W4283208018,A5045437960,Monther Abu-Remaileh,0000-0003-3772-0477,Co-PI,Team Alessi,Monther Abu-Remaileh
9,9.0,Whole proteome copy number dataset in primary mouse cortical neurons,Alessi,none? review,10.1016/j.dib.2023.109336,0.0,W4381848193,A5084528692,Miratul M. K. Muqit,0000-0001-9733-2404,Co-PI,Team Alessi,Miratul Muqit
13,13.0,Role of autophagy pathway in Parkinson’s disease and related Genetic Neurological disorders,Alessi,review,10.1016/j.jmb.2023.168144,0.0,W4376272271,A5084528692,Miratul M. K. Muqit,0000-0001-9733-2404,Co-PI,Team Alessi,Miratul Muqit
22,22.0,Impact of 100 LRRK2 variants linked to Parkinson's disease on kinase activity and microtubule binding,Alessi,10.1101/2022.04.01.486724,10.1042/BCJ20220161,1.0,W4290803974,A5054181982,Dario R. Alessi,0000-0002-2140-9185,Lead-PI,Team Alessi,Dario Alessi
32,32.0,"PKC isoforms activate LRRK1 kinase by phosphorylating conserved residues (Ser1064, Ser1074 and Thr1075) within the CORB GTPase domain",Alessi,10.1101/2022.06.09.495448,10.1042/BCJ20220308,1.0,W4293567400,A5013336817,Stefan Knapp,0000-0001-5995-6494,Co-PI,Team Reck-Peterson,Stefan Knapp
33,33.0,"PKC isoforms activate LRRK1 kinase by phosphorylating conserved residues (Ser1064, Ser1074 and Thr1075) within the CORB GTPase domain",Alessi,10.1101/2022.06.09.495448,10.1042/BCJ20220308,1.0,W4293567400,A5054181982,Dario R. Alessi,0000-0002-2140-9185,Lead-PI,Team Alessi,Dario Alessi
43,43.0,"Golgi-IP, a novel tool for multimodal analysis of Golgi molecular content",Alessi,10.1101/2022.11.22.517583,10.1073/pnas.2219953120,1.0,W4375956084,A5054181982,Dario R. Alessi,0000-0002-2140-9185,Lead-PI,Team Alessi,Dario Alessi
44,44.0,"Golgi-IP, a novel tool for multimodal analysis of Golgi molecular content",Alessi,10.1101/2022.11.22.517583,10.1073/pnas.2219953120,1.0,W4375956084,A5045437960,Monther Abu-Remaileh,0000-0003-3772-0477,Co-PI,Team Alessi,Monther Abu-Remaileh
49,49.0,CURTAIN – A Unique Web-based tool for exploration and sharing of MS-based proteomics data | bioRxiv,Alessi,10.1101/2023.07.25.550405,10.1073/pnas.2312676121,1.0,W4391594220,A5084528692,Miratul M. K. Muqit,0000-0001-9733-2404,Co-PI,Team Alessi,Miratul Muqit
50,50.0,CURTAIN – A Unique Web-based tool for exploration and sharing of MS-based proteomics data | bioRxiv,Alessi,10.1101/2023.07.25.550405,10.1073/pnas.2312676121,1.0,W4391594220,A5054181982,Dario R. Alessi,0000-0002-2140-9185,Lead-PI,Team Alessi,Dario Alessi
57,57.0,Localization of PPM1H phosphatase tunes Parkinson’s disease-linked LRRK2 kinase-mediated Rab GTPase phosphorylation and ciliogenesis,Alessi,10.1101/2023.06.15.545139,10.1073/pnas.2315171120,1.0,W4387970169,A5033452410,Suzanne R. Pfeffer,0000-0002-6462-984X,Co-PI,Team Alessi,Suzanne Pfeffer
63,63.0,Loss of primary cilia and dopaminergic neuroprotection in pathogenic LRRK2-driven and idiopathic Parkinsons disease | bioRxiv,Alessi,10.1101/2024.01.15.575737,10.1073/pnas.2402206121,1.0,W4401213995,A5054181982,Dario R. Alessi,0000-0002-2140-9185,Lead-PI,Team Alessi,Dario Alessi
64,64.0,Loss of primary cilia and dopaminergic neuroprotection in pathogenic LRRK2-driven and idiopathic Parkinsons disease | bioRxiv,Alessi,10.1101/2024.01.15.575737,10.1073/pnas.2402206121,1.0,W4401213995,A5033452410,Suzanne R. Pfeffer,0000-0002-6462-984X,Co-PI,Team Alessi,Suzanne Pfeffer
75,75.0,Global ubiquitylation analysis of mitochondria in primary neurons identifies endogenous Parkin targets following activation of PINK1,Alessi,10.1101/2021.04.01.438131,10.1126/sciadv.abj0722,1.0,W3213349298,A5001971427,Ian G. Ganley,0000-0003-1481-9407,Co-PI,Team Hurley,Ian Ganley
76,76.0,Global ubiquitylation analysis of mitochondria in primary neurons identifies endogenous Parkin targets following activation of PINK1,Alessi,10.1101/2021.04.01.438131,10.1126/sciadv.abj0722,1.0,W3213349298,A5047746208,J. Wade Harper,0000-0002-6944-7236,Lead PI,Team Harper,J. Harper
77,77.0,Global ubiquitylation analysis of mitochondria in primary neurons identifies endogenous Parkin targets following activation of PINK1,Alessi,10.1101/2021.04.01.438131,10.1126/sciadv.abj0722,1.0,W3213349298,A5084528692,Miratul M. K. Muqit,0000-0001-9733-2404,Co-PI,Team Alessi,Miratul Muqit
92,92.0,Parkinson's VPS35[D620N] mutation induces LRRK2 mediated lysosomal association of RILPL1 and TMEM55B,Alessi,10.1101/2023.06.07.544051,10.1126/sciadv.adj1205,1.0,W4389697128,A5033452410,Suzanne R. Pfeffer,0000-0002-6462-984X,Co-PI,Team Alessi,Suzanne Pfeffer
93,93.0,Parkinson's VPS35[D620N] mutation induces LRRK2 mediated lysosomal association of RILPL1 and TMEM55B,Alessi,10.1101/2023.06.07.544051,10.1126/sciadv.adj1205,1.0,W4389697128,A5054181982,Dario R. Alessi,0000-0002-2140-9185,Lead-PI,Team Alessi,Dario Alessi
107,107.0,Mechanism of human PINK1 activation at the TOM complex in a reconstituted system | bioRxiv,Alessi,10.1101/2023.12.23.573181,10.1126/sciadv.adn7191,1.0,W4399425564,A5061030857,Rubén Fernández‐Busnadiego,0000-0002-8366-7622,Co-PI,Team Harper,Rubén Fernández‐Busnadiego
108,108.0,Mechanism of human PINK1 activation at the TOM complex in a reconstituted system | bioRxiv,Alessi,10.1101/2023.12.23.573181,10.1126/sciadv.adn7191,1.0,W4399425564,A5084528692,Miratul M. K. Muqit,0000-0001-9733-2404,Co-PI,Team Alessi,Miratul Muqit
113,113.0,Rab29-dependent asymmetrical activation of leucine-rich repeat kinase 2,Alessi,10.1101/2022.04.26.489605,10.1126/science.adi9926,1.0,W4390046099,A5054181982,Dario R. Alessi,0000-0002-2140-9185,Lead-PI,Team Alessi,Dario Alessi
120,120.0,Structural basis for the specificity of PPM1H phosphatase for Rab GTPases,Alessi,10.1101/2021.02.17.431620,10.15252/embr.202152675,1.0,W3204672542,A5054181982,Dario R. Alessi,0000-0002-2140-9185,Lead-PI,Team Alessi,Dario Alessi
127,127.0,Pathogenic LRRK2 control of primary cilia and Hedgehog signaling in neurons and astrocytes of mouse brain,Alessi,10.1101/2021.03.02.433576,10.7554/eLife.67900,1.0,W3205174301,A5054181982,Dario R. Alessi,0000-0002-2140-9185,Lead-PI,Team Alessi,Dario Alessi
128,128.0,Pathogenic LRRK2 control of primary cilia and Hedgehog signaling in neurons and astrocytes of mouse brain,Alessi,10.1101/2021.03.02.433576,10.7554/eLife.67900,1.0,W3205174301,A5033452410,Suzanne R. Pfeffer,0000-0002-6462-984X,Co-PI,Team Alessi,Suzanne Pfeffer
138,138.0,A feed-forward pathway drives LRRK2 kinase membrane recruitment and activation,Alessi,10.1101/2022.04.25.489459,10.7554/eLife.79771,1.0,W4296793671,A5054181982,Dario R. Alessi,0000-0002-2140-9185,Lead-PI,Team Alessi,Dario Alessi
139,139.0,A feed-forward pathway drives LRRK2 kinase membrane recruitment and activation,Alessi,10.1101/2022.04.25.489459,10.7554/eLife.79771,1.0,W4296793671,A5033452410,Suzanne R. Pfeffer,0000-0002-6462-984X,Co-PI,Team Alessi,Suzanne Pfeffer
147,147.0,Genome-wide screen reveals Rab12 GTPase as a critical activator of pathogenic LRRK2 kinase,Alessi,10.1101/2023.02.17.529028,10.7554/elife.87098,1.0,W4387892944,A5054181982,Dario R. Alessi,0000-0002-2140-9185,Lead-PI,Team Alessi,Dario Alessi
148,148.0,Genome-wide screen reveals Rab12 GTPase as a critical activator of pathogenic LRRK2 kinase,Alessi,10.1101/2023.02.17.529028,10.7554/elife.87098,1.0,W4387892944,A5033452410,Suzanne R. Pfeffer,0000-0002-6462-984X,Co-PI,Team Alessi,Suzanne Pfeffer
172,172.0,Tagless LysoIP method for molecular profiling of lysosomal content in clinical samples,Alessi,10.1101/2024.05.17.594681,,1.0,W4397293294,A5054181982,Dario R. Alessi,0000-0002-2140-9185,Lead-PI,Team Alessi,Dario Alessi
173,173.0,Tagless LysoIP method for molecular profiling of lysosomal content in clinical samples,Alessi,10.1101/2024.05.17.594681,,1.0,W4397293294,A5045437960,Monther Abu-Remaileh,0000-0003-3772-0477,Co-PI,Team Alessi,Monther Abu-Remaileh
190,190.0,Endogenous LRRK2 and PINK1 function in a convergent neuroprotective ciliogenesis pathway in the brain,Alessi,10.1101/2024.06.11.598416,,1.0,W4399592645,A5054181982,Dario R. Alessi,0000-0002-2140-9185,Lead-PI,Team Alessi,Dario Alessi
191,191.0,Endogenous LRRK2 and PINK1 function in a convergent neuroprotective ciliogenesis pathway in the brain,Alessi,10.1101/2024.06.11.598416,,1.0,W4399592645,A5033452410,Suzanne R. Pfeffer,0000-0002-6462-984X,Co-PI,Team Alessi,Suzanne Pfeffer
192,192.0,Endogenous LRRK2 and PINK1 function in a convergent neuroprotective ciliogenesis pathway in the brain,Alessi,10.1101/2024.06.11.598416,,1.0,W4399592645,A5084528692,Miratul M. K. Muqit,0000-0001-9733-2404,Co-PI,Team Alessi,Miratul Muqit
196,196.0,Pathogenic LRRK2 mutations cause loss of primary cilia and Neurturin in striatal Parvalbumin interneurons,Alessi,10.1101/2024.06.17.599289,,1.0,W4399726608,A5033452410,Suzanne R. Pfeffer,0000-0002-6462-984X,Co-PI,Team Alessi,Suzanne Pfeffer
201,201.0,Restoration of striatal neuroprotective pathways by kinase inhibitor treatment of Parkinson’s linked-LRRK2 mutant mice,Alessi,10.1101/2024.07.31.606089,,1.0,W4401316242,A5054181982,Dario R. Alessi,0000-0002-2140-9185,Lead-PI,Team Alessi,Dario Alessi
202,202.0,Restoration of striatal neuroprotective pathways by kinase inhibitor treatment of Parkinson’s linked-LRRK2 mutant mice,Alessi,10.1101/2024.07.31.606089,,1.0,W4401316242,A5033452410,Suzanne R. Pfeffer,0000-0002-6462-984X,Co-PI,Team Alessi,Suzanne Pfeffer
212,212.0,A role for the subthalamic nucleus in aversive learning,Awatramani,10.1101/2023.07.18.549513,10.1016/j.celrep.2023.113328,1.0,W4388335298,A5050070314,Åsa Wallén‐Mackenzie,0000-0002-8713-070X,Collaborating PI,Team Awatramani,Åsa Wallén‐Mackenzie
220,220.0,Excessive firing of dyskinesia-associated striatal direct pathway neurons is gated by dopamine and excitatory synaptic input,Awatramani,10.1101/2022.10.31.514594,10.1016/j.celrep.2024.114483,1.0,W4400735534,A5013611528,Thomas S. Hnasko,0000-0001-6176-8513,Co-PI,Team Awatramani,Thomas Hnasko
222,222.0,Excessive firing of dyskinesia-associated striatal direct pathway neurons is gated by dopamine and excitatory synaptic input,Awatramani,10.1101/2022.10.31.514594,10.1016/j.celrep.2024.114483,1.0,W4400735534,A5015829168,Alexandra Nelson,0000-0002-9305-5662,Co-PI,Team Edwards,Alexandra Nelson
228,228.0,Movement-related increases in subthalamic activity optimize locomotion,Awatramani,10.1101/2023.12.07.570617,10.1016/j.celrep.2024.114495,1.0,W4401057336,A5069851964,Mark D. Bevan,0000-0001-9759-0163,Co-PI,Team Awatramani,Mark Bevan
231,231.0,Molecular heterogeneity in the substantia nigra: A roadmap for understanding PD motor pathophysiology - PubMed (nih.gov),Awatramani,review,10.1016/j.nbd.2022.105925,0.0,W4309078860,A5035273874,Daniel A. Dombeck,0000-0003-2576-5918,Co-PI,Team Awatramani,Daniel Dombeck
232,232.0,Molecular heterogeneity in the substantia nigra: A roadmap for understanding PD motor pathophysiology - PubMed (nih.gov),Awatramani,review,10.1016/j.nbd.2022.105925,0.0,W4309078860,A5082378596,Rajeshwar Awatramani,0000-0002-0713-2140,Lead-PI,Team Awatramani,Rajeshwar Awatramani
236,236.0,"Concerning neuromodulation as treatment of neurological and neuropsychiatric disorder: Insights gained from selective targeting of the subthalamic nucleus, para-subthalamic nucleus and zona incerta in rodents",Awatramani,NA_Review,10.1016/j.neuropharm.2024.110003,0.0,W4398194745,A5050070314,Åsa Wallén‐Mackenzie,0000-0002-8713-070X,Collaborating PI,Team Awatramani,Åsa Wallén‐Mackenzie
249,249.0,Unique functional responses differentially map onto genetic subtypes of dopamine neurons,Awatramani,10.1101/2022.12.19.521076,10.1038/s41593-023-01401-9,1.0,W4385543838,A5082378596,Rajeshwar Awatramani,0000-0002-0713-2140,Lead-PI,Team Awatramani,Rajeshwar Awatramani
250,250.0,Unique functional responses differentially map onto genetic subtypes of dopamine neurons,Awatramani,10.1101/2022.12.19.521076,10.1038/s41593-023-01401-9,1.0,W4385543838,A5035273874,Daniel A. Dombeck,0000-0003-2576-5918,Co-PI,Team Awatramani,Daniel Dombeck
260,260.0,"R1441C and G2019S LRRK2 knockin mice have distinct striatal molecular, physiological, and behavioral alterations",Awatramani,10.1101/2020.03.11.986455,10.1038/s42003-022-04136-8,1.0,W4309076165,A5066027781,Loukia Parisiadou,0000-0002-2569-4200,Co-PI,Team Awatramani,Loukia Parisiadou
263,263.0,LRRK2 at Striatal Synapses: Cell-Type Specificity and Mechanistic Insights,Awatramani,NA Review,10.3390/cells11010169,0.0,W4205765336,A5066027781,Loukia Parisiadou,0000-0002-2569-4200,Co-PI,Team Awatramani,Loukia Parisiadou
268,268.0,Proportion and distribution of neurotransmitter-defined cell types in the ventral tegmental area and substantia nigra pars compacta,Awatramani,10.1101/2024.02.28.582356,,1.0,W4392291506,A5013611528,Thomas S. Hnasko,0000-0001-6176-8513,Co-PI,Team Awatramani,Thomas Hnasko
279,279.0,LRRK2 mediates haloperidol-induced changes in indirect pathway striatal projection neurons,Awatramani,10.1101/2024.06.06.597594,,1.0,W4399456209,A5066027781,Loukia Parisiadou,0000-0002-2569-4200,Co-PI,Team Awatramani,Loukia Parisiadou
286,286.0,Molecular and spatial transcriptomic classification of midbrain dopamine neurons and their alterations in a LRRK2G2019S model of Parkinson’s disease,Awatramani,10.1101/2024.06.06.597807,,1.0,W4399457078,A5035273874,Daniel A. Dombeck,0000-0003-2576-5918,Co-PI,Team Awatramani,Daniel Dombeck
287,287.0,Molecular and spatial transcriptomic classification of midbrain dopamine neurons and their alterations in a LRRK2G2019S model of Parkinson’s disease,Awatramani,10.1101/2024.06.06.597807,,1.0,W4399457078,A5066027781,Loukia Parisiadou,0000-0002-2569-4200,Co-PI,Team Awatramani,Loukia Parisiadou
289,289.0,Molecular and spatial transcriptomic classification of midbrain dopamine neurons and their alterations in a LRRK2G2019S model of Parkinson’s disease,Awatramani,10.1101/2024.06.06.597807,,1.0,W4399457078,A5082378596,Rajeshwar Awatramani,0000-0002-0713-2140,Lead-PI,Team Awatramani,Rajeshwar Awatramani
300,300.0,Spatial transcriptomics reveals molecular dysfunction associated with Lewy pathology,Biederer,10.1101/2023.05.17.541144,10.1038/s41467-024-47027-8,1.0,W4393196586,A5034385515,Michael X. Henderson,0000-0001-9710-0726,Co-PI,Team Biederer,Michael Henderson
301,301.0,Spatial transcriptomics reveals molecular dysfunction associated with Lewy pathology,Biederer,10.1101/2023.05.17.541144,10.1038/s41467-024-47027-8,1.0,W4393196586,A5034385515,Michael X. Henderson,0000-0001-9710-0726,Co-PI,Team Lee,Michael Henderson
304,304.0,Vibrational Stabilization of Cluster Synchronization in Oscillator Networks,Biederer,10.48550/arXiv.2308.07302,10.1109/ojcsys.2023.3331195,1.0,W4388505368,A5009266404,Danielle S. Bassett,0000-0002-6183-4493,Collaborating PI,Team Biederer,Danielle Bassett
320,320.0,LRRK2 kinase inhibition reverses G2019S mutation-dependent effects on tau pathology spread,Biederer,10.1101/2023.10.06.561190,10.1186/s40035-024-00403-2,1.0,W4392375298,A5034385515,Michael X. Henderson,0000-0001-9710-0726,Co-PI,Team Biederer,Michael Henderson
321,321.0,LRRK2 kinase inhibition reverses G2019S mutation-dependent effects on tau pathology spread,Biederer,10.1101/2023.10.06.561190,10.1186/s40035-024-00403-2,1.0,W4392375298,A5034385515,Michael X. Henderson,0000-0001-9710-0726,Co-PI,Team Lee,Michael Henderson
325,325.0,Vibrational Stabilization of Complex Network Systems,Biederer,10.48550/arXiv.2308.05823,10.23919/acc55779.2023.10156032,1.0,W4382936236,A5009266404,Danielle S. Bassett,0000-0002-6183-4493,Collaborating PI,Team Biederer,Danielle Bassett
334,334.0,Cortico-amygdala synaptic structural abnormalities produced by templated aggregation of α-synuclein,Biederer,10.1101/2024.05.15.594419,,1.0,W4396965087,A5049620072,Laura A. Volpicelli‐Daley,0000-0001-8934-4018,Co-PI,Team Biederer,Laura Volpicelli‐Daley
338,338.0,Vibrational Control of Complex Networks,Biederer,10.48550/arXiv.2408.08263,,1.0,W4406024079,A5009266404,Danielle S. Bassett,0000-0002-6183-4493,Collaborating PI,Team Biederer,Danielle Bassett
341,341.0,The integrated stress response in brain diseases: a double-edged sword for proteostasis and synapses,Calakos,NA_Review,10.1016/j.conb.2024.102886,0.0,W4399795832,A5085465113,Nicole Calakos,0000-0002-9918-3294,Lead-PI,Team Calakos,Nicole Calakos
347,347.0,SynBot: An open-source image analysis software for automated quantification of synapses,Calakos,10.1101/2023.06.26.546578,10.1016/j.crmeth.2024.100861,1.0,W4402357127,A5017962710,Çağla Eroğlu,0000-0002-7204-0218,Co-PI,Team Calakos,Çağla Eroğlu
350,350.0,An open-source head-fixation and implant-protection system for mice,Calakos,NA_hardware article,10.1016/j.ohx.2022.e00391,0.0,W4313219376,A5078373067,Michael R. Tadross,0000-0002-7752-6380,Co-PI,Team Calakos,Michael Tadross
357,357.0,GEARBOCS: An Adeno Associated Virus Tool for In Vivo Gene Editing in Astrocytes,Calakos,10.1101/2023.01.17.524433,,1.0,W4317490316,A5017962710,Çağla Eroğlu,0000-0002-7204-0218,Co-PI,Team Calakos,Çağla Eroğlu
369,369.0,Astrocytic LRRK2 Controls Synaptic Connectivity through ERM Phosphorylation,Calakos,10.1101/2023.04.09.536178,,1.0,W4363676015,A5080635428,Scott H. Soderling,0000-0001-7808-197X,Co-PI,Team Calakos,Scott Soderling
371,371.0,Astrocytic LRRK2 Controls Synaptic Connectivity through ERM Phosphorylation,Calakos,10.1101/2023.04.09.536178,,1.0,W4363676015,A5017962710,Çağla Eroğlu,0000-0002-7204-0218,Co-PI,Team Calakos,Çağla Eroğlu
376,376.0,Reward perseveration is shaped by GABAA-mediated dopamine pauses,Calakos,10.1101/2024.05.09.593320,,1.0,W4396811761,A5078373067,Michael R. Tadross,0000-0002-7752-6380,Co-PI,Team Calakos,Michael Tadross
384,384.0,Peripheral MC1R activation modulates immune responses and is neuroprotective in a mouse model of Parkinson's disease,Chen,10.21203/rs.3.rs-3042571/v1,10.1007/s11481-023-10094-7,1.0,W4389947944,A5071360122,Weiyi Peng,0000-0002-7785-6240,Co-PI,Team Chen,Weiyi Peng
386,386.0,Peripheral MC1R activation modulates immune responses and is neuroprotective in a mouse model of Parkinson's disease,Chen,10.21203/rs.3.rs-3042571/v1,10.1007/s11481-023-10094-7,1.0,W4389947944,A5041777746,Michael A. Schwarzschild,0000-0001-6019-8280,Co-PI,Team Chen,Michael Schwarzschild
387,387.0,Peripheral MC1R activation modulates immune responses and is neuroprotective in a mouse model of Parkinson's disease,Chen,10.21203/rs.3.rs-3042571/v1,10.1007/s11481-023-10094-7,1.0,W4389947944,A5012470875,Xiqun Chen,0000-0001-8582-8891,Lead-PI,Team Chen,Xiqun Chen
400,400.0,DOPA pheomelanin is increased in nigral neuromelanin of Parkinson’s disease,Chen,10.1101/2022.06.30.22277063,10.1016/j.pneurobio.2023.102414,1.0,W4319071820,A5031896665,Xiqun Chen,0000-0001-8285-084X,Lead-PI,Team Chen,Xiqun Chen
404,404.0,Parkinson’s disease and cancer: a systematic review and meta-analysis of over 17 million participants,Chen,missing,10.1136/bmjopen-2020-046329,1.0,W3177121370,A5031896665,Xiqun Chen,0000-0001-8285-084X,Lead-PI,Team Chen,Xiqun Chen
415,415.0,Melanocortin 1 receptor activation protects against alpha-synuclein pathologies in models of Parkinson’s disease,Chen,10.21203/rs.3.rs-286792/v1,10.1186/s13024-022-00520-4,1.0,W4214701465,A5041777746,Michael A. Schwarzschild,0000-0001-6019-8280,Co-PI,Team Chen,Michael Schwarzschild
416,416.0,Melanocortin 1 receptor activation protects against alpha-synuclein pathologies in models of Parkinson’s disease,Chen,10.21203/rs.3.rs-286792/v1,10.1186/s13024-022-00520-4,1.0,W4214701465,A5012470875,Xiqun Chen,0000-0001-8582-8891,Lead-PI,Team Chen,Xiqun Chen
417,417.0,Oncogenic BRAFV600E induces microglial proliferation through extracellular signal-regulated kinase and neuronal death through c-Jun N-terminal kinase,Chen,10.21203/rs.3.rs-220057/v2,10.4103/1673-5374.361516,1.0,W4312195675,A5012470875,Xiqun Chen,0000-0001-8582-8891,Lead-PI,Team Chen,Xiqun Chen
432,432.0,LRRK2 G2019S mutation suppresses differentiation of Th9 and Treg cells via JAK/STAT3,Chen,10.1101/2024.02.28.582561,,1.0,W4392571096,A5041777746,Michael A. Schwarzschild,0000-0001-6019-8280,Co-PI,Team Chen,Michael Schwarzschild
433,433.0,LRRK2 G2019S mutation suppresses differentiation of Th9 and Treg cells via JAK/STAT3,Chen,10.1101/2024.02.28.582561,,1.0,W4392571096,A5012470875,Xiqun Chen,0000-0001-8582-8891,Lead-PI,Team Chen,Xiqun Chen
434,434.0,LRRK2 G2019S mutation suppresses differentiation of Th9 and Treg cells via JAK/STAT3,Chen,10.1101/2024.02.28.582561,,1.0,W4392571096,A5071360122,Weiyi Peng,0000-0002-7785-6240,Co-PI,Team Chen,Weiyi Peng
445,445.0,"Single cell spatial transcriptomic and translatomic profiling of dopaminergic neurons in health, ageing and disease",Cragg,10.1101/2023.04.20.537553,10.1016/j.celrep.2024.113784,1.0,W4392010121,A5028723665,Richard Wade‐Martins,0000-0001-6691-580X,Co-PI,Team Cragg,Richard Wade‐Martins
456,456.0,"Targeted micro-fiber arrays for measuring and manipulating localized multi-scale neural dynamics over large, deep brain volumes during behavior",Cragg,10.1101/2023.11.17.567425,10.1016/j.neuron.2023.12.011,1.0,W4391056187,A5100428710,Yulong Li,0000-0002-9166-9919,Collaborating PI,Team Cragg,Yulong Li
458,458.0,"Targeted micro-fiber arrays for measuring and manipulating localized multi-scale neural dynamics over large, deep brain volumes during behavior",Cragg,10.1101/2023.11.17.567425,10.1016/j.neuron.2023.12.011,1.0,W4391056187,A5080490976,Lin Tian,0000-0001-7012-6926,Collaborating PI,Team Gradinaru,Lin Tian
461,461.0,"Targeted micro-fiber arrays for measuring and manipulating localized multi-scale neural dynamics over large, deep brain volumes during behavior",Cragg,10.1101/2023.11.17.567425,10.1016/j.neuron.2023.12.011,1.0,W4391056187,A5003078833,Mark W. Howe,0000-0002-6865-5084,Co-PI,Team Cragg,Mark Howe
475,475.0,Early deficits in an in vitro striatal microcircuit model carrying the Parkinson’s GBA-N370S mutation | npj Parkinson's Disease (springer.com),Cragg,10.1101/2023.03.01.530566,10.1038/s41531-024-00694-2,1.0,W4394753925,A5028723665,Richard Wade‐Martins,0000-0001-6691-580X,Co-PI,Team Cragg,Richard Wade‐Martins
480,480.0,A fluid-walled microfluidic platform for human neuron microcircuits and directed axotomy | bioRxiv,Cragg,10.1101/2023.10.14.562004,10.1039/d4lc00107a,1.0,W4399401317,A5028723665,Richard Wade‐Martins,0000-0001-6691-580X,Co-PI,Team Cragg,Richard Wade‐Martins
483,483.0,Impaired dopamine release in Parkinson’s disease,Cragg,review,10.1093/brain/awad064,0.0,W4323036321,A5087084011,Stephanie J. Cragg,0000-0001-9677-2256,Lead-PI,Team Cragg,Stephanie Cragg
484,484.0,Impaired dopamine release in Parkinson’s disease,Cragg,review,10.1093/brain/awad064,0.0,W4323036321,A5028723665,Richard Wade‐Martins,0000-0001-6691-580X,Co-PI,Team Cragg,Richard Wade‐Martins
494,494.0,Inhibition of striatal dopamine release by the L-type calcium channel inhibitor isradipine co-varies with risk factors for Parkinson’s,Cragg,10.1101/2020.07.03.186411,10.1111/ejn.16180,1.0,W4388535022,A5028723665,Richard Wade‐Martins,0000-0001-6691-580X,Co-PI,Team Cragg,Richard Wade‐Martins
495,495.0,Inhibition of striatal dopamine release by the L-type calcium channel inhibitor isradipine co-varies with risk factors for Parkinson’s,Cragg,10.1101/2020.07.03.186411,10.1111/ejn.16180,1.0,W4388535022,A5087084011,Stephanie J. Cragg,0000-0001-9677-2256,Lead-PI,Team Cragg,Stephanie Cragg
500,500.0,Unconventional secretion of α-synuclein mediated by palmitoylated DNAJC5 oligomers,Cragg,10.1101/2022.01.27.477991,10.7554/eLife.85837,1.0,W4313988037,A5028723665,Richard Wade‐Martins,0000-0001-6691-580X,Co-PI,Team Cragg,Richard Wade‐Martins
507,507.0,Sst+ GPi output neurons provide direct feedback to key nodes of the basal ganglia and drive behavioral flexibility,Cragg,10.1101/2022.03.16.484460,,1.0,W4220818899,A5004457607,Konstantinos Meletis,0000-0001-5665-4781,Co-PI,Team Cragg,Konstantinos Meletis
514,514.0,An axonal brake on striatal dopamine output by cholinergic interneurons,Cragg,10.1101/2024.02.17.580796,,1.0,W4392201373,A5061736694,Michael Z. Lin,0000-0002-0492-1961,Collaborating PI,Team Cragg,Michael Lin
518,518.0,An axonal brake on striatal dopamine output by cholinergic interneurons,Cragg,10.1101/2024.02.17.580796,,1.0,W4392201373,A5087084011,Stephanie J. Cragg,0000-0001-9677-2256,Lead-PI,Team Cragg,Stephanie Cragg
526,526.0,Rapid modulation of striatal cholinergic interneurons and dopamine release by satellite astrocytes,Cragg,10.1101/2024.05.15.594341,,1.0,W4396975587,A5015406158,Peter J. Magill,0000-0001-7141-7071,Co-PI,Team Cragg,Peter Magill
528,528.0,Rapid modulation of striatal cholinergic interneurons and dopamine release by satellite astrocytes,Cragg,10.1101/2024.05.15.594341,,1.0,W4396975587,A5087084011,Stephanie J. Cragg,0000-0001-9677-2256,Lead-PI,Team Cragg,Stephanie Cragg
535,535.0,Spatially organized striatum-wide acetylcholine dynamics for the learning and extinction of Pavlovian cues and actions,Cragg,10.1101/2024.07.10.602947,,1.0,W4400672529,A5003078833,Mark W. Howe,0000-0002-6865-5084,Co-PI,Team Cragg,Mark Howe
537,537.0,Insights into VPS13 properties and function reveal a new mechanism of eukaryotic lipid transport,De Camilli,NA Review,10.1016/j.bbalip.2021.159003,0.0,W3181271241,A5059224100,Karin M. Reinisch,0000-0001-9140-6150,Co-PI,Team De Camilli,Karin Reinisch
538,538.0,Insights into VPS13 properties and function reveal a new mechanism of eukaryotic lipid transport,De Camilli,NA Review,10.1016/j.bbalip.2021.159003,0.0,W3181271241,A5037459294,Pietro De Camilli,0000-0001-9045-0723,Lead PI,Team De Camilli,Pietro Camilli
552,552.0,Presynaptic autophagy is coupled to the synaptic vesicle cycle via ATG-9,De Camilli,10.1101/2020.12.28.424508,10.1016/j.neuron.2021.12.031,1.0,W4220988819,A5037459294,Pietro De Camilli,0000-0001-9045-0723,Lead PI,Team De Camilli,Pietro Camilli
559,559.0,Mutations in Parkinsonism-linked endocytic proteins synaptojanin1 and auxilin have synergistic effects on dopaminergic axonal pathology,De Camilli,10.1101/2022.02.28.482419,10.1038/s41531-023-00465-5,1.0,W4321002449,A5037459294,Pietro De Camilli,0000-0001-9045-0723,Lead PI,Team De Camilli,Pietro Camilli
563,563.0,Lysosomal TBK1 Responds to Amino Acid Availability to Relieve Rab7-Dependent mTORC1 Inhibition | bioRxiv,De Camilli,10.1101/2023.12.16.571979,10.1038/s44318-024-00180-8,1.0,W4401332739,A5091271525,Shawn M. Ferguson,0000-0002-3092-7718,Co-PI,Team De Camilli,Shawn Ferguson
569,569.0,In situ architecture of the lipid transport protein VPS13C at ER–lysosome membrane contacts,De Camilli,10.1101/2022.03.08.482579,10.1073/pnas.2203769119,1.0,W4285088070,A5037459294,Pietro De Camilli,0000-0001-9045-0723,Lead PI,Team De Camilli,Pietro Camilli
571,571.0,LRRK2 suppresses lysosome degradative activity in macrophages and microglia through MiT-TFE transcription factor inhibition | PNAS,De Camilli,10.1101/2022.12.17.520834,10.1073/pnas.2303789120,1.0,W4385191034,A5091271525,Shawn M. Ferguson,0000-0002-3092-7718,Co-PI,Team De Camilli,Shawn Ferguson
579,579.0,Membrane remodeling properties of the Parkinson’s disease protein LRRK2 | PNAS,De Camilli,10.1101/2022.08.10.503505,10.1073/pnas.2309698120,1.0,W4387665107,A5037459294,Pietro De Camilli,0000-0001-9045-0723,Lead PI,Team De Camilli,Pietro Camilli
587,587.0,iATPSnFR2: a high dynamic range fluorescent sensor for monitoring intracellular ATP,De Camilli,10.1101/2023.08.24.554624,10.1073/pnas.2314604121,1.0,W4396919562,A5051928889,Timothy A. Ryan,0000-0003-2533-9548,Co-PI,Team De Camilli,Timothy Ryan
592,592.0,Parkinsonism Sac domain mutation in Synaptojanin-1 affects ciliary properties in iPSC-derived dopaminergic neurons,De Camilli,10.1101/2023.10.12.562142,10.1073/pnas.2318943121,1.0,W4394909958,A5037459294,Pietro De Camilli,0000-0001-9045-0723,Lead PI,Team De Camilli,Pietro Camilli
598,598.0,VPS13D bridges the ER to mitochondria and peroxisomes via Miro,De Camilli,10.1101/2020.10.07.328906,10.1083/jcb.202010004,1.0,W3156441532,A5037459294,Pietro De Camilli,0000-0001-9045-0723,Lead PI,Team De Camilli,Pietro Camilli
605,605.0,ER-lysosome lipid transfer protein VPS13C/PARK23 prevents aberrant mtDNA-dependent STING signaling,De Camilli,10.1101/2021.06.08.447593,10.1083/jcb.202106046,1.0,W4281946664,A5091271525,Shawn M. Ferguson,0000-0002-3092-7718,Co-PI,Team De Camilli,Shawn Ferguson
607,607.0,ER-lysosome lipid transfer protein VPS13C/PARK23 prevents aberrant mtDNA-dependent STING signaling,De Camilli,10.1101/2021.06.08.447593,10.1083/jcb.202106046,1.0,W4281946664,A5037459294,Pietro De Camilli,0000-0001-9045-0723,Lead PI,Team De Camilli,Pietro Camilli
611,611.0,SHIP164 is a chorein motif lipid transfer protein that controls endosome–Golgi membrane traffic,De Camilli,10.1101/2021.11.04.467353,10.1083/jcb.202111018,1.0,W4225282945,A5059224100,Karin M. Reinisch,0000-0001-9140-6150,Co-PI,Team De Camilli,Karin Reinisch
612,612.0,SHIP164 is a chorein motif lipid transfer protein that controls endosome–Golgi membrane traffic,De Camilli,10.1101/2021.11.04.467353,10.1083/jcb.202111018,1.0,W4225282945,A5037459294,Pietro De Camilli,0000-0001-9045-0723,Lead PI,Team De Camilli,Pietro Camilli
616,616.0,Structural and biochemical insights into lipid transport by VPS13 proteins,De Camilli,10.1101/2022.03.11.484024,10.1083/jcb.202202030,1.0,W4221090868,A5059224100,Karin M. Reinisch,0000-0001-9140-6150,Co-PI,Team De Camilli,Karin Reinisch
622,622.0,Mitoguardin-2–mediated lipid transfer preserves mitochondrial morphology and lipid droplet formation,De Camilli,10.1101/2022.07.08.499339,10.1083/jcb.202207022,1.0,W4307585140,A5038262390,Kallol Gupta,0000-0002-3557-3242,Co-PI,Team De Camilli,Kallol Gupta
623,623.0,Mitoguardin-2–mediated lipid transfer preserves mitochondrial morphology and lipid droplet formation,De Camilli,10.1101/2022.07.08.499339,10.1083/jcb.202207022,1.0,W4307585140,A5019657763,Thomas J. Melia,0000-0002-5798-4624,Collaborating PI,Team De Camilli,Thomas Melia
624,624.0,Mitoguardin-2–mediated lipid transfer preserves mitochondrial morphology and lipid droplet formation,De Camilli,10.1101/2022.07.08.499339,10.1083/jcb.202207022,1.0,W4307585140,A5059224100,Karin M. Reinisch,0000-0001-9140-6150,Co-PI,Team De Camilli,Karin Reinisch
626,626.0,"Endoplasmic Reticulum Membrane Contact Sites, Lipid Transport, and Neurodegeneration",De Camilli,NA review,10.1101/cshperspect.a041257,0.0,W4296290327,A5037459294,Pietro De Camilli,0000-0001-9045-0723,Lead PI,Team De Camilli,Pietro Camilli
633,633.0,Phosphoglycerate kinase is a central leverage point in Parkinson’s Disease driven neuronal metabolic deficits | bioRxiv,De Camilli,10.1101/2023.10.10.561760,10.1126/sciadv.adn6016,1.0,W4401724314,A5027250646,Michael G. Kaplitt,0000-0002-8979-2459,Lead-PI,Team Kaplitt,Michael Kaplitt
634,634.0,Phosphoglycerate kinase is a central leverage point in Parkinson’s Disease driven neuronal metabolic deficits | bioRxiv,De Camilli,10.1101/2023.10.10.561760,10.1126/sciadv.adn6016,1.0,W4401724314,A5037459294,Pietro De Camilli,0000-0001-9045-0723,Lead PI,Team De Camilli,Pietro Camilli
635,635.0,Phosphoglycerate kinase is a central leverage point in Parkinson’s Disease driven neuronal metabolic deficits | bioRxiv,De Camilli,10.1101/2023.10.10.561760,10.1126/sciadv.adn6016,1.0,W4401724314,A5051928889,Timothy A. Ryan,0000-0003-2533-9548,Co-PI,Team De Camilli,Timothy Ryan
638,638.0,"RBG Motif Bridge-Like Lipid Transport Proteins: Structure, Functions, and Open Questions",De Camilli,review,10.1146/annurev-cellbio-120420-014634,0.0,W4383198320,A5037459294,Pietro De Camilli,0000-0001-9045-0723,Lead PI,Team De Camilli,Pietro Camilli
641,641.0,"Erythroid Differentiation Dependent Interaction of VPS13A with XK at the Plasma Membrane of K562 Cells - Chase Amos, Peng Xu, Pietro De Camilli, 2023 (sagepub.com)",De Camilli,10.1101/2023.08.09.552634,10.1177/25152564231215133,1.0,W4390118003,A5037459294,Pietro De Camilli,0000-0001-9045-0723,Lead PI,Team De Camilli,Pietro Camilli
642,642.0,"A possible role for VPS13-family proteins in bulk lipid transfer, membrane expansion and organelle biogenesis",De Camilli,review,10.1242/jcs.259357,0.0,W4221056627,A5019657763,Thomas J. Melia,0000-0002-5798-4624,Collaborating PI,Team De Camilli,Thomas Melia
643,643.0,"A possible role for VPS13-family proteins in bulk lipid transfer, membrane expansion and organelle biogenesis",De Camilli,review,10.1242/jcs.259357,0.0,W4221056627,A5059224100,Karin M. Reinisch,0000-0001-9140-6150,Co-PI,Team De Camilli,Karin Reinisch
646,646.0,A STING-CASM-GABARAP Pathway Activates LRRK2 at Lysosomes | bioRxiv,De Camilli,10.1101/2023.10.31.564602,,1.0,W4388141595,A5091271525,Shawn M. Ferguson,0000-0002-3092-7718,Co-PI,Team De Camilli,Shawn Ferguson
649,649.0,Isolation and Lipidomic Profiling of Neuronal Lipid Droplets: Unveiling the Lipid Landscape for insights into Neurodegenerative Disorders,De Camilli,10.1101/2023.12.13.571527,,1.0,W4389722926,A5038262390,Kallol Gupta,0000-0002-3557-3242,Co-PI,Team De Camilli,Kallol Gupta
650,650.0,Isolation and Lipidomic Profiling of Neuronal Lipid Droplets: Unveiling the Lipid Landscape for insights into Neurodegenerative Disorders,De Camilli,10.1101/2023.12.13.571527,,1.0,W4389722926,A5051928889,Timothy A. Ryan,0000-0003-2533-9548,Co-PI,Team De Camilli,Timothy Ryan
663,663.0,VPS13B is localized at the cis-trans Golgi complex interface and is a functional partner of FAM177A1 | bioRxiv,De Camilli,10.1101/2023.12.18.572081,,1.0,W4389903301,A5037459294,Pietro De Camilli,0000-0001-9045-0723,Lead PI,Team De Camilli,Pietro Camilli
678,678.0,A proteome-wide quantitative platform for nanoscale spatially resolved extraction of membrane proteins into native nanodiscs,De Camilli,10.1101/2024.02.10.579775,,1.0,W4391757018,A5038262390,Kallol Gupta,0000-0002-3557-3242,Co-PI,Team De Camilli,Kallol Gupta
688,688.0,Lysosome damage triggers acute formation of ER to lysosomes membrane tethers mediated by the bridge-like lipid transport protein VPS13C,De Camilli,10.1101/2024.06.08.598070,,1.0,W4399456222,A5054181982,Dario R. Alessi,0000-0002-2140-9185,Lead-PI,Team Alessi,Dario Alessi
689,689.0,Lysosome damage triggers acute formation of ER to lysosomes membrane tethers mediated by the bridge-like lipid transport protein VPS13C,De Camilli,10.1101/2024.06.08.598070,,1.0,W4399456222,A5091271525,Shawn M. Ferguson,0000-0002-3092-7718,Co-PI,Team De Camilli,Shawn Ferguson
690,690.0,Lysosome damage triggers acute formation of ER to lysosomes membrane tethers mediated by the bridge-like lipid transport protein VPS13C,De Camilli,10.1101/2024.06.08.598070,,1.0,W4399456222,A5037459294,Pietro De Camilli,0000-0001-9045-0723,Lead PI,Team De Camilli,Pietro Camilli
692,692.0,Microbes and Parkinson’s disease: from associations to mechanisms: Trends in Microbiology (cell.com),Desjardins,review,10.1016/j.tim.2022.01.004,0.0,W4210482530,A5007887366,Samantha Gruenheid,0000-0002-0908-6715,Co-PI,Team Desjardins,Samantha Gruenheid
708,708.0,Synaptotagmin-1-dependent phasic axonal dopamine release is dispensable for basic motor behaviors in mice,Desjardins,10.1101/2021.09.15.460511,10.1038/s41467-023-39805-7,1.0,W4383888069,A5024580674,Louis‐Éric Trudeau,0000-0003-4684-1377,Co-PI,Team Desjardins,Louis‐Éric Trudeau
715,715.0,Comparative analysis of methods to reduce activation signature gene expression in PBMCs,Desjardins,10.1101/2023.07.31.549036,10.1038/s41598-023-49611-2,1.0,W4390338919,A5074478086,Jo Anne Stratton,0000-0002-1205-1353,Collaborating PI,Team Desjardins,Jo Stratton
723,723.0,Characterizing enteric neurons in dopamine transporter (DAT)-Cre reporter mice reveals dopaminergic subtypes with dual-transmitter content,Desjardins,10.1101/2023.06.16.545271,10.1111/ejn.16307,1.0,W4392852013,A5007887366,Samantha Gruenheid,0000-0002-0908-6715,Co-PI,Team Desjardins,Samantha Gruenheid
724,724.0,Characterizing enteric neurons in dopamine transporter (DAT)-Cre reporter mice reveals dopaminergic subtypes with dual-transmitter content,Desjardins,10.1101/2023.06.16.545271,10.1111/ejn.16307,1.0,W4392852013,A5024580674,Louis‐Éric Trudeau,0000-0003-4684-1377,Co-PI,Team Desjardins,Louis‐Éric Trudeau
725,725.0,Characterizing enteric neurons in dopamine transporter (DAT)-Cre reporter mice reveals dopaminergic subtypes with dual-transmitter content,Desjardins,10.1101/2023.06.16.545271,10.1111/ejn.16307,1.0,W4392852013,A5074478086,Jo Anne Stratton,0000-0002-1205-1353,Collaborating PI,Team Desjardins,Jo Stratton
735,735.0,LRRK2 regulates the activation of the unfolded protein response and antigen presentation in macrophages during inflammation,Desjardins,10.1101/2023.06.14.545012,,1.0,W4380675113,A5037740355,Erwin Schurr,0000-0002-2640-536X,Collaborating PI,Team Desjardins,Erwin Schurr
737,737.0,LRRK2 regulates the activation of the unfolded protein response and antigen presentation in macrophages during inflammation,Desjardins,10.1101/2023.06.14.545012,,1.0,W4380675113,A5009187210,Pierre Thibault,0000-0001-5993-0331,Collaborating PI,Team Desjardins,Pierre Thibault
738,738.0,LRRK2 regulates the activation of the unfolded protein response and antigen presentation in macrophages during inflammation,Desjardins,10.1101/2023.06.14.545012,,1.0,W4380675113,A5007887366,Samantha Gruenheid,0000-0002-0908-6715,Co-PI,Team Desjardins,Samantha Gruenheid
739,739.0,LRRK2 regulates the activation of the unfolded protein response and antigen presentation in macrophages during inflammation,Desjardins,10.1101/2023.06.14.545012,,1.0,W4380675113,A5074688125,Heidi M. McBride,0000-0003-4666-2280,Co-PI,Team Desjardins,Heidi McBride
740,740.0,LRRK2 regulates the activation of the unfolded protein response and antigen presentation in macrophages during inflammation,Desjardins,10.1101/2023.06.14.545012,,1.0,W4380675113,A5086104642,Michel Desjardins,0000-0002-5684-5980,Lead-PI,Team Desjardins,Michel Desjardins
746,746.0,Parkinson’s genes orchestrate pyroptosis through selective trafficking of mtDNA to leaky lysosomes | bioRxiv,Desjardins,10.1101/2023.09.11.557213,,1.0,W4386638944,A5086104642,Michel Desjardins,0000-0002-5684-5980,Lead-PI,Team Desjardins,Michel Desjardins
747,747.0,Parkinson’s genes orchestrate pyroptosis through selective trafficking of mtDNA to leaky lysosomes | bioRxiv,Desjardins,10.1101/2023.09.11.557213,,1.0,W4386638944,A5074688125,Heidi M. McBride,0000-0003-4666-2280,Co-PI,Team Desjardins,Heidi McBride
763,763.0,Modeling gene-environment interactions in Parkinson’s Disease: Helicobacter pylori infection of Pink1−/− mice induces CD8 T cell-dependent motor and cognitive dysfunction,Desjardins,10.1101/2024.02.25.580545,,1.0,W4392200935,A5009187210,Pierre Thibault,0000-0001-5993-0331,Collaborating PI,Team Desjardins,Pierre Thibault
764,764.0,Modeling gene-environment interactions in Parkinson’s Disease: Helicobacter pylori infection of Pink1−/− mice induces CD8 T cell-dependent motor and cognitive dysfunction,Desjardins,10.1101/2024.02.25.580545,,1.0,W4392200935,A5074688125,Heidi M. McBride,0000-0003-4666-2280,Co-PI,Team Desjardins,Heidi McBride
765,765.0,Modeling gene-environment interactions in Parkinson’s Disease: Helicobacter pylori infection of Pink1−/− mice induces CD8 T cell-dependent motor and cognitive dysfunction,Desjardins,10.1101/2024.02.25.580545,,1.0,W4392200935,A5086104642,Michel Desjardins,0000-0002-5684-5980,Lead-PI,Team Desjardins,Michel Desjardins
766,766.0,Modeling gene-environment interactions in Parkinson’s Disease: Helicobacter pylori infection of Pink1−/− mice induces CD8 T cell-dependent motor and cognitive dysfunction,Desjardins,10.1101/2024.02.25.580545,,1.0,W4392200935,A5074478086,Jo Anne Stratton,0000-0002-1205-1353,Collaborating PI,Team Desjardins,Jo Stratton
767,767.0,Modeling gene-environment interactions in Parkinson’s Disease: Helicobacter pylori infection of Pink1−/− mice induces CD8 T cell-dependent motor and cognitive dysfunction,Desjardins,10.1101/2024.02.25.580545,,1.0,W4392200935,A5052493476,Nathalie Labrecque,0000-0001-7563-1542,Collaborating PI,Team Desjardins,Nathalie Labrecque
768,768.0,Modeling gene-environment interactions in Parkinson’s Disease: Helicobacter pylori infection of Pink1−/− mice induces CD8 T cell-dependent motor and cognitive dysfunction,Desjardins,10.1101/2024.02.25.580545,,1.0,W4392200935,A5007887366,Samantha Gruenheid,0000-0002-0908-6715,Co-PI,Team Desjardins,Samantha Gruenheid
778,778.0,Adoptive transfer of mitochondrial antigen-specific CD8+ T-cells in mice causes parkinsonism and compromises the dopamine system,Desjardins,10.1101/2024.02.26.582098,,1.0,W4392243978,A5074478086,Jo Anne Stratton,0000-0002-1205-1353,Collaborating PI,Team Desjardins,Jo Stratton
779,779.0,Adoptive transfer of mitochondrial antigen-specific CD8+ T-cells in mice causes parkinsonism and compromises the dopamine system,Desjardins,10.1101/2024.02.26.582098,,1.0,W4392243978,A5052493476,Nathalie Labrecque,0000-0001-7563-1542,Collaborating PI,Team Desjardins,Nathalie Labrecque
780,780.0,Adoptive transfer of mitochondrial antigen-specific CD8+ T-cells in mice causes parkinsonism and compromises the dopamine system,Desjardins,10.1101/2024.02.26.582098,,1.0,W4392243978,A5024580674,Louis‐Éric Trudeau,0000-0003-4684-1377,Co-PI,Team Desjardins,Louis‐Éric Trudeau
792,792.0,A rewiring of the earliest immune events leading to T-cell mediated disease following intestinal microbial infection in a PINK1KO mouse model of Parkinson’s disease,Desjardins,10.1101/2024.06.18.598931,,1.0,W4399929413,A5074688125,Heidi M. McBride,0000-0003-4666-2280,Co-PI,Team Desjardins,Heidi McBride
793,793.0,A rewiring of the earliest immune events leading to T-cell mediated disease following intestinal microbial infection in a PINK1KO mouse model of Parkinson’s disease,Desjardins,10.1101/2024.06.18.598931,,1.0,W4399929413,A5024580674,Louis‐Éric Trudeau,0000-0003-4684-1377,Co-PI,Team Desjardins,Louis‐Éric Trudeau
794,794.0,A rewiring of the earliest immune events leading to T-cell mediated disease following intestinal microbial infection in a PINK1KO mouse model of Parkinson’s disease,Desjardins,10.1101/2024.06.18.598931,,1.0,W4399929413,A5007887366,Samantha Gruenheid,0000-0002-0908-6715,Co-PI,Team Desjardins,Samantha Gruenheid
795,795.0,A rewiring of the earliest immune events leading to T-cell mediated disease following intestinal microbial infection in a PINK1KO mouse model of Parkinson’s disease,Desjardins,10.1101/2024.06.18.598931,,1.0,W4399929413,A5074478086,Jo Anne Stratton,0000-0002-1205-1353,Collaborating PI,Team Desjardins,Jo Stratton
797,797.0,Alterations in neurotransmitter co-release in Parkinson's disease,Edwards,NA_review,10.1016/j.expneurol.2023.114562,0.0,W4387373549,A5029464086,Christopher Ford,0000-0002-4175-2933,Collaborating PI,Team Edwards,Christopher Ford
799,799.0,Role of dopamine neuron activity in Parkinson's disease pathophysiology,Edwards,NA_review,10.1016/j.expneurol.2023.114645,0.0,W4389537908,A5081058318,Ken Nakamura,0000-0002-9192-182X,Co-PI,Team Edwards,Ken Nakamura
801,801.0,The role of α-synuclein in exocytosis,Edwards,NA_review,10.1016/j.expneurol.2023.114668,0.0,W4390168938,A5027616900,Robert H. Edwards,0000-0002-8650-3260,Lead-PI,Team Edwards,Robert Edwards
804,804.0,Dopamine across timescales and cell types: Relevance for phenotypes in Parkinson's disease progression,Edwards,NA_review,10.1016/j.expneurol.2024.114693,0.0,W4391055627,A5015829168,Alexandra Nelson,0000-0002-9305-5662,Co-PI,Team Edwards,Alexandra Nelson
805,805.0,Dopamine across timescales and cell types: Relevance for phenotypes in Parkinson's disease progression,Edwards,NA_review,10.1016/j.expneurol.2024.114693,0.0,W4391055627,A5042504580,Talia N. Lerner,0000-0002-3875-0654,Co-PI,Team Edwards,Talia Lerner
809,809.0,Systems-level analyses dissociate genetic regualtors of reactive oxygen species and energy production,Edwards,10.1101/2023.10.14.562276,10.1073/pnas.2307904121,1.0,W4390734167,A5081058318,Ken Nakamura,0000-0002-9192-182X,Co-PI,Team Edwards,Ken Nakamura
817,817.0,Adaptor protein-3 produces synaptic vesicles that release phasic dopamine | PNAS,Edwards,10.1101/2023.08.07.552338,10.1073/pnas.2309843120,1.0,W4387448734,A5015829168,Alexandra Nelson,0000-0002-9305-5662,Co-PI,Team Edwards,Alexandra Nelson
819,819.0,Adaptor protein-3 produces synaptic vesicles that release phasic dopamine | PNAS,Edwards,10.1101/2023.08.07.552338,10.1073/pnas.2309843120,1.0,W4387448734,A5029464086,Christopher Ford,0000-0002-4175-2933,Collaborating PI,Team Edwards,Christopher Ford
820,820.0,Adaptor protein-3 produces synaptic vesicles that release phasic dopamine | PNAS,Edwards,10.1101/2023.08.07.552338,10.1073/pnas.2309843120,1.0,W4387448734,A5027616900,Robert H. Edwards,0000-0002-8650-3260,Lead-PI,Team Edwards,Robert Edwards
828,828.0,Therapeutic deep brain stimulation disrupts movement-related subthalamic nucleus activity in parkinsonian mice,Edwards,10.1101/2021.11.12.468404,10.7554/eLife.75253,1.0,W4283795759,A5015829168,Alexandra Nelson,0000-0002-9305-5662,Co-PI,Team Edwards,Alexandra Nelson
830,830.0,M4-mediated cholinergic transmission is reduced in parkinsonian mice and its restoration alleviates motor deficits and levodopa-induced dyskinesia,Edwards,10.1101/2023.08.23.554510,,1.0,W4386117919,A5029464086,Christopher Ford,0000-0002-4175-2933,Collaborating PI,Team Edwards,Christopher Ford
834,834.0,Inhibition of Indirect Pathway Activity Causes Abnormal Decision-Making In a Mouse Model of Impulse Control Disorder in Parkinson’s Disease,Edwards,10.1101/2024.02.19.581062,,1.0,W4392200679,A5015829168,Alexandra Nelson,0000-0002-9305-5662,Co-PI,Team Edwards,Alexandra Nelson
851,851.0,Chronic hyperactivation of midbrain dopamine neurons causes preferential dopamine neuron degeneration,Edwards,10.1101/2024.04.05.588321,,1.0,W4394692897,A5047141421,Glenda M. Halliday,0000-0003-0422-8398,Collaborating PI,Team Edwards,Glenda Halliday
852,852.0,Chronic hyperactivation of midbrain dopamine neurons causes preferential dopamine neuron degeneration,Edwards,10.1101/2024.04.05.588321,,1.0,W4394692897,A5047141421,Glenda M. Halliday,0000-0003-0422-8398,Co-PI,Team Kirik,Glenda Halliday
853,853.0,Chronic hyperactivation of midbrain dopamine neurons causes preferential dopamine neuron degeneration,Edwards,10.1101/2024.04.05.588321,,1.0,W4394692897,A5047141421,Glenda M. Halliday,0000-0003-0422-8398,Co-PI,Team Vila,Glenda Halliday
854,854.0,Chronic hyperactivation of midbrain dopamine neurons causes preferential dopamine neuron degeneration,Edwards,10.1101/2024.04.05.588321,,1.0,W4394692897,A5015829168,Alexandra Nelson,0000-0002-9305-5662,Co-PI,Team Edwards,Alexandra Nelson
856,856.0,Chronic hyperactivation of midbrain dopamine neurons causes preferential dopamine neuron degeneration,Edwards,10.1101/2024.04.05.588321,,1.0,W4394692897,A5081058318,Ken Nakamura,0000-0002-9192-182X,Co-PI,Team Edwards,Ken Nakamura
862,862.0,Presynaptic GABAA receptors control integration of nicotinic input onto dopaminergic axons in the striatum,Edwards,10.1101/2024.06.25.600616,,1.0,W4400052608,A5050910385,Zayd M. Khaliq,0000-0002-1445-1457,Co-PI,Team Edwards,Zayd Khaliq
883,883.0,CHCHD2 mutant mice display mitochondrial protein accumulation and disrupted energy metabolism,Edwards,10.1101/2024.08.30.610586,,1.0,W4402100495,A5047141421,Glenda M. Halliday,0000-0003-0422-8398,Collaborating PI,Team Edwards,Glenda Halliday
884,884.0,CHCHD2 mutant mice display mitochondrial protein accumulation and disrupted energy metabolism,Edwards,10.1101/2024.08.30.610586,,1.0,W4402100495,A5047141421,Glenda M. Halliday,0000-0003-0422-8398,Co-PI,Team Kirik,Glenda Halliday
885,885.0,CHCHD2 mutant mice display mitochondrial protein accumulation and disrupted energy metabolism,Edwards,10.1101/2024.08.30.610586,,1.0,W4402100495,A5047141421,Glenda M. Halliday,0000-0003-0422-8398,Co-PI,Team Vila,Glenda Halliday
887,887.0,CHCHD2 mutant mice display mitochondrial protein accumulation and disrupted energy metabolism,Edwards,10.1101/2024.08.30.610586,,1.0,W4402100495,A5081058318,Ken Nakamura,0000-0002-9192-182X,Co-PI,Team Edwards,Ken Nakamura
925,925.0,Polygenic Parkinson’s disease genetic risk score as risk modifier of parkinsonism in Gaucher disease,GP2,10.1101/2022.12.19.22280175,10.1002/mds.29342,1.0,W4323066990,A5082416184,Huw R. Morris,0000-0002-5473-3774,Collaborating PI,Team Hardy,Huw Morris
926,926.0,Polygenic Parkinson’s disease genetic risk score as risk modifier of parkinsonism in Gaucher disease,GP2,10.1101/2022.12.19.22280175,10.1002/mds.29342,1.0,W4323066990,A5059770430,Anthony H.V. Schapira,0000-0002-3018-3966,Lead-PI,Team Schapira,Anthony Schapira
928,928.0,Polygenic Parkinson’s disease genetic risk score as risk modifier of parkinsonism in Gaucher disease,GP2,10.1101/2022.12.19.22280175,10.1002/mds.29342,1.0,W4323066990,A5009140419,Ellen Sidransky,0000-0002-3019-8500,Co-PI,Team Vangheluwe,Ellen Sidransky
1019,1019.0,Global Parkinson’s Genetics Program (GP2) Complex Network Protocol: Defining the causes of sporadic Parkinson’s disease,GP2,10.1101/2022.11.25.22282764,10.1038/s41531-023-00533-w,1.0,W4386640166,A5082416184,Huw R. Morris,0000-0002-5473-3774,Collaborating PI,Team Hardy,Huw Morris
1060,1060.0,Global Parkinson’s Genetics Program (GP2) Complex Network Protocol: Defining the causes of sporadic Parkinson’s disease,GP2,10.1101/2022.11.25.22282764,10.1038/s41531-023-00533-w,1.0,W4386640166,A5082185657,Brit Mollenhauer,0000-0001-8437-3645,Co-PI,Team Schlossmacher,Brit Mollenhauer
1165,1165.0,Global Parkinson’s Genetics Program (GP2) Complex Network Protocol: Defining the causes of sporadic Parkinson’s disease,GP2,10.1101/2022.11.25.22282764,10.1038/s41531-023-00533-w,1.0,W4386640166,A5059770430,Anthony H.V. Schapira,0000-0002-3018-3966,Lead-PI,Team Schapira,Anthony Schapira
1170,1170.0,Global Parkinson’s Genetics Program (GP2) Complex Network Protocol: Defining the causes of sporadic Parkinson’s disease,GP2,10.1101/2022.11.25.22282764,10.1038/s41531-023-00533-w,1.0,W4386640166,A5020514779,John Hardy,0000-0002-3122-0423,Lead-PI,Team Hardy,John Hardy
1173,1173.0,Global Parkinson’s Genetics Program (GP2) Complex Network Protocol: Defining the causes of sporadic Parkinson’s disease,GP2,10.1101/2022.11.25.22282764,10.1038/s41531-023-00533-w,1.0,W4386640166,A5064529704,Nicholas Wood,0000-0002-9500-3348,Lead-PI,Team Wood,Nicholas Wood
1176,1176.0,Global Parkinson’s Genetics Program (GP2) Complex Network Protocol: Defining the causes of sporadic Parkinson’s disease,GP2,10.1101/2022.11.25.22282764,10.1038/s41531-023-00533-w,1.0,W4386640166,A5000831279,Patrick A. Lewis,0000-0003-4537-0489,Collaborating PI,Team Hardy,Patrick Lewis
1352,1352.0,Multi-ancestry genome-wide meta-analysis in Parkinson’s disease,GP2,10.1101/2022.08.04.22278432,10.1038/s41588-023-01584-8,1.0,W4390345401,A5082185657,Brit Mollenhauer,0000-0001-8437-3645,Co-PI,Team Schlossmacher,Brit Mollenhauer
1458,1458.0,Multi-ancestry genome-wide meta-analysis in Parkinson’s disease,GP2,10.1101/2022.08.04.22278432,10.1038/s41588-023-01584-8,1.0,W4390345401,A5059770430,Anthony H.V. Schapira,0000-0002-3018-3966,Lead-PI,Team Schapira,Anthony Schapira
1464,1464.0,Multi-ancestry genome-wide meta-analysis in Parkinson’s disease,GP2,10.1101/2022.08.04.22278432,10.1038/s41588-023-01584-8,1.0,W4390345401,A5082416184,Huw R. Morris,0000-0002-5473-3774,Collaborating PI,Team Hardy,Huw Morris
1465,1465.0,Multi-ancestry genome-wide meta-analysis in Parkinson’s disease,GP2,10.1101/2022.08.04.22278432,10.1038/s41588-023-01584-8,1.0,W4390345401,A5020514779,John Hardy,0000-0002-3122-0423,Lead-PI,Team Hardy,John Hardy
1468,1468.0,Multi-ancestry genome-wide meta-analysis in Parkinson’s disease,GP2,10.1101/2022.08.04.22278432,10.1038/s41588-023-01584-8,1.0,W4390345401,A5064529704,Nicholas Wood,0000-0002-9500-3348,Lead-PI,Team Wood,Nicholas Wood
1471,1471.0,Multi-ancestry genome-wide meta-analysis in Parkinson’s disease,GP2,10.1101/2022.08.04.22278432,10.1038/s41588-023-01584-8,1.0,W4390345401,A5000831279,Patrick A. Lewis,0000-0003-4537-0489,Collaborating PI,Team Hardy,Patrick Lewis
1562,1562.0,Genome-wide Association Identifies Novel Etiological Insights Associated with Parkinson’s Disease in African and African Admixed Populations,GP2,10.1101/2023.05.05.23289529,,1.0,W4372782409,A5000374325,David G. Standaert,0000-0003-2921-8348,Key Personnel (PI),Team Sulzer,David Standaert
1609,1609.0,Genome-wide Association Identifies Novel Etiological Insights Associated with Parkinson’s Disease in African and African Admixed Populations,GP2,10.1101/2023.05.05.23289529,,1.0,W4372782409,A5082416184,Huw R. Morris,0000-0002-5473-3774,Collaborating PI,Team Hardy,Huw Morris
1610,1610.0,Genome-wide Association Identifies Novel Etiological Insights Associated with Parkinson’s Disease in African and African Admixed Populations,GP2,10.1101/2023.05.05.23289529,,1.0,W4372782409,A5020514779,John Hardy,0000-0002-3122-0423,Lead-PI,Team Hardy,John Hardy
1640,1640.0,NeuroBooster Array: A Genome-Wide Genotyping Platform to Study Neurological Disorders Across Diverse Populations | medRxiv,GP2,10.1101/2023.11.06.23298176,,1.0,W4388487627,A5082416184,Huw R. Morris,0000-0002-5473-3774,Collaborating PI,Team Hardy,Huw Morris
1644,1644.0,NeuroBooster Array: A Genome-Wide Genotyping Platform to Study Neurological Disorders Across Diverse Populations | medRxiv,GP2,10.1101/2023.11.06.23298176,,1.0,W4388487627,A5020514779,John Hardy,0000-0002-3122-0423,Lead-PI,Team Hardy,John Hardy
1694,1694.0,Parkinson’s Families Project: a UK-wide study of early onset and familial Parkinson’s disease,GP2,10.1101/2023.12.05.23299397,,1.0,W4389428169,A5059770430,Anthony H.V. Schapira,0000-0002-3018-3966,Lead-PI,Team Schapira,Anthony Schapira
1700,1700.0,Parkinson’s Families Project: a UK-wide study of early onset and familial Parkinson’s disease,GP2,10.1101/2023.12.05.23299397,,1.0,W4389428169,A5064529704,Nicholas Wood,0000-0002-9500-3348,Lead-PI,Team Wood,Nicholas Wood
1702,1702.0,Parkinson’s Families Project: a UK-wide study of early onset and familial Parkinson’s disease,GP2,10.1101/2023.12.05.23299397,,1.0,W4389428169,A5082416184,Huw R. Morris,0000-0002-5473-3774,Collaborating PI,Team Hardy,Huw Morris
1721,1721.0,African ancestry neurodegeneration risk variant disrupts an intronic branchpoint in GBA1,GP2,10.1101/2024.02.20.24302827,,1.0,W4405363576,A5082416184,Huw R. Morris,0000-0002-5473-3774,Collaborating PI,Team Hardy,Huw Morris
1728,1728.0,African ancestry neurodegeneration risk variant disrupts an intronic branchpoint in GBA1,GP2,10.1101/2024.02.20.24302827,,1.0,W4405363576,A5020514779,John Hardy,0000-0002-3122-0423,Lead-PI,Team Hardy,John Hardy
1737,1737.0,African ancestry neurodegeneration risk variant disrupts an intronic branchpoint in GBA1,GP2,10.1101/2024.02.20.24302827,,1.0,W4405363576,A5042439287,Mina Ryten,0000-0001-9520-6957,Co-PI,Team Hardy,Mina Ryten
1738,1738.0,African ancestry neurodegeneration risk variant disrupts an intronic branchpoint in GBA1,GP2,10.1101/2024.02.20.24302827,,1.0,W4405363576,A5042439287,Mina Ryten,0000-0001-9520-6957,Co-PI,Team Wood,Mina Ryten
1789,1789.0,Global Perspectives on Returning Genetic Research Results in Parkinson’s Disease,GP2,10.1101/2024.07.06.24309029,,1.0,W4400399398,A5082416184,Huw R. Morris,0000-0002-5473-3774,Collaborating PI,Team Hardy,Huw Morris
1815,1815.0,"RAB32 Ser71Arg in autosomal dominant Parkinson's disease: linkage, association, and functional analyses","GP2, Alessi (+Hardy, Wood)",10.1101/2024.01.17.24300927,10.1016/S1474-4422(24)00121-2,1.0,W4394695501,A5042439287,Mina Ryten,0000-0001-9520-6957,Co-PI,Team Hardy,Mina Ryten
1816,1816.0,"RAB32 Ser71Arg in autosomal dominant Parkinson's disease: linkage, association, and functional analyses","GP2, Alessi (+Hardy, Wood)",10.1101/2024.01.17.24300927,10.1016/S1474-4422(24)00121-2,1.0,W4394695501,A5042439287,Mina Ryten,0000-0001-9520-6957,Co-PI,Team Wood,Mina Ryten
1818,1818.0,"RAB32 Ser71Arg in autosomal dominant Parkinson's disease: linkage, association, and functional analyses","GP2, Alessi (+Hardy, Wood)",10.1101/2024.01.17.24300927,10.1016/S1474-4422(24)00121-2,1.0,W4394695501,A5071278272,Andrew B. West,0000-0002-3034-4061,Co-PI,Team Liddle,Andrew West
1820,1820.0,"RAB32 Ser71Arg in autosomal dominant Parkinson's disease: linkage, association, and functional analyses","GP2, Alessi (+Hardy, Wood)",10.1101/2024.01.17.24300927,10.1016/S1474-4422(24)00121-2,1.0,W4394695501,A5082416184,Huw R. Morris,0000-0002-5473-3774,Collaborating PI,Team Hardy,Huw Morris
1830,1830.0,"RAB32 Ser71Arg in autosomal dominant Parkinson's disease: linkage, association, and functional analyses","GP2, Alessi (+Hardy, Wood)",10.1101/2024.01.17.24300927,10.1016/S1474-4422(24)00121-2,1.0,W4394695501,A5054181982,Dario R. Alessi,0000-0002-2140-9185,Lead-PI,Team Alessi,Dario Alessi
1847,1847.0,Integrated Multi-Cohort Analysis of the Parkinson's Disease Gut Metagenome,Gradinaru,10.1101/2022.07.20.500694,10.1002/mds.29300,1.0,W4317830385,A5053569958,Sarkis K. Mazmanian,0000-0003-2713-1513,Co-PI,Team Gradinaru,Sarkis Mazmanian
1848,1848.0,Integrated Multi-Cohort Analysis of the Parkinson's Disease Gut Metagenome,Gradinaru,10.1101/2022.07.20.500694,10.1002/mds.29300,1.0,W4317830385,A5053569958,Sarkis K. Mazmanian,0000-0003-2713-1513,Co-PI,Team Sulzer,Sarkis Mazmanian
1854,1854.0,Advances in AAV technology for delivering genetically encoded cargo to the nonhuman primate nervous system,Gradinaru,review,10.1016/j.crneur.2023.100086,0.0,W4362699913,A5050240445,Viviana Gradinaru,0000-0001-5868-348X,Lead-PI,Team Gradinaru,Viviana Gradinaru
1855,1855.0,Advances in AAV technology for delivering genetically encoded cargo to the nonhuman primate nervous system,Gradinaru,review,10.1016/j.crneur.2023.100086,0.0,W4362699913,A5101580701,Andrew S. Fox,0000-0003-0695-3323,Co-PI,Team Gradinaru,Andrew Fox
1872,1872.0,Serine-129 phosphorylation of α-synuclein is an activity-dependent trigger for physiologic protein-protein interactions and synaptic function: Neuron (cell.com),Gradinaru,10.1101/2022.12.22.521485,10.1016/j.neuron.2023.11.020,1.0,W4389992959,A5076742196,Subhojit Roy,0000-0002-1571-2735,Collaborating PI,Team Gradinaru,Subhojit Roy
1903,1903.0,Adeno-associated viral vectors for functional intravenous gene transfer throughout the non-human primate brain,Gradinaru,10.1101/2022.01.08.475342,10.1038/s41565-023-01419-x,1.0,W4383868431,A5080490976,Lin Tian,0000-0001-7012-6926,Collaborating PI,Team Gradinaru,Lin Tian
1904,1904.0,Adeno-associated viral vectors for functional intravenous gene transfer throughout the non-human primate brain,Gradinaru,10.1101/2022.01.08.475342,10.1038/s41565-023-01419-x,1.0,W4383868431,A5101580701,Andrew S. Fox,0000-0003-0695-3323,Co-PI,Team Gradinaru,Andrew Fox
1905,1905.0,Adeno-associated viral vectors for functional intravenous gene transfer throughout the non-human primate brain,Gradinaru,10.1101/2022.01.08.475342,10.1038/s41565-023-01419-x,1.0,W4383868431,A5050240445,Viviana Gradinaru,0000-0001-5868-348X,Lead-PI,Team Gradinaru,Viviana Gradinaru
1911,1911.0,Synapsin E-domain is essential for α-synuclein function,Gradinaru,10.1101/2023.06.24.546170,10.7554/elife.89687,1.0,W4385664850,A5076742196,Subhojit Roy,0000-0002-1571-2735,Collaborating PI,Team Gradinaru,Subhojit Roy
1917,1917.0,α-Synuclein Overexpression and the Microbiome Shape the Gut and Brain Metabolome in Mice,Gradinaru/Sulzer,10.1101/2024.06.07.597975,,1.0,W4399484859,A5053569958,Sarkis K. Mazmanian,0000-0003-2713-1513,Co-PI,Team Gradinaru,Sarkis Mazmanian
1918,1918.0,α-Synuclein Overexpression and the Microbiome Shape the Gut and Brain Metabolome in Mice,Gradinaru/Sulzer,10.1101/2024.06.07.597975,,1.0,W4399484859,A5053569958,Sarkis K. Mazmanian,0000-0003-2713-1513,Co-PI,Team Sulzer,Sarkis Mazmanian
1922,1922.0,The immunology of Parkinson’s disease - PMC (nih.gov),Hafler,review,10.1007/s00281-022-00947-3,0.0,W4282921514,A5017375396,Le Zhang,0000-0002-4860-831X,Key Personnel (PI),Team De Camilli,Le Zhang
1925,1925.0,Gut instincts in neuroimmunity from the eighteenth to twenty-first centuries,Hafler,NA Review,10.1007/s00281-022-00948-2,0.0,W4283796233,A5022058492,Noah W. Palm,0000-0001-7262-9455,Co-PI,Team Hafler,Noah Palm
1937,1937.0,Dopamine transporter and synaptic vesicle sorting defects underlie auxilin-associated Parkinson’s disease,Hafler,10.1101/2022.02.04.479203,10.1016/j.celrep.2023.112231,1.0,W4324145225,A5026787858,David Sulzer,0000-0001-7632-0439,Lead PI,Team Sulzer,David Sulzer
1938,1938.0,Dopamine transporter and synaptic vesicle sorting defects underlie auxilin-associated Parkinson’s disease,Hafler,10.1101/2022.02.04.479203,10.1016/j.celrep.2023.112231,1.0,W4324145225,A5059606057,Sreeganga S. Chandra,0000-0001-9035-1733,Co-PI,Team Hafler,Sreeganga Chandra
1941,1941.0,A Markov random field model-based approach for differentially expressed gene detection from single-cell RNA-seq data,Hafler,10.1101/2020.11.11.378976,10.1093/bib/bbac166,1.0,W4226113200,A5017375396,Le Zhang,0000-0002-4860-831X,Key Personnel (PI),Team De Camilli,Le Zhang
1943,1943.0,A Markov random field model-based approach for differentially expressed gene detection from single-cell RNA-seq data,Hafler,10.1101/2020.11.11.378976,10.1093/bib/bbac166,1.0,W4226113200,A5059606057,Sreeganga S. Chandra,0000-0001-9035-1733,Co-PI,Team Hafler,Sreeganga Chandra
1949,1949.0,scNAT: a deep learning method for integrating paired single-cell RNA and T cell receptor sequencing profiles,Hafler,does_not_exist,10.1186/s13059-023-03129-y,1.0,W4389893752,A5017375396,Le Zhang,0000-0002-4860-831X,Key Personnel (PI),Team De Camilli,Le Zhang
1951,1951.0,scNAT: a deep learning method for integrating paired single-cell RNA and T cell receptor sequencing profiles,Hafler,does_not_exist,10.1186/s13059-023-03129-y,1.0,W4389893752,A5004216670,David A. Hafler,0000-0003-4664-535X,Lead PI,Team Hafler,David Hafler
1963,1963.0,Single-cell transcriptomic and proteomic analysis of Parkinson’s disease Brains,Hafler,10.1101/2022.02.14.480397,,1.0,W4213123943,A5004216670,David A. Hafler,0000-0003-4664-535X,Lead PI,Team Hafler,David Hafler
1964,1964.0,Single-cell transcriptomic and proteomic analysis of Parkinson’s disease Brains,Hafler,10.1101/2022.02.14.480397,,1.0,W4213123943,A5059606057,Sreeganga S. Chandra,0000-0001-9035-1733,Co-PI,Team Hafler,Sreeganga Chandra
1965,1965.0,Single-cell transcriptomic and proteomic analysis of Parkinson’s disease Brains,Hafler,10.1101/2022.02.14.480397,,1.0,W4213123943,A5017375396,Le Zhang,0000-0002-4860-831X,Key Personnel (PI),Team De Camilli,Le Zhang
1973,1973.0,Diabetes and neuroaxonal damage in Parkinson’s disease,Hardy,10.1101/2022.04.19.22274027,10.1002/mds.29067,1.0,W4286268352,A5101470156,Sonia Gandhi,0000-0003-4395-2661,Co-PI,Team Wood,Sonia Gandhi
1978,1978.0,Diabetes and neuroaxonal damage in Parkinson’s disease,Hardy,10.1101/2022.04.19.22274027,10.1002/mds.29067,1.0,W4286268352,A5082416184,Huw R. Morris,0000-0002-5473-3774,Collaborating PI,Team Hardy,Huw Morris
1984,1984.0,Integrating protein networks and machine learning for disease stratification in the Hereditary Spastic Paraplegias,Hardy,10.1101/2021.01.14.425874,10.1016/j.isci.2021.102484,1.0,W3157413169,A5020514779,John Hardy,0000-0002-3122-0423,Lead-PI,Team Hardy,John Hardy
1986,1986.0,Integrating protein networks and machine learning for disease stratification in the Hereditary Spastic Paraplegias,Hardy,10.1101/2021.01.14.425874,10.1016/j.isci.2021.102484,1.0,W3157413169,A5000831279,Patrick A. Lewis,0000-0003-4537-0489,Collaborating PI,Team Hardy,Patrick Lewis
1993,1993.0,Local genetic correlations exist among neurodegenerative and neuropsychiatric diseases,Hardy,10.1101/2022.05.30.22275781,10.1038/s41531-023-00504-1,1.0,W4367316359,A5020514779,John Hardy,0000-0002-3122-0423,Lead-PI,Team Hardy,John Hardy
1995,1995.0,Local genetic correlations exist among neurodegenerative and neuropsychiatric diseases,Hardy,10.1101/2022.05.30.22275781,10.1038/s41531-023-00504-1,1.0,W4367316359,A5042439287,Mina Ryten,0000-0001-9520-6957,Co-PI,Team Hardy,Mina Ryten
1996,1996.0,Local genetic correlations exist among neurodegenerative and neuropsychiatric diseases,Hardy,10.1101/2022.05.30.22275781,10.1038/s41531-023-00504-1,1.0,W4367316359,A5042439287,Mina Ryten,0000-0001-9520-6957,Co-PI,Team Wood,Mina Ryten
2007,2007.0,Genetic meta-analysis of levodopa induced dyskinesia in Parkinson’s disease | npj Parkinson's Disease (nature.com),Hardy,10.1101/2023.05.24.23290362,10.1038/s41531-023-00573-2,1.0,W4386316574,A5020514779,John Hardy,0000-0002-3122-0423,Lead-PI,Team Hardy,John Hardy
2008,2008.0,Genetic meta-analysis of levodopa induced dyskinesia in Parkinson’s disease | npj Parkinson's Disease (nature.com),Hardy,10.1101/2023.05.24.23290362,10.1038/s41531-023-00573-2,1.0,W4386316574,A5042439287,Mina Ryten,0000-0001-9520-6957,Co-PI,Team Hardy,Mina Ryten
2009,2009.0,Genetic meta-analysis of levodopa induced dyskinesia in Parkinson’s disease | npj Parkinson's Disease (nature.com),Hardy,10.1101/2023.05.24.23290362,10.1038/s41531-023-00573-2,1.0,W4386316574,A5042439287,Mina Ryten,0000-0001-9520-6957,Co-PI,Team Wood,Mina Ryten
2013,2013.0,Genetic meta-analysis of levodopa induced dyskinesia in Parkinson’s disease | npj Parkinson's Disease (nature.com),Hardy,10.1101/2023.05.24.23290362,10.1038/s41531-023-00573-2,1.0,W4386316574,A5082416184,Huw R. Morris,0000-0002-5473-3774,Collaborating PI,Team Hardy,Huw Morris
2030,2030.0,Genome-wide determinants of mortality and clinical progression in Parkinson’s disease,Hardy,10.1101/2022.07.07.22277297,10.1038/s41531-024-00729-8,1.0,W4399432024,A5084748006,Roger A. Barker,0000-0001-8843-7730,Co-PI,Team Jakobsson,Roger Barker
2034,2034.0,Genome-wide determinants of mortality and clinical progression in Parkinson’s disease,Hardy,10.1101/2022.07.07.22277297,10.1038/s41531-024-00729-8,1.0,W4399432024,A5064529704,Nicholas Wood,0000-0002-9500-3348,Lead-PI,Team Wood,Nicholas Wood
2048,2048.0,Genome-wide determinants of mortality and clinical progression in Parkinson’s disease,Hardy,10.1101/2022.07.07.22277297,10.1038/s41531-024-00729-8,1.0,W4399432024,A5020514779,John Hardy,0000-0002-3122-0423,Lead-PI,Team Hardy,John Hardy
2053,2053.0,Genome-wide determinants of mortality and clinical progression in Parkinson’s disease,Hardy,10.1101/2022.07.07.22277297,10.1038/s41531-024-00729-8,1.0,W4399432024,A5082416184,Huw R. Morris,0000-0002-5473-3774,Collaborating PI,Team Hardy,Huw Morris
2058,2058.0,KAT8 compound inhibition inhibits PINK1/Parkin-dependent mitophagy and initiates mitochondrial delivery to lysosomes | bioRxiv,Hardy,10.1101/2023.08.03.551835,10.1038/s41598-024-60602-9,1.0,W4398200995,A5045997682,Hélène Plun‐Favreau,0000-0002-1401-9656,Collaborating PI,Team Hardy,Hélène Plun‐Favreau
2060,2060.0,Protein network analysis links the NSL complex to Parkinson’s disease and mitochondrial biology,Hardy,10.1101/2023.01.27.524249,10.1039/d2mo00325b,1.0,W4380683663,A5000831279,Patrick A. Lewis,0000-0003-4537-0489,Collaborating PI,Team Hardy,Patrick Lewis
2061,2061.0,Protein network analysis links the NSL complex to Parkinson’s disease and mitochondrial biology,Hardy,10.1101/2023.01.27.524249,10.1039/d2mo00325b,1.0,W4380683663,A5045997682,Hélène Plun‐Favreau,0000-0002-1401-9656,Collaborating PI,Team Hardy,Hélène Plun‐Favreau
2064,2064.0,From structure to ætiology: a new window on the biology of leucine-rich repeat kinase 2 and Parkinson's disease | Biochemical Journal | Portland Press,Hardy,review,10.1042/BCJ20210383,0.0,W3184877446,A5000831279,Patrick A. Lewis,0000-0003-4537-0489,Collaborating PI,Team Hardy,Patrick Lewis
2066,2066.0,The emerging role of LRRK2 in tauopathies,Hardy,review,10.1042/CS20220067,0.0,W4285040643,A5000831279,Patrick A. Lewis,0000-0003-4537-0489,Collaborating PI,Team Hardy,Patrick Lewis
2067,2067.0,The emerging role of LRRK2 in tauopathies,Hardy,review,10.1042/CS20220067,0.0,W4285040643,A5082416184,Huw R. Morris,0000-0002-5473-3774,Collaborating PI,Team Hardy,Huw Morris
2068,2068.0,Vesicular dysfunction and pathways to neurodegeneration | Essays in Biochemistry | Portland Press,Hardy,review,10.1042/EBC20210034,0.0,W4200025093,A5000831279,Patrick A. Lewis,0000-0003-4537-0489,Collaborating PI,Team Hardy,Patrick Lewis
2074,2074.0,ggtranscript: an R package for the visualization and interpretation of transcript isoforms using ggplot2,Hardy,10.1101/2022.03.28.486050,10.1093/bioinformatics/btac409,1.0,W4283511977,A5042439287,Mina Ryten,0000-0001-9520-6957,Co-PI,Team Hardy,Mina Ryten
2075,2075.0,ggtranscript: an R package for the visualization and interpretation of transcript isoforms using ggplot2,Hardy,10.1101/2022.03.28.486050,10.1093/bioinformatics/btac409,1.0,W4283511977,A5042439287,Mina Ryten,0000-0001-9520-6957,Co-PI,Team Wood,Mina Ryten
2091,2091.0,Regulation of mitophagy by the NSL complex underlies genetic risk for Parkinson’s disease at Chr16q11.2 and on the MAPT H1 allele,Hardy,10.1101/2020.01.06.896241,10.1093/brain/awac325,1.0,W4295078575,A5101470156,Sonia Gandhi,0000-0003-4395-2661,Co-PI,Team Wood,Sonia Gandhi
2095,2095.0,Regulation of mitophagy by the NSL complex underlies genetic risk for Parkinson’s disease at Chr16q11.2 and on the MAPT H1 allele,Hardy,10.1101/2020.01.06.896241,10.1093/brain/awac325,1.0,W4295078575,A5064529704,Nicholas Wood,0000-0002-9500-3348,Lead-PI,Team Wood,Nicholas Wood
2097,2097.0,Regulation of mitophagy by the NSL complex underlies genetic risk for Parkinson’s disease at Chr16q11.2 and on the MAPT H1 allele,Hardy,10.1101/2020.01.06.896241,10.1093/brain/awac325,1.0,W4295078575,A5020514779,John Hardy,0000-0002-3122-0423,Lead-PI,Team Hardy,John Hardy
2102,2102.0,Regulation of mitophagy by the NSL complex underlies genetic risk for Parkinson’s disease at Chr16q11.2 and on the MAPT H1 allele,Hardy,10.1101/2020.01.06.896241,10.1093/brain/awac325,1.0,W4295078575,A5042439287,Mina Ryten,0000-0001-9520-6957,Co-PI,Team Hardy,Mina Ryten
2103,2103.0,Regulation of mitophagy by the NSL complex underlies genetic risk for Parkinson’s disease at Chr16q11.2 and on the MAPT H1 allele,Hardy,10.1101/2020.01.06.896241,10.1093/brain/awac325,1.0,W4295078575,A5042439287,Mina Ryten,0000-0001-9520-6957,Co-PI,Team Wood,Mina Ryten
2104,2104.0,Regulation of mitophagy by the NSL complex underlies genetic risk for Parkinson’s disease at Chr16q11.2 and on the MAPT H1 allele,Hardy,10.1101/2020.01.06.896241,10.1093/brain/awac325,1.0,W4295078575,A5000831279,Patrick A. Lewis,0000-0003-4537-0489,Collaborating PI,Team Hardy,Patrick Lewis
2105,2105.0,Regulation of mitophagy by the NSL complex underlies genetic risk for Parkinson’s disease at Chr16q11.2 and on the MAPT H1 allele,Hardy,10.1101/2020.01.06.896241,10.1093/brain/awac325,1.0,W4295078575,A5045997682,Hélène Plun‐Favreau,0000-0002-1401-9656,Collaborating PI,Team Hardy,Hélène Plun‐Favreau
2113,2113.0,Association between the LRP1B and APOE loci and the development of Parkinson’s disease dementia,Hardy,10.1101/2022.05.23.22275465,10.1093/brain/awac414,1.0,W4308571577,A5042439287,Mina Ryten,0000-0001-9520-6957,Co-PI,Team Hardy,Mina Ryten
2114,2114.0,Association between the LRP1B and APOE loci and the development of Parkinson’s disease dementia,Hardy,10.1101/2022.05.23.22275465,10.1093/brain/awac414,1.0,W4308571577,A5042439287,Mina Ryten,0000-0001-9520-6957,Co-PI,Team Wood,Mina Ryten
2126,2126.0,Association between the LRP1B and APOE loci and the development of Parkinson’s disease dementia,Hardy,10.1101/2022.05.23.22275465,10.1093/brain/awac414,1.0,W4308571577,A5020514779,John Hardy,0000-0002-3122-0423,Lead-PI,Team Hardy,John Hardy
2127,2127.0,Association between the LRP1B and APOE loci and the development of Parkinson’s disease dementia,Hardy,10.1101/2022.05.23.22275465,10.1093/brain/awac414,1.0,W4308571577,A5082416184,Huw R. Morris,0000-0002-5473-3774,Collaborating PI,Team Hardy,Huw Morris
2135,2135.0,The chromatin modulating NSL complex regulates genes and pathways genetically linked to Parkinson’s disease,Hardy,10.1101/2023.01.16.523926,10.1093/brain/awad246,1.0,W4385406197,A5045997682,Hélène Plun‐Favreau,0000-0002-1401-9656,Collaborating PI,Team Hardy,Hélène Plun‐Favreau
2136,2136.0,The chromatin modulating NSL complex regulates genes and pathways genetically linked to Parkinson’s disease,Hardy,10.1101/2023.01.16.523926,10.1093/brain/awad246,1.0,W4385406197,A5042439287,Mina Ryten,0000-0001-9520-6957,Co-PI,Team Hardy,Mina Ryten
2137,2137.0,The chromatin modulating NSL complex regulates genes and pathways genetically linked to Parkinson’s disease,Hardy,10.1101/2023.01.16.523926,10.1093/brain/awad246,1.0,W4385406197,A5042439287,Mina Ryten,0000-0001-9520-6957,Co-PI,Team Wood,Mina Ryten
2147,2147.0,Investigation of the genetic aetiology of Lewy body diseases with and without dementia | medRxiv,Hardy,10.1101/2023.10.17.23297157,10.1093/braincomms/fcae190,1.0,W4399200646,A5042439287,Mina Ryten,0000-0001-9520-6957,Co-PI,Team Hardy,Mina Ryten
2148,2148.0,Investigation of the genetic aetiology of Lewy body diseases with and without dementia | medRxiv,Hardy,10.1101/2023.10.17.23297157,10.1093/braincomms/fcae190,1.0,W4399200646,A5042439287,Mina Ryten,0000-0001-9520-6957,Co-PI,Team Wood,Mina Ryten
2199,2199.0,Investigation of the genetic aetiology of Lewy body diseases with and without dementia | medRxiv,Hardy,10.1101/2023.10.17.23297157,10.1093/braincomms/fcae190,1.0,W4399200646,A5008377476,Clemens R. Scherzer,0000-0002-0567-9193,Lead-PI,Team Scherzer,Clemens Scherzer
2203,2203.0,Investigation of the genetic aetiology of Lewy body diseases with and without dementia | medRxiv,Hardy,10.1101/2023.10.17.23297157,10.1093/braincomms/fcae190,1.0,W4399200646,A5009140419,Ellen Sidransky,0000-0002-3019-8500,Co-PI,Team Vangheluwe,Ellen Sidransky
2223,2223.0,Investigation of the genetic aetiology of Lewy body diseases with and without dementia | medRxiv,Hardy,10.1101/2023.10.17.23297157,10.1093/braincomms/fcae190,1.0,W4399200646,A5020514779,John Hardy,0000-0002-3122-0423,Lead-PI,Team Hardy,John Hardy
2228,2228.0,Investigation of the genetic aetiology of Lewy body diseases with and without dementia | medRxiv,Hardy,10.1101/2023.10.17.23297157,10.1093/braincomms/fcae190,1.0,W4399200646,A5082416184,Huw R. Morris,0000-0002-5473-3774,Collaborating PI,Team Hardy,Huw Morris
2232,2232.0,Investigation of the genetic aetiology of Lewy body diseases with and without dementia | medRxiv,Hardy,10.1101/2023.10.17.23297157,10.1093/braincomms/fcae190,1.0,W4399200646,A5042439287,Mina Ryten,0000-0001-9520-6957,Co-PI,Team Hardy,Mina Ryten
2233,2233.0,Investigation of the genetic aetiology of Lewy body diseases with and without dementia | medRxiv,Hardy,10.1101/2023.10.17.23297157,10.1093/braincomms/fcae190,1.0,W4399200646,A5042439287,Mina Ryten,0000-0001-9520-6957,Co-PI,Team Wood,Mina Ryten
2268,2268.0,Investigation of the genetic aetiology of Lewy body diseases with and without dementia | medRxiv,Hardy,10.1101/2023.10.17.23297157,10.1093/braincomms/fcae190,1.0,W4399200646,A5020514779,John Hardy,0000-0002-3122-0423,Lead-PI,Team Hardy,John Hardy
2269,2269.0,Investigation of the genetic aetiology of Lewy body diseases with and without dementia | medRxiv,Hardy,10.1101/2023.10.17.23297157,10.1093/braincomms/fcae190,1.0,W4399200646,A5082416184,Huw R. Morris,0000-0002-5473-3774,Collaborating PI,Team Hardy,Huw Morris
2289,2289.0,The annotation of GBA1 has been concealed by its protein-coding pseudogene GBAP1,Hardy,10.1101/2022.10.21.513169,10.1126/sciadv.adk1296,1.0,W4400033871,A5101470156,Sonia Gandhi,0000-0003-4395-2661,Co-PI,Team Wood,Sonia Gandhi
2297,2297.0,The annotation of GBA1 has been concealed by its protein-coding pseudogene GBAP1,Hardy,10.1101/2022.10.21.513169,10.1126/sciadv.adk1296,1.0,W4400033871,A5084748006,Roger A. Barker,0000-0001-8843-7730,Co-PI,Team Jakobsson,Roger Barker
2299,2299.0,The annotation of GBA1 has been concealed by its protein-coding pseudogene GBAP1,Hardy,10.1101/2022.10.21.513169,10.1126/sciadv.adk1296,1.0,W4400033871,A5078895245,Frances M. Platt,0000-0001-7614-0403,Co-PI,Team Hardy,Frances Platt
2300,2300.0,The annotation of GBA1 has been concealed by its protein-coding pseudogene GBAP1,Hardy,10.1101/2022.10.21.513169,10.1126/sciadv.adk1296,1.0,W4400033871,A5021760406,Johan Jakobsson,0000-0003-0669-7673,Lead PI,Team Jakobsson,Johan Jakobsson
2301,2301.0,The annotation of GBA1 has been concealed by its protein-coding pseudogene GBAP1,Hardy,10.1101/2022.10.21.513169,10.1126/sciadv.adk1296,1.0,W4400033871,A5064529704,Nicholas Wood,0000-0002-9500-3348,Lead-PI,Team Wood,Nicholas Wood
2305,2305.0,The annotation of GBA1 has been concealed by its protein-coding pseudogene GBAP1,Hardy,10.1101/2022.10.21.513169,10.1126/sciadv.adk1296,1.0,W4400033871,A5020514779,John Hardy,0000-0002-3122-0423,Lead-PI,Team Hardy,John Hardy
2306,2306.0,The annotation of GBA1 has been concealed by its protein-coding pseudogene GBAP1,Hardy,10.1101/2022.10.21.513169,10.1126/sciadv.adk1296,1.0,W4400033871,A5042439287,Mina Ryten,0000-0001-9520-6957,Co-PI,Team Hardy,Mina Ryten
2307,2307.0,The annotation of GBA1 has been concealed by its protein-coding pseudogene GBAP1,Hardy,10.1101/2022.10.21.513169,10.1126/sciadv.adk1296,1.0,W4400033871,A5042439287,Mina Ryten,0000-0001-9520-6957,Co-PI,Team Wood,Mina Ryten
2308,2308.0,A step forward for LRRK2 inhibitors in Parkinson’s disease,Hardy,review,10.1126/scitranslmed.abq7374,0.0,W4282928088,A5000831279,Patrick A. Lewis,0000-0003-4537-0489,Collaborating PI,Team Hardy,Patrick Lewis
2321,2321.0,Combining biomarkers for prognostic modelling of Parkinson’s disease,Hardy,10.1101/2021.11.01.21265751,10.1136/jnnp-2021-328365,1.0,W4280560966,A5084748006,Roger A. Barker,0000-0001-8843-7730,Co-PI,Team Jakobsson,Roger Barker
2322,2322.0,Combining biomarkers for prognostic modelling of Parkinson’s disease,Hardy,10.1101/2021.11.01.21265751,10.1136/jnnp-2021-328365,1.0,W4280560966,A5020514779,John Hardy,0000-0002-3122-0423,Lead-PI,Team Hardy,John Hardy
2323,2323.0,Combining biomarkers for prognostic modelling of Parkinson’s disease,Hardy,10.1101/2021.11.01.21265751,10.1136/jnnp-2021-328365,1.0,W4280560966,A5064529704,Nicholas Wood,0000-0002-9500-3348,Lead-PI,Team Wood,Nicholas Wood
2330,2330.0,Combining biomarkers for prognostic modelling of Parkinson’s disease,Hardy,10.1101/2021.11.01.21265751,10.1136/jnnp-2021-328365,1.0,W4280560966,A5082416184,Huw R. Morris,0000-0002-5473-3774,Collaborating PI,Team Hardy,Huw Morris
2342,2342.0,Association of genetic variation at the GJA5/ACP6 locus with motor progression in Parkinson’s,Hardy,10.1101/2022.10.28.22281645,10.1212/nxg.0000000000200092,1.0,W4385650789,A5020514779,John Hardy,0000-0002-3122-0423,Lead-PI,Team Hardy,John Hardy
2343,2343.0,Association of genetic variation at the GJA5/ACP6 locus with motor progression in Parkinson’s,Hardy,10.1101/2022.10.28.22281645,10.1212/nxg.0000000000200092,1.0,W4385650789,A5042439287,Mina Ryten,0000-0001-9520-6957,Co-PI,Team Hardy,Mina Ryten
2344,2344.0,Association of genetic variation at the GJA5/ACP6 locus with motor progression in Parkinson’s,Hardy,10.1101/2022.10.28.22281645,10.1212/nxg.0000000000200092,1.0,W4385650789,A5042439287,Mina Ryten,0000-0001-9520-6957,Co-PI,Team Wood,Mina Ryten
2347,2347.0,Association of genetic variation at the GJA5/ACP6 locus with motor progression in Parkinson’s,Hardy,10.1101/2022.10.28.22281645,10.1212/nxg.0000000000200092,1.0,W4385650789,A5082416184,Huw R. Morris,0000-0002-5473-3774,Collaborating PI,Team Hardy,Huw Morris
2350,2350.0,Leucine-rich repeat kinase 2 at a glance,Hardy,review,10.1242/jcs.259724,0.0,W4386624202,A5000831279,Patrick A. Lewis,0000-0003-4537-0489,Collaborating PI,Team Hardy,Patrick Lewis
2352,2352.0,PINK1: From Parkinson’s disease to mitophagy and back again,Hardy,review,10.1371/journal.pbio.3002196,0.0,W4382601233,A5020514779,John Hardy,0000-0002-3122-0423,Lead-PI,Team Hardy,John Hardy
2353,2353.0,PINK1: From Parkinson’s disease to mitophagy and back again,Hardy,review,10.1371/journal.pbio.3002196,0.0,W4382601233,A5045997682,Hélène Plun‐Favreau,0000-0002-1401-9656,Collaborating PI,Team Hardy,Hélène Plun‐Favreau
2360,2360.0,Evaluation Of The Rims2 Locus As A Risk Locus For Parkinson’s Disease Dementia,Hardy,10.1101/2021.07.26.21261131,,1.0,W3186738626,A5064529704,Nicholas Wood,0000-0002-9500-3348,Lead-PI,Team Wood,Nicholas Wood
2368,2368.0,Evaluation Of The Rims2 Locus As A Risk Locus For Parkinson’s Disease Dementia,Hardy,10.1101/2021.07.26.21261131,,1.0,W3186738626,A5082416184,Huw R. Morris,0000-0002-5473-3774,Collaborating PI,Team Hardy,Huw Morris
2382,2382.0,"Splicing accuracy varies across human introns, tissues and age",Hardy,10.1101/2023.03.29.534370,,1.0,W4361262952,A5034073565,Donald C. Rio,,Lead-PI,Team Rio,Donald Rio
2386,2386.0,"Splicing accuracy varies across human introns, tissues and age",Hardy,10.1101/2023.03.29.534370,,1.0,W4361262952,A5042439287,Mina Ryten,0000-0001-9520-6957,Co-PI,Team Hardy,Mina Ryten
2387,2387.0,"Splicing accuracy varies across human introns, tissues and age",Hardy,10.1101/2023.03.29.534370,,1.0,W4361262952,A5042439287,Mina Ryten,0000-0001-9520-6957,Co-PI,Team Wood,Mina Ryten
2389,2389.0,Mutations in GPNMB associated with Amyloid cutis dyschromica alter intracellular trafficking and processing of GPNMB | bioRxiv,Hardy,10.1101/2023.12.19.572409,,1.0,W4389986385,A5000831279,Patrick A. Lewis,0000-0003-4537-0489,Collaborating PI,Team Hardy,Patrick Lewis
2391,2391.0,The pathogenesis of Parkinson's disease - The Lancet,Hardy/Kirik,review,10.1016/S0140-6736(23)01478-2,0.0,W4390964116,A5082416184,Huw R. Morris,0000-0002-5473-3774,Collaborating PI,Team Hardy,Huw Morris
2392,2392.0,The pathogenesis of Parkinson's disease - The Lancet,Hardy/Kirik,review,10.1016/S0140-6736(23)01478-2,0.0,W4390964116,A5037609259,Maria Grazia Spillantini,0000-0002-8544-7332,Co-PI,Team Hardy,Maria Spillantini
2397,2397.0,The chaperone Clusterin in neurodegeneration−friend or foe?,Harper,review,10.1002/bies.202100287,0.0,W4229006902,A5086048712,F. Ulrich Hartl,0000-0002-7941-135X,Co-PI,Team Harper,F. Hartl
2400,2400.0,Mechanisms Controlling Selective Elimination of Damaged Lysosomes - PMC (nih.gov),Harper,review,10.1016/j.cophys.2022.100590,0.0,W4293724281,A5047746208,J. Wade Harper,0000-0002-6944-7236,Lead PI,Team Harper,J. Harper
2403,2403.0,Mechanisms underlying ubiquitin-driven selective mitochondrial and bacterial autophagy: Molecular Cell,Harper,review,10.1016/j.molcel.2022.03.012,0.0,W4220684596,A5047746208,J. Wade Harper,0000-0002-6944-7236,Lead PI,Team Harper,J. Harper
2407,2407.0,Autophagy preferentially degrades non-fibrillar polyQ aggregates,Harper,10.1101/2023.08.08.552291,10.1016/j.molcel.2024.04.018,1.0,W4396980221,A5086048712,F. Ulrich Hartl,0000-0002-7941-135X,Co-PI,Team Harper,F. Hartl
2420,2420.0,In situ architecture of neuronal α-Synuclein inclusions,Harper,10.1101/2020.08.07.234138,10.1038/s41467-021-22108-0,1.0,W3156701803,A5086048712,F. Ulrich Hartl,0000-0002-7941-135X,Co-PI,Team Harper,F. Hartl
2421,2421.0,In situ architecture of neuronal α-Synuclein inclusions,Harper,10.1101/2020.08.07.234138,10.1038/s41467-021-22108-0,1.0,W3156701803,A5061030857,Rubén Fernández‐Busnadiego,0000-0002-8366-7622,Co-PI,Team Harper,Rubén Fernández‐Busnadiego
2431,2431.0,The extracellular chaperone Clusterin enhances Tau aggregate seeding in a cellular model,Harper,10.1101/2021.07.16.452659,10.1038/s41467-021-25060-1,1.0,W3187288550,A5086048712,F. Ulrich Hartl,0000-0002-7941-135X,Co-PI,Team Harper,F. Hartl
2441,2441.0,The Hsc70 disaggregation machinery removes monomer units directly from α-synuclein fibril ends,Harper,10.1101/2020.11.02.365825,10.1038/s41467-021-25966-w,1.0,W3206809879,A5038452125,Michele Vendruscolo,0000-0002-3616-1610,Co-PI,Team Wood,Michele Vendruscolo
2444,2444.0,The Hsc70 disaggregation machinery removes monomer units directly from α-synuclein fibril ends,Harper,10.1101/2020.11.02.365825,10.1038/s41467-021-25966-w,1.0,W3206809879,A5086048712,F. Ulrich Hartl,0000-0002-7941-135X,Co-PI,Team Harper,F. Hartl
2462,2462.0,Deficiency of the frontotemporal dementia gene GRN results in gangliosidosis,Harper,10.1101/2021.09.30.461806,10.1038/s41467-022-33500-9,1.0,W4303446525,A5047746208,J. Wade Harper,0000-0002-6944-7236,Lead PI,Team Harper,J. Harper
2476,2476.0,Spatial snapshots of amyloid precursor protein intramembrane processing via early endosome proteomics,Harper,10.1101/2022.03.31.486371,10.1038/s41467-022-33881-x,1.0,W4306353218,A5047746208,J. Wade Harper,0000-0002-6944-7236,Lead PI,Team Harper,J. Harper
2485,2485.0,The AAA+ chaperone VCP disaggregates Tau fibrils and generates aggregate seeds in a cellular system,Harper,10.1101/2022.02.18.481043,10.1038/s41467-023-36058-2,1.0,W4319017939,A5061030857,Rubén Fernández‐Busnadiego,0000-0002-8366-7622,Co-PI,Team Harper,Rubén Fernández‐Busnadiego
2490,2490.0,The AAA+ chaperone VCP disaggregates Tau fibrils and generates aggregate seeds in a cellular system,Harper,10.1101/2022.02.18.481043,10.1038/s41467-023-36058-2,1.0,W4319017939,A5086048712,F. Ulrich Hartl,0000-0002-7941-135X,Co-PI,Team Harper,F. Hartl
2503,2503.0,Combinatorial selective ER-phagy remodels the ER during neurogensis,Harper,10.1101/2023.06.26.546565,10.1038/s41556-024-01356-4,1.0,W4392356816,A5023564164,Brenda A. Schulman,0000-0002-3083-1126,Co-PI,Team Harper,Brenda Schulman
2504,2504.0,Combinatorial selective ER-phagy remodels the ER during neurogensis,Harper,10.1101/2023.06.26.546565,10.1038/s41556-024-01356-4,1.0,W4392356816,A5047746208,J. Wade Harper,0000-0002-6944-7236,Lead PI,Team Harper,J. Harper
2511,2511.0,Proteome census upon nutrient stress reveals Golgiphagy membrane receptors | Nature,Harper,10.1101/2022.12.06.519342,10.1038/s41586-023-06657-6,1.0,W4387095425,A5047746208,J. Wade Harper,0000-0002-6944-7236,Lead PI,Team Harper,J. Harper
2518,2518.0,Visualizing chaperone-mediated multistep assembly of the human 20S proteasome,Harper,10.1101/2024.01.27.577538,10.1038/s41594-024-01268-9,1.0,W4394691490,A5047746208,J. Wade Harper,0000-0002-6944-7236,Lead PI,Team Harper,J. Harper
2520,2520.0,Visualizing chaperone-mediated multistep assembly of the human 20S proteasome,Harper,10.1101/2024.01.27.577538,10.1038/s41594-024-01268-9,1.0,W4394691490,A5023564164,Brenda A. Schulman,0000-0002-3083-1126,Co-PI,Team Harper,Brenda Schulman
2529,2529.0,In situ structural analysis reveals membrane shape transitions during autophagosome formation,Harper,10.1101/2022.05.02.490291,10.1073/pnas.2209823119,1.0,W4296297488,A5023564164,Brenda A. Schulman,0000-0002-3083-1126,Co-PI,Team Harper,Brenda Schulman
2534,2534.0,UniProtExtractR: an app and R package for easily extracting protein-specific UniProtKB information and fine-tuning organelle resolution | Bioinformatics Advances | Oxford Academic (oup.com),Harper,review,10.1093/bioadv/vbad157,0.0,W4388422308,A5047746208,J. Wade Harper,0000-0002-6944-7236,Lead PI,Team Harper,J. Harper
2543,2543.0,PARK15/FBXO7 is dispensable for PINK1/Parkin mitophagy in iNeurons and HeLa cell systems,Harper,10.1101/2022.11.02.514817,10.15252/embr.202256399,1.0,W4381164613,A5023564164,Brenda A. Schulman,0000-0002-3083-1126,Co-PI,Team Harper,Brenda Schulman
2544,2544.0,PARK15/FBXO7 is dispensable for PINK1/Parkin mitophagy in iNeurons and HeLa cell systems,Harper,10.1101/2022.11.02.514817,10.15252/embr.202256399,1.0,W4381164613,A5047746208,J. Wade Harper,0000-0002-6944-7236,Lead PI,Team Harper,J. Harper
2549,2549.0,Quantitative proteomics reveals the selectivity of ubiquitin-binding autophagy receptors in the turnover of damaged lysosomes by lysophagy,Harper,10.1101/2021.07.19.452535,10.7554/eLife.72328,1.0,W3202373309,A5047746208,J. Wade Harper,0000-0002-6944-7236,Lead PI,Team Harper,J. Harper
2564,2564.0,Proteostasis and lysosomal quality control deficits in Alzheimer’s disease neurons | bioRxiv,Harper,10.1101/2023.03.27.534444,,1.0,W4361215982,A5041204065,Judith Frydman,0000-0003-2302-6943,Co-PI,Team Harper,Judith Frydman
2580,2580.0,Lysosomal storage disease proteo/lipidomic profiling using nMOST links ferritinophagy with mitochondrial iron deficiencies in cells lacking NPC2,Harper,10.1101/2024.03.26.586828,,1.0,W4393217948,A5023564164,Brenda A. Schulman,0000-0002-3083-1126,Co-PI,Team Harper,Brenda Schulman
2584,2584.0,Lysosomal storage disease proteo/lipidomic profiling using nMOST links ferritinophagy with mitochondrial iron deficiencies in cells lacking NPC2,Harper,10.1101/2024.03.26.586828,,1.0,W4393217948,A5047746208,J. Wade Harper,0000-0002-6944-7236,Lead PI,Team Harper,J. Harper
2592,2592.0,Temporal control of acute protein aggregate turnover by UBE3C and NRF1-dependent proteasomal pathways,Harper,10.1101/2024.08.30.610524,,1.0,W4402101311,A5061030857,Rubén Fernández‐Busnadiego,0000-0002-8366-7622,Co-PI,Team Harper,Rubén Fernández‐Busnadiego
2593,2593.0,Temporal control of acute protein aggregate turnover by UBE3C and NRF1-dependent proteasomal pathways,Harper,10.1101/2024.08.30.610524,,1.0,W4402101311,A5047746208,J. Wade Harper,0000-0002-6944-7236,Lead PI,Team Harper,J. Harper
2596,2596.0,"Regulatory imbalance between LRRK2 kinase, PPM1H phosphatase, and ARF6 GTPase disrupts the axonal transport of autophagosomes",Hurley,10.1101/2022.11.14.516471,10.1016/j.celrep.2023.112448,1.0,W4367625974,A5033015769,Chantell S. Evans,0000-0001-9401-8604,Collaborating PI,Team Calakos,Chantell Evans
2598,2598.0,"Regulatory imbalance between LRRK2 kinase, PPM1H phosphatase, and ARF6 GTPase disrupts the axonal transport of autophagosomes",Hurley,10.1101/2022.11.14.516471,10.1016/j.celrep.2023.112448,1.0,W4367625974,A5075390520,Erika L.F. Holzbaur,0000-0001-5389-4114,Co-PI,Team Hurley,Erika Holzbaur
2601,2601.0,Orchestration of selective autophagy by cargo receptors,Hurley,review,10.1016/j.cub.2022.11.002,0.0,W4312094513,A5029002091,Sascha Martens,0000-0003-3786-8199,Co-PI,Team Hurley,Sascha Martens
2613,2613.0,Unconventional Initiation of PINK1/Parkin Mitophagy by Optineurin,Hurley,10.1101/2022.08.14.503930,10.1016/j.molcel.2023.04.021,1.0,W4377047698,A5029002091,Sascha Martens,0000-0003-3786-8199,Co-PI,Team Hurley,Sascha Martens
2614,2614.0,Unconventional Initiation of PINK1/Parkin Mitophagy by Optineurin,Hurley,10.1101/2022.08.14.503930,10.1016/j.molcel.2023.04.021,1.0,W4377047698,A5061877082,Michael Lazarou,0000-0003-2150-5545,Co-PI,Team Hurley,Michael Lazarou
2618,2618.0,Damaged mitochondria recruit the effector NEMO to activate NF-κB signaling: Molecular Cell,Hurley,10.1101/2022.06.21.496850,10.1016/j.molcel.2023.08.005,1.0,W4386496532,A5029002091,Sascha Martens,0000-0003-3786-8199,Co-PI,Team Hurley,Sascha Martens
2619,2619.0,Damaged mitochondria recruit the effector NEMO to activate NF-κB signaling: Molecular Cell,Hurley,10.1101/2022.06.21.496850,10.1016/j.molcel.2023.08.005,1.0,W4386496532,A5075390520,Erika L.F. Holzbaur,0000-0001-5389-4114,Co-PI,Team Hurley,Erika Holzbaur
2622,2622.0,Mitochondrial degradation: Mitophagy and beyond: Molecular Cell,Hurley,review,10.1016/j.molcel.2023.08.021,0.0,W4386757254,A5061877082,Michael Lazarou,0000-0003-2150-5545,Co-PI,Team Hurley,Michael Lazarou
2633,2633.0,Control of mitophagy initiation and progression by the TBK1 adaptors NAP1 and SINTBAD,Hurley,10.1101/2023.09.25.559255,10.1038/s41594-024-01338-y,1.0,W4400007735,A5061877082,Michael Lazarou,0000-0003-2150-5545,Co-PI,Team Hurley,Michael Lazarou
2634,2634.0,Control of mitophagy initiation and progression by the TBK1 adaptors NAP1 and SINTBAD,Hurley,10.1101/2023.09.25.559255,10.1038/s41594-024-01338-y,1.0,W4400007735,A5029002091,Sascha Martens,0000-0003-3786-8199,Co-PI,Team Hurley,Sascha Martens
2636,2636.0,ALS and FTD-associated missense mutations in TBK1 differentially disrupt mitophagy,Hurley,10.1101/2021.04.12.439050,10.1073/pnas.2025053118,1.0,W3156864965,A5033015769,Chantell S. Evans,0000-0001-9401-8604,Collaborating PI,Team Calakos,Chantell Evans
2640,2640.0,ALS and FTD-associated missense mutations in TBK1 differentially disrupt mitophagy,Hurley,10.1101/2021.04.12.439050,10.1073/pnas.2025053118,1.0,W3156864965,A5075390520,Erika L.F. Holzbaur,0000-0001-5389-4114,Co-PI,Team Hurley,Erika Holzbaur
2642,2642.0,Toward a standard model for autophagosome biogenesis | Journal of Cell Biology | Rockefeller University Press (rupress.org),Hurley,review,10.1083/jcb.202304011,0.0,W4379376257,A5061450716,James H. Hurley,0000-0001-5054-5445,Lead PI,Team Hurley,James Hurley
2645,2645.0,RAB3 phosphorylation by pathogenic LRRK2 impairs trafficking of synaptic vesicle precursors,Hurley,10.1101/2023.07.25.550521,10.1083/jcb.202307092,1.0,W4393040800,A5075390520,Erika L.F. Holzbaur,0000-0001-5389-4114,Co-PI,Team Hurley,Erika Holzbaur
2651,2651.0,A RAB7A Phosphoswitch Coordinates Rubicon Homology Protein Regulation of PINK1/Parkin-Dependent Mitophagy,Hurley,10.1101/2023.08.28.555228,10.1083/jcb.202309015,1.0,W4396811660,A5061877082,Michael Lazarou,0000-0003-2150-5545,Co-PI,Team Hurley,Michael Lazarou
2652,2652.0,A RAB7A Phosphoswitch Coordinates Rubicon Homology Protein Regulation of PINK1/Parkin-Dependent Mitophagy,Hurley,10.1101/2023.08.28.555228,10.1083/jcb.202309015,1.0,W4396811660,A5075390520,Erika L.F. Holzbaur,0000-0001-5389-4114,Co-PI,Team Hurley,Erika Holzbaur
2653,2653.0,A RAB7A Phosphoswitch Coordinates Rubicon Homology Protein Regulation of PINK1/Parkin-Dependent Mitophagy,Hurley,10.1101/2023.08.28.555228,10.1083/jcb.202309015,1.0,W4396811660,A5061450716,James H. Hurley,0000-0001-5054-5445,Lead PI,Team Hurley,James Hurley
2659,2659.0,Reconstitution of cargo-induced LC3 lipidation in mammalian selective autophagy,Hurley,10.1101/2021.01.08.425958,10.1126/sciadv.abg4922,1.0,W3153643350,A5029002091,Sascha Martens,0000-0003-3786-8199,Co-PI,Team Hurley,Sascha Martens
2660,2660.0,Reconstitution of cargo-induced LC3 lipidation in mammalian selective autophagy,Hurley,10.1101/2021.01.08.425958,10.1126/sciadv.abg4922,1.0,W3153643350,A5061450716,James H. Hurley,0000-0001-5054-5445,Lead PI,Team Hurley,James Hurley
2665,2665.0,Membrane curvature sensing and stabilization by the autophagic LC3 lipidation machinery,Hurley,10.1101/2022.05.03.490522,10.1126/sciadv.add1436,1.0,W4311441084,A5029002091,Sascha Martens,0000-0003-3786-8199,Co-PI,Team Hurley,Sascha Martens
2667,2667.0,Membrane curvature sensing and stabilization by the autophagic LC3 lipidation machinery,Hurley,10.1101/2022.05.03.490522,10.1126/sciadv.add1436,1.0,W4311441084,A5061450716,James H. Hurley,0000-0001-5054-5445,Lead PI,Team Hurley,James Hurley
2672,2672.0,Structural basis for ATG9A recruitment to the ULK1 complex in mitophagy initiation,Hurley,10.1101/2022.07.12.499634,10.1126/sciadv.adg2997,1.0,W4320896717,A5061877082,Michael Lazarou,0000-0003-2150-5545,Co-PI,Team Hurley,Michael Lazarou
2674,2674.0,Structural basis for ATG9A recruitment to the ULK1 complex in mitophagy initiation,Hurley,10.1101/2022.07.12.499634,10.1126/sciadv.adg2997,1.0,W4320896717,A5061450716,James H. Hurley,0000-0001-5054-5445,Lead PI,Team Hurley,James Hurley
2685,2685.0,Temporal landscape of mitochondrial proteostasis governed by the UPRmt,Hurley,10.1101/2022.11.30.518286,10.1126/sciadv.adh8228,1.0,W4386952060,A5061877082,Michael Lazarou,0000-0003-2150-5545,Co-PI,Team Hurley,Michael Lazarou
2690,2690.0,"Three-step docking by WIPI2, ATG16L1 and ATG3 delivers LC3 to the phagophore",Hurley,10.1101/2023.07.17.549391,10.1126/sciadv.adj8027,1.0,W4391629214,A5061877082,Michael Lazarou,0000-0003-2150-5545,Co-PI,Team Hurley,Michael Lazarou
2691,2691.0,"Three-step docking by WIPI2, ATG16L1 and ATG3 delivers LC3 to the phagophore",Hurley,10.1101/2023.07.17.549391,10.1126/sciadv.adj8027,1.0,W4391629214,A5061450716,James H. Hurley,0000-0001-5054-5445,Lead PI,Team Hurley,James Hurley
2694,2694.0,A unifying model for the role of the ATG8 system in autophagy,Hurley,review,10.1242/jcs.258997,0.0,W4282006334,A5061877082,Michael Lazarou,0000-0003-2150-5545,Co-PI,Team Hurley,Michael Lazarou
2703,2703.0,Structural Basis for Membrane Recruitment of ATG16L1 by WIPI2 in Autophagy,Hurley,10.1101/2021.05.14.444175,10.7554/eLife.70372,1.0,W3196608509,A5075390520,Erika L.F. Holzbaur,0000-0001-5389-4114,Co-PI,Team Hurley,Erika Holzbaur
2704,2704.0,Structural Basis for Membrane Recruitment of ATG16L1 by WIPI2 in Autophagy,Hurley,10.1101/2021.05.14.444175,10.7554/eLife.70372,1.0,W3196608509,A5061450716,James H. Hurley,0000-0001-5054-5445,Lead PI,Team Hurley,James Hurley
2709,2709.0,Distinct adaptations revealed by unbiased proteomic analysis of autophagy cargos in the brain in PINK1 and LRRK2 models of Parkinson’s disease,Hurley,10.1101/2022.10.03.510717,,1.0,W4301373231,A5047746208,J. Wade Harper,0000-0002-6944-7236,Lead PI,Team Harper,J. Harper
2710,2710.0,Distinct adaptations revealed by unbiased proteomic analysis of autophagy cargos in the brain in PINK1 and LRRK2 models of Parkinson’s disease,Hurley,10.1101/2022.10.03.510717,,1.0,W4301373231,A5075390520,Erika L.F. Holzbaur,0000-0001-5389-4114,Co-PI,Team Hurley,Erika Holzbaur
2718,2718.0,Structure and activation of the human autophagy-initiating ULK1C:PI3KC3-C1 supercomplex,Hurley,10.1101/2023.06.01.543278,,1.0,W4379145226,A5061877082,Michael Lazarou,0000-0003-2150-5545,Co-PI,Team Hurley,Michael Lazarou
2719,2719.0,Structure and activation of the human autophagy-initiating ULK1C:PI3KC3-C1 supercomplex,Hurley,10.1101/2023.06.01.543278,,1.0,W4379145226,A5061450716,James H. Hurley,0000-0001-5054-5445,Lead PI,Team Hurley,James Hurley
2727,2727.0,Structure and activation of the human autophagy-initiating ULK1C:PI3KC3-C1 supercomplex,Hurley,10.1101/2023.06.01.543278,,1.0,W4379145226,A5061877082,Michael Lazarou,0000-0003-2150-5545,Co-PI,Team Hurley,Michael Lazarou
2728,2728.0,Structure and activation of the human autophagy-initiating ULK1C:PI3KC3-C1 supercomplex,Hurley,10.1101/2023.06.01.543278,,1.0,W4379145226,A5061450716,James H. Hurley,0000-0001-5054-5445,Lead PI,Team Hurley,James Hurley
2737,2737.0,Structural pathway for class III PI 3-kinase activation by the myristoylated GTP-binding pseudokinase VPS15 | bioRxiv,Hurley,10.1101/2023.09.28.559894,,1.0,W4387184698,A5061450716,James H. Hurley,0000-0001-5054-5445,Lead PI,Team Hurley,James Hurley
2739,2739.0,Mitochondrial damage triggers concerted degradation of negative regulators of neuronal autophagy,Hurley,10.1101/2024.06.12.598718,,1.0,W4399602719,A5075390520,Erika L.F. Holzbaur,0000-0001-5389-4114,Co-PI,Team Hurley,Erika Holzbaur
2750,2750.0,Reconstitution of BNIP3/NIX-mediated autophagy reveals two pathways and hierarchical flexibility of the initiation machinery,Hurley,10.1101/2024.08.28.609967,,1.0,W4401944929,A5061877082,Michael Lazarou,0000-0003-2150-5545,Co-PI,Team Hurley,Michael Lazarou
2752,2752.0,Reconstitution of BNIP3/NIX-mediated autophagy reveals two pathways and hierarchical flexibility of the initiation machinery,Hurley,10.1101/2024.08.28.609967,,1.0,W4401944929,A5061450716,James H. Hurley,0000-0001-5054-5445,Lead PI,Team Hurley,James Hurley
2753,2753.0,Reconstitution of BNIP3/NIX-mediated autophagy reveals two pathways and hierarchical flexibility of the initiation machinery,Hurley,10.1101/2024.08.28.609967,,1.0,W4401944929,A5029002091,Sascha Martens,0000-0003-3786-8199,Co-PI,Team Hurley,Sascha Martens
2769,2769.0,Presynapses are mitophagy pit stops that prevent axon degeneration,Hurley,10.1101/2024.09.09.611943,,1.0,W4402420172,A5061877082,Michael Lazarou,0000-0003-2150-5545,Co-PI,Team Hurley,Michael Lazarou
2788,2788.0,LINE-1 retrotransposons drive human neuronal transcriptome complexity and functional diversification | Science Advances,Jakobsson,10.1101/2023.03.04.531072,10.1126/sciadv.adh9543,1.0,W4388173917,A5032075946,Molly Hammell,0000-0003-0405-8392,Co-PI,Team Jakobsson,Molly Hammell
2789,2789.0,LINE-1 retrotransposons drive human neuronal transcriptome complexity and functional diversification | Science Advances,Jakobsson,10.1101/2023.03.04.531072,10.1126/sciadv.adh9543,1.0,W4388173917,A5084748006,Roger A. Barker,0000-0001-8843-7730,Co-PI,Team Jakobsson,Roger Barker
2792,2792.0,LINE-1 retrotransposons drive human neuronal transcriptome complexity and functional diversification | Science Advances,Jakobsson,10.1101/2023.03.04.531072,10.1126/sciadv.adh9543,1.0,W4388173917,A5021760406,Johan Jakobsson,0000-0003-0669-7673,Lead PI,Team Jakobsson,Johan Jakobsson
2796,2796.0,State-of-the-art review of the clinical research on menopause and hormone replacement therapy association with Parkinson’s disease: What meta-analysis studies cannot tell us,Kaplitt,NA Review,10.3389/fnagi.2022.971007,0.0,W4306943613,A5000487408,Roberta Marongiu,0000-0002-7609-7000,Co-PI,Team Kaplitt,Roberta Marongiu
2799,2799.0,Cognitive dysfunction in animal models of human lewy-body dementia,Kaplitt,,10.3389/fnagi.2024.1369733,0.0,W4400896439,A5027250646,Michael G. Kaplitt,0000-0002-8979-2459,Lead-PI,Team Kaplitt,Michael Kaplitt
2805,2805.0,Gut-Initiated Alpha Synuclein Fibrils Drive Parkinson’s Disease Phenotypes: Temporal Mapping of non-Motor Symptoms and REM Sleep Behavior Disorder,Kaplitt,10.1101/2024.04.22.590542,,1.0,W4395660291,A5027250646,Michael G. Kaplitt,0000-0002-8979-2459,Lead-PI,Team Kaplitt,Michael Kaplitt
2807,2807.0,Gut-Initiated Alpha Synuclein Fibrils Drive Parkinson’s Disease Phenotypes: Temporal Mapping of non-Motor Symptoms and REM Sleep Behavior Disorder,Kaplitt,10.1101/2024.04.22.590542,,1.0,W4395660291,A5025568267,Valina L. Dawson,0000-0002-2915-3970,Collaborating PI,Team Kaplitt,Valina Dawson
2809,2809.0,Gut-Initiated Alpha Synuclein Fibrils Drive Parkinson’s Disease Phenotypes: Temporal Mapping of non-Motor Symptoms and REM Sleep Behavior Disorder,Kaplitt,10.1101/2024.04.22.590542,,1.0,W4395660291,A5021759485,Ted M. Dawson,0000-0002-6459-0893,Co-PI,Team Kaplitt,Ted Dawson
2810,2810.0,Gut-Initiated Alpha Synuclein Fibrils Drive Parkinson’s Disease Phenotypes: Temporal Mapping of non-Motor Symptoms and REM Sleep Behavior Disorder,Kaplitt,10.1101/2024.04.22.590542,,1.0,W4395660291,A5036364090,Per Svenningsson,0000-0001-6727-3802,Co-PI,Team Kaplitt,Per Svenningsson
2819,2819.0,Generation of the iPSC line FINi002-A from a male Parkinson's disease patient carrying compound heterozygous mutations in the PRKN gene - ScienceDirect,Kirik,NA (lab resource),10.1016/j.scr.2023.103211,0.0,W4387711107,A5047141421,Glenda M. Halliday,0000-0003-0422-8398,Collaborating PI,Team Edwards,Glenda Halliday
2820,2820.0,Generation of the iPSC line FINi002-A from a male Parkinson's disease patient carrying compound heterozygous mutations in the PRKN gene - ScienceDirect,Kirik,NA (lab resource),10.1016/j.scr.2023.103211,0.0,W4387711107,A5047141421,Glenda M. Halliday,0000-0003-0422-8398,Co-PI,Team Kirik,Glenda Halliday
2821,2821.0,Generation of the iPSC line FINi002-A from a male Parkinson's disease patient carrying compound heterozygous mutations in the PRKN gene - ScienceDirect,Kirik,NA (lab resource),10.1016/j.scr.2023.103211,0.0,W4387711107,A5047141421,Glenda M. Halliday,0000-0003-0422-8398,Co-PI,Team Vila,Glenda Halliday
2822,2822.0,Generation of the iPSC line FINi002-A from a male Parkinson's disease patient carrying compound heterozygous mutations in the PRKN gene - ScienceDirect,Kirik,NA (lab resource),10.1016/j.scr.2023.103211,0.0,W4387711107,A5083016310,Deniz Kirik,0000-0002-1360-1265,Lead-PI,Team Kirik,Deniz Kirik
2823,2823.0,Generation of the iPSC line FINi002-A from a male Parkinson's disease patient carrying compound heterozygous mutations in the PRKN gene - ScienceDirect,Kirik,NA (lab resource),10.1016/j.scr.2023.103211,0.0,W4387711107,A5044118193,Clare L. Parish,0000-0001-8212-9884,Co-PI,Team Kirik,Clare Parish
2824,2824.0,Generation of the iPSC line FINi002-A from a male Parkinson's disease patient carrying compound heterozygous mutations in the PRKN gene - ScienceDirect,Kirik,NA (lab resource),10.1016/j.scr.2023.103211,0.0,W4387711107,A5067345526,Lachlan H. Thompson,0000-0003-2632-0304,Co-PI,Team Kirik,Lachlan Thompson
2829,2829.0,Generation of human-induced pluripotent-stem-cell-derived cortical neurons for high-throughput imaging of neurite morphology and neuron maturation,Kirik,NA (protocol),10.1016/j.xpro.2023.102325,0.0,W4380204562,A5083016310,Deniz Kirik,0000-0002-1360-1265,Lead-PI,Team Kirik,Deniz Kirik
2830,2830.0,Generation of human-induced pluripotent-stem-cell-derived cortical neurons for high-throughput imaging of neurite morphology and neuron maturation,Kirik,NA (protocol),10.1016/j.xpro.2023.102325,0.0,W4380204562,A5044118193,Clare L. Parish,0000-0001-8212-9884,Co-PI,Team Kirik,Clare Parish
2835,2835.0,Neither alpha-synuclein fibril strain nor host murine genotype influences seeding efficacy,Kordower,10.1101/2023.08.24.554646,10.1038/s41531-024-00679-1,1.0,W4398172122,A5009140419,Ellen Sidransky,0000-0002-3019-8500,Co-PI,Team Vangheluwe,Ellen Sidransky
2840,2840.0,Neither alpha-synuclein fibril strain nor host murine genotype influences seeding efficacy,Kordower,10.1101/2023.08.24.554646,10.1038/s41531-024-00679-1,1.0,W4398172122,A5074765508,Jeffrey H. Kordower,0000-0001-8629-3294,Lead-PI,Team Kordower,Jeffrey Kordower
2842,2842.0,Nigrostriatal tau pathology in parkinsonism and Parkinson’s disease,Kordower,10.1101/2022.08.04.502831,10.1093/brain/awad388,1.0,W4388994083,A5020699970,Warren D. Hirst,0000-0003-0389-8891,Co-PI,Team Kordower,Warren Hirst
2844,2844.0,Nigrostriatal tau pathology in parkinsonism and Parkinson’s disease,Kordower,10.1101/2022.08.04.502831,10.1093/brain/awad388,1.0,W4388994083,A5046016738,Ashley S. Harms,0000-0002-7054-2812,Co-PI,Team Kordower,Ashley Harms
2845,2845.0,Nigrostriatal tau pathology in parkinsonism and Parkinson’s disease,Kordower,10.1101/2022.08.04.502831,10.1093/brain/awad388,1.0,W4388994083,A5046016738,Ashley S. Harms,0000-0002-7054-2812,Co-PI,Team Sulzer,Ashley Harms
2847,2847.0,Nigrostriatal tau pathology in parkinsonism and Parkinson’s disease,Kordower,10.1101/2022.08.04.502831,10.1093/brain/awad388,1.0,W4388994083,A5103177177,Jeffrey H. Kordower,0000-0003-0407-1861,Lead-PI,Team Kordower,Jeffrey Kordower
2851,2851.0,Alpha-synuclein aggregates are phosphatase resistant,Kordower,10.1101/2023.11.20.567854,10.1186/s40478-024-01785-0,1.0,W4399230878,A5103177177,Jeffrey H. Kordower,0000-0003-0407-1861,Lead-PI,Team Kordower,Jeffrey Kordower
2858,2858.0,Adult-Onset Deletion of ATP13A2 in Mice Induces Progressive Nigrostriatal Pathway Dopaminergic Degeneration and Lysosomal Abnormalities,Lee,10.1101/2024.01.25.577280,10.1038/s41531-024-00748-5,1.0,W4400859109,A5037205059,Darren J. Moore,0000-0003-2359-5679,Co-PI,Team Lee,Darren Moore
2862,2862.0,Targeting cellular senescence with senotherapeutics: senolytics and senomorphics,Lee,NA Review,10.1111/febs.16350,0.0,W4205869028,A5043039694,Laura J. Niedernhofer,0000-0002-1074-1385,Co-PI,Team Lee,Laura Niedernhofer
2867,2867.0,Cellular senescence: a key therapeutic target in aging and diseases,Lee,NA review,10.1172/JCI158450,0.0,W4289028880,A5043039694,Laura J. Niedernhofer,0000-0002-1074-1385,Co-PI,Team Lee,Laura Niedernhofer
2876,2876.0,Loss of Tau Expression Attenuates Neurodegeneration Associated with α-Synucleinopathy,Lee,10.21203/rs.3.rs-1150251/v1,10.1186/s40035-022-00309-x,1.0,W4283764255,A5021234825,Michael K. Lee,0000-0001-5865-9682,Lead-PI,Team Lee,Michael Lee
2887,2887.0,Internalized α-synuclein fibrils become truncated and resist degradation in neurons while glial cells rapidly degrade α-synuclein fibrils,Lee,10.1101/2024.06.05.597615,,1.0,W4399466972,A5021234825,Michael K. Lee,0000-0001-5865-9682,Lead-PI,Team Lee,Michael Lee
2895,2895.0,"A leaky gut dysregulates gene networks in the brain associated with immune activation, oxidative stress, and myelination in a mouse model of colitis",Liddle,10.1101/2023.08.10.552488,10.1016/j.bbi.2024.02.007,1.0,W4391656225,A5008036209,Malú G. Tansey,0000-0002-1719-4708,Co-PI,Team Liddle,Malú Tansey
2897,2897.0,Calcium influx into astrocytes plays a pivotal role in inflammation-driven behaviors - ScienceDirect,Liddle,review,10.1016/j.ceca.2023.102838,0.0,W4389331039,A5008036209,Malú G. Tansey,0000-0002-1719-4708,Co-PI,Team Liddle,Malú Tansey
2903,2903.0,Metagenomics of Parkinson’s disease implicates the gut microbiome in multiple disease mechanisms,Liddle,10.1101/2022.06.08.495316,10.1038/s41467-022-34667-x,1.0,W4309109636,A5000374325,David G. Standaert,0000-0003-2921-8348,Key Personnel (PI),Team Sulzer,David Standaert
2904,2904.0,Metagenomics of Parkinson’s disease implicates the gut microbiome in multiple disease mechanisms,Liddle,10.1101/2022.06.08.495316,10.1038/s41467-022-34667-x,1.0,W4309109636,A5058647225,Timothy R. Sampson,0000-0002-2486-8766,Co-PI,Team Liddle,Timothy Sampson
2905,2905.0,Metagenomics of Parkinson’s disease implicates the gut microbiome in multiple disease mechanisms,Liddle,10.1101/2022.06.08.495316,10.1038/s41467-022-34667-x,1.0,W4309109636,A5055969440,Haydeh Payami,0000-0001-9084-5338,Co-PI,Team Liddle,Haydeh Payami
2906,2906.0,Population fraction of Parkinson’s disease attributable to preventable risk factors - PMC (nih.gov),Liddle,10.1101/2023.05.19.23290231,10.1038/s41531-023-00603-z,1.0,W4389331336,A5055969440,Haydeh Payami,0000-0001-9084-5338,Co-PI,Team Liddle,Haydeh Payami
2909,2909.0,Population fraction of Parkinson’s disease attributable to preventable risk factors - PMC (nih.gov),Liddle,10.1101/2023.05.19.23290231,10.1038/s41531-023-00603-z,1.0,W4389331336,A5058647225,Timothy R. Sampson,0000-0002-2486-8766,Co-PI,Team Liddle,Timothy Sampson
2910,2910.0,Population fraction of Parkinson’s disease attributable to preventable risk factors - PMC (nih.gov),Liddle,10.1101/2023.05.19.23290231,10.1038/s41531-023-00603-z,1.0,W4389331336,A5000374325,David G. Standaert,0000-0003-2921-8348,Key Personnel (PI),Team Sulzer,David Standaert
2912,2912.0,Microbial amyloids in neurodegenerative amyloid diseases (wiley.com),Liddle,review,10.1111/febs.17023,0.0,W4389264036,A5058647225,Timothy R. Sampson,0000-0002-2486-8766,Co-PI,Team Liddle,Timothy Sampson
2930,2930.0,Anionic nanoplastic contaminants promote Parkinson’s disease–associated α-synuclein aggregation | Science Advances,Liddle,10.21203/rs.3.rs-3439102/v1,10.1126/sciadv.adi8716,1.0,W4388757415,A5071278272,Andrew B. West,0000-0002-3034-4061,Co-PI,Team Liddle,Andrew West
2931,2931.0,Central and peripheral innate and adaptive immunity in Parkinson’s disease | Science Translational Medicine,Liddle,review,10.1126/scitranslmed.adk3225,0.0,W4388486600,A5046016738,Ashley S. Harms,0000-0002-7054-2812,Co-PI,Team Kordower,Ashley Harms
2932,2932.0,Central and peripheral innate and adaptive immunity in Parkinson’s disease | Science Translational Medicine,Liddle,review,10.1126/scitranslmed.adk3225,0.0,W4388486600,A5046016738,Ashley S. Harms,0000-0002-7054-2812,Co-PI,Team Sulzer,Ashley Harms
2935,2935.0,Central and peripheral innate and adaptive immunity in Parkinson’s disease | Science Translational Medicine,Liddle,review,10.1126/scitranslmed.adk3225,0.0,W4388486600,A5008036209,Malú G. Tansey,0000-0002-1719-4708,Co-PI,Team Liddle,Malú Tansey
2942,2942.0,Gut mucosal cells transfer α-synuclein to the vagus nerve,Liddle,10.1101/2023.08.14.553305,10.1172/jci.insight.172192,1.0,W4389429458,A5071278272,Andrew B. West,0000-0002-3034-4061,Co-PI,Team Liddle,Andrew West
2943,2943.0,Gut mucosal cells transfer α-synuclein to the vagus nerve,Liddle,10.1101/2023.08.14.553305,10.1172/jci.insight.172192,1.0,W4389429458,A5058874182,Rodger A. Liddle,0000-0002-5498-4151,Lead-PI,Team Liddle,Rodger Liddle
2948,2948.0,Biochemical fractionation of human α-Synuclein in a Drosophila model of synucleinopathies,Liddle,10.1101/2024.02.05.579034,10.3390/ijms25073643,1.0,W4393142786,A5008036209,Malú G. Tansey,0000-0002-1719-4708,Co-PI,Team Liddle,Malú Tansey
2961,2961.0,Structural and functional landscape of α-synuclein fibril conformations amplified from cerebrospinal fluid,Liddle,10.1101/2022.07.13.499896,,1.0,W4285393454,A5071278272,Andrew B. West,0000-0002-3034-4061,Co-PI,Team Liddle,Andrew West
2972,2972.0,The R1441C-LRRK2 mutation induces myeloid immune cell exhaustion in an age- and sex-dependent manner | bioRxiv,Liddle,10.1101/2023.10.12.562063,,1.0,W4387705483,A5008036209,Malú G. Tansey,0000-0002-1719-4708,Co-PI,Team Liddle,Malú Tansey
2973,2973.0,Alpha-synuclein overexpression can drive microbiome dysbiosis in mice,Liddle,10.1101/2024.02.01.578464,,1.0,W4391482318,A5058647225,Timothy R. Sampson,0000-0002-2486-8766,Co-PI,Team Liddle,Timothy Sampson
2976,2976.0,Alpha-synuclein overexpression can drive microbiome dysbiosis in mice,Liddle,10.1101/2024.02.01.578464,,1.0,W4391482318,A5000374325,David G. Standaert,0000-0003-2921-8348,Key Personnel (PI),Team Sulzer,David Standaert
2977,2977.0,Alpha-synuclein overexpression can drive microbiome dysbiosis in mice,Liddle,10.1101/2024.02.01.578464,,1.0,W4391482318,A5055969440,Haydeh Payami,0000-0001-9084-5338,Co-PI,Team Liddle,Haydeh Payami
2978,2978.0,Alpha-synuclein overexpression can drive microbiome dysbiosis in mice,Liddle,10.1101/2024.02.01.578464,,1.0,W4391482318,A5046016738,Ashley S. Harms,0000-0002-7054-2812,Co-PI,Team Kordower,Ashley Harms
2979,2979.0,Alpha-synuclein overexpression can drive microbiome dysbiosis in mice,Liddle,10.1101/2024.02.01.578464,,1.0,W4391482318,A5046016738,Ashley S. Harms,0000-0002-7054-2812,Co-PI,Team Sulzer,Ashley Harms
2986,2986.0,Locus coeruleus injury modulates ventral midbrain neuroinflammation during DSS-induced colitis,Liddle,10.1101/2024.02.12.580010,,1.0,W4391770806,A5008036209,Malú G. Tansey,0000-0002-1719-4708,Co-PI,Team Liddle,Malú Tansey
2987,2987.0,Microbiome-based biomarkers to guide personalized microbiome-based therapies for Parkinson's disease,Liddle,10.1101/2024.04.03.24305273,,1.0,W4393931755,A5055969440,Haydeh Payami,0000-0001-9084-5338,Co-PI,Team Liddle,Haydeh Payami
2988,2988.0,Microbiome-based biomarkers to guide personalized microbiome-based therapies for Parkinson's disease,Liddle,10.1101/2024.04.03.24305273,,1.0,W4393931755,A5058647225,Timothy R. Sampson,0000-0002-2486-8766,Co-PI,Team Liddle,Timothy Sampson
2999,2999.0,A comparative analysis of Parkinson’s disease and inflammatory bowel disease gut microbiomes highlights shared depletions in key butyrate-producing bacteria,Liddle,10.1101/2024.04.26.591350,,1.0,W4396215826,A5008036209,Malú G. Tansey,0000-0002-1719-4708,Co-PI,Team Liddle,Malú Tansey
3019,3019.0,Mouse α-synuclein fibrils are structurally and functionally distinct from human fibrils associated with Lewy body diseases,Liddle,10.1101/2024.05.09.593334,,1.0,W4396809691,A5071278272,Andrew B. West,0000-0002-3034-4061,Co-PI,Team Liddle,Andrew West
3028,3028.0,Peripheral Blood Immune Cells from Individuals with Parkinson’s Disease or Inflammatory Bowel Disease Share Deficits in Iron Storage and Transport that are Modulated by Non-Steroidal Anti-Inflammatory Drugs,Liddle,10.1101/2024.08.19.608634,,1.0,W4401712885,A5008036209,Malú G. Tansey,0000-0002-1719-4708,Co-PI,Team Liddle,Malú Tansey
3029,3029.0,Delivery of RNA Therapeutics: The Great Endosomal Escape!,Mobley,NA review,10.1089/nat.2022.0004,0.0,W4281486640,A5048054072,Steven F. Dowdy,0000-0003-3083-2257,Co-PI,Team Mobley,Steven Dowdy
3033,3033.0,Therapeutic Potential of PTB Inhibition Through Converting Glial Cells to Neurons in the Brain | Annual Review of Neuroscience (annualreviews.org),Mobley,review,10.1146/annurev-neuro-083022-113120,0.0,W4383815147,A5103144746,Xiang‐Dong Fu,0000-0001-5499-8732,Lead-PI,Team Mobley,Xiang‐Dong Fu
3034,3034.0,Therapeutic Potential of PTB Inhibition Through Converting Glial Cells to Neurons in the Brain | Annual Review of Neuroscience (annualreviews.org),Mobley,review,10.1146/annurev-neuro-083022-113120,0.0,W4383815147,A5009879178,William C. Mobley,0000-0002-6408-9548,Co-PI,Team Mobley,William Mobley
3035,3035.0,Endosomal escape of RNA therapeutics: How do we solve this rate-limiting problem? (cshlp.org),Mobley,review,10.1261/rna.079507.122,0.0,W4317600205,A5048054072,Steven F. Dowdy,0000-0003-3083-2257,Co-PI,Team Mobley,Steven Dowdy
3040,3040.0,Dopamine transporter imaging predicts clinically-defined α-synucleinopathy in REM sleep behavior disorder,PPMI,missing,10.1002/acn3.51269,1.0,W3118160052,A5082185657,Brit Mollenhauer,0000-0001-8437-3645,Co-PI,Team Schlossmacher,Brit Mollenhauer
3041,3041.0,Dopamine transporter imaging predicts clinically-defined α-synucleinopathy in REM sleep behavior disorder,PPMI,missing,10.1002/acn3.51269,1.0,W3118160052,A5067845430,Amy W. Amara,0000-0003-0762-9656,Key Personnel (PI),Team Sulzer,Amy Amara
3076,3076.0,Impact of the dopamine system on long-term cognitive impairment in Parkinson disease: an exploratory study,PPMI,missing,10.1002/mdc3.13751,1.0,W4364360245,A5082185657,Brit Mollenhauer,0000-0001-8437-3645,Co-PI,Team Schlossmacher,Brit Mollenhauer
3105,3105.0,Longitudinal Analysis of Multiple Neurotransmitter Metabolites in Cerebrospinal Fluid in Early Parkinson's Disease,PPMI,missing,10.1002/mds.28608,1.0,W3157129664,A5082185657,Brit Mollenhauer,0000-0001-8437-3645,Co-PI,Team Schlossmacher,Brit Mollenhauer
3130,3130.0,Assessment of heterogeneity and disease onset in the Parkinson’s Progression Markers Initiative (PPMI) cohort using the α-synuclein seed amplification assay: a cross-sectional study,PPMI,10.1101/2023.02.27.23286156,10.1016/S1474-4422(23)00109-6,1.0,W4365459497,A5082185657,Brit Mollenhauer,0000-0001-8437-3645,Co-PI,Team Schlossmacher,Brit Mollenhauer
3165,3165.0,A biological definition of neuronal α-synuclein disease: towards an integrated staging system for research - The Lancet Neurology,PPMI,commentary,10.1016/S1474-4422(23)00405-2,0.0,W4391090353,A5082185657,Brit Mollenhauer,0000-0001-8437-3645,Co-PI,Team Schlossmacher,Brit Mollenhauer
3217,3217.0,Biomarkers of neurodegeneration and glial activation validated in Alzheimer’s disease assessed in longitudinal cerebrospinal fluid samples of Parkinson’s disease,PPMI,missing,10.1371/journal.pone.0257372,1.0,W3201883528,A5082185657,Brit Mollenhauer,0000-0001-8437-3645,Co-PI,Team Schlossmacher,Brit Mollenhauer
3260,3260.0,Parkinson’s Progression Markers Initiative: A Milestone-Based Strategy to Monitor PD Progression,PPMI,10.1101/2023.05.23.23290344,,1.0,W4377967472,A5082185657,Brit Mollenhauer,0000-0001-8437-3645,Co-PI,Team Schlossmacher,Brit Mollenhauer
3292,3292.0,"Neuronal alpha-Synuclein Disease Integrated Staging System performance in PPMI, PASADENA, and SPARK baseline cohorts",PPMI,10.1101/2024.02.14.24302818,,1.0,W4391846234,A5082185657,Brit Mollenhauer,0000-0001-8437-3645,Co-PI,Team Schlossmacher,Brit Mollenhauer
3356,3356.0,Urinary bis(monacylglycerol) phosphate (BMP) levels are higher in LRRK2 and GBA1 variant carriers but do not predict disease progression in PPMI cohorts,PPMI,10.21203/rs.3.rs-2065993/v1,,1.0,W4302007502,A5082185657,Brit Mollenhauer,0000-0001-8437-3645,Co-PI,Team Schlossmacher,Brit Mollenhauer
3359,3359.0,Scientific Perspectives: Structural Biology of LRRK2 and its Interaction with Microtubules,Reck-Peterson,review,10.1002/mds.28755,0.0,W3196071261,A5011173483,Andres E. Leschziner,0000-0002-7732-7023,Co-PI,Team Reck-Peterson,Andres Leschziner
3360,3360.0,Scientific Perspectives: Structural Biology of LRRK2 and its Interaction with Microtubules,Reck-Peterson,review,10.1002/mds.28755,0.0,W3196071261,A5021023250,Samara L. Reck‐Peterson,0000-0002-1553-465X,Lead-PI,Team Reck-Peterson,Samara Reck‐Peterson
3374,3374.0,Development of LRRK2 designed ankyrin-repeat proteins,Reck-Peterson,10.1101/2023.11.14.567123,10.1016/j.jbc.2024.107469,1.0,W4399566509,A5011173483,Andres E. Leschziner,0000-0002-7732-7023,Co-PI,Team Reck-Peterson,Andres Leschziner
3375,3375.0,Development of LRRK2 designed ankyrin-repeat proteins,Reck-Peterson,10.1101/2023.11.14.567123,10.1016/j.jbc.2024.107469,1.0,W4399566509,A5021023250,Samara L. Reck‐Peterson,0000-0002-1553-465X,Lead-PI,Team Reck-Peterson,Samara Reck‐Peterson
3376,3376.0,Development of LRRK2 designed ankyrin-repeat proteins,Reck-Peterson,10.1101/2023.11.14.567123,10.1016/j.jbc.2024.107469,1.0,W4399566509,A5013336817,Stefan Knapp,0000-0001-5995-6494,Co-PI,Team Reck-Peterson,Stefan Knapp
3384,3384.0,Mono- and Intralink Filter (Mi-Filter) To Reduce False Identifications in Cross-Linking Mass Spectrometry Data | Analytical Chemistry (acs.org),Reck-Peterson,10.1101/2022.02.03.478943,10.1021/acs.analchem.2c00494,1.0,W4311220075,A5006736501,Florian Stengel,0000-0003-1447-4509,Collaborating PI,Team Reck-Peterson,Florian Stengel
3389,3389.0,Structural basis for Parkinson’s Disease-linked LRRK2’s binding to microtubules,Reck-Peterson,10.1101/2022.01.21.477284,10.1038/s41594-022-00863-y,1.0,W4311901922,A5011173483,Andres E. Leschziner,0000-0002-7732-7023,Co-PI,Team Reck-Peterson,Andres Leschziner
3390,3390.0,Structural basis for Parkinson’s Disease-linked LRRK2’s binding to microtubules,Reck-Peterson,10.1101/2022.01.21.477284,10.1038/s41594-022-00863-y,1.0,W4311901922,A5021023250,Samara L. Reck‐Peterson,0000-0002-1553-465X,Lead-PI,Team Reck-Peterson,Samara Reck‐Peterson
3398,3398.0,Structure of LRRK1 and mechanisms of autoinhibition and activation,Reck-Peterson,10.1101/2022.11.22.517582,10.1038/s41594-023-01109-1,1.0,W4387782462,A5013336817,Stefan Knapp,0000-0001-5995-6494,Co-PI,Team Reck-Peterson,Stefan Knapp
3400,3400.0,Structure of LRRK1 and mechanisms of autoinhibition and activation,Reck-Peterson,10.1101/2022.11.22.517582,10.1038/s41594-023-01109-1,1.0,W4387782462,A5021023250,Samara L. Reck‐Peterson,0000-0002-1553-465X,Lead-PI,Team Reck-Peterson,Samara Reck‐Peterson
3401,3401.0,Structure of LRRK1 and mechanisms of autoinhibition and activation,Reck-Peterson,10.1101/2022.11.22.517582,10.1038/s41594-023-01109-1,1.0,W4387782462,A5011173483,Andres E. Leschziner,0000-0002-7732-7023,Co-PI,Team Reck-Peterson,Andres Leschziner
3407,3407.0,Inhibition of Parkinson’s Disease-related LRRK2 by type-I and type-II kinase inhibitors: activity and structures | bioRxiv,Reck-Peterson,10.1101/2023.09.07.556689,10.1126/sciadv.adk6191,1.0,W4389233086,A5013336817,Stefan Knapp,0000-0001-5995-6494,Co-PI,Team Reck-Peterson,Stefan Knapp
3409,3409.0,Inhibition of Parkinson’s Disease-related LRRK2 by type-I and type-II kinase inhibitors: activity and structures | bioRxiv,Reck-Peterson,10.1101/2023.09.07.556689,10.1126/sciadv.adk6191,1.0,W4389233086,A5011173483,Andres E. Leschziner,0000-0002-7732-7023,Co-PI,Team Reck-Peterson,Andres Leschziner
3416,3416.0,Cryo-electron tomography reveals the microtubule-bound form of inactive LRRK2,Reck-Peterson,10.1101/2024.06.18.599606,,1.0,W4399852907,A5011173483,Andres E. Leschziner,0000-0002-7732-7023,Co-PI,Team Reck-Peterson,Andres Leschziner
3417,3417.0,Cryo-electron tomography reveals the microtubule-bound form of inactive LRRK2,Reck-Peterson,10.1101/2024.06.18.599606,,1.0,W4399852907,A5087861735,Elizabeth Villa,0000-0003-4677-9809,Co-PI,Team Reck-Peterson,Elizabeth Villa
3425,3425.0,Highly efficient generation of isogenic pluripotent stem cell models using prime editing,Rio,10.1101/2022.02.15.480601,10.7554/eLife.79208,1.0,W4294904866,A5089305536,Helen S. Bateup,0000-0002-0135-0972,Co-PI,Team Rio,Helen Bateup
3426,3426.0,Highly efficient generation of isogenic pluripotent stem cell models using prime editing,Rio,10.1101/2022.02.15.480601,10.7554/eLife.79208,1.0,W4294904866,A5034073565,Donald C. Rio,,Lead-PI,Team Rio,Donald Rio
3427,3427.0,Highly efficient generation of isogenic pluripotent stem cell models using prime editing,Rio,10.1101/2022.02.15.480601,10.7554/eLife.79208,1.0,W4294904866,A5045835078,Dirk Hockemeyer,0000-0002-5598-5092,Co-PI,Team Rio,Dirk Hockemeyer
3428,3428.0,Highly efficient generation of isogenic pluripotent stem cell models using prime editing,Rio,10.1101/2022.02.15.480601,10.7554/eLife.79208,1.0,W4294904866,A5070152031,Frank Soldner,0000-0002-7102-8655,Co-PI,Team Rio,Frank Soldner
3451,3451.0,iSCORE-PD: an isogenic stem cell collection to research Parkinson’s Disease,Rio,10.1101/2024.02.12.579917,,1.0,W4391820161,A5089305536,Helen S. Bateup,0000-0002-0135-0972,Co-PI,Team Rio,Helen Bateup
3452,3452.0,iSCORE-PD: an isogenic stem cell collection to research Parkinson’s Disease,Rio,10.1101/2024.02.12.579917,,1.0,W4391820161,A5034073565,Donald C. Rio,,Lead-PI,Team Rio,Donald Rio
3454,3454.0,iSCORE-PD: an isogenic stem cell collection to research Parkinson’s Disease,Rio,10.1101/2024.02.12.579917,,1.0,W4391820161,A5045835078,Dirk Hockemeyer,0000-0002-5598-5092,Co-PI,Team Rio,Dirk Hockemeyer
3455,3455.0,iSCORE-PD: an isogenic stem cell collection to research Parkinson’s Disease,Rio,10.1101/2024.02.12.579917,,1.0,W4391820161,A5070152031,Frank Soldner,0000-0002-7102-8655,Co-PI,Team Rio,Frank Soldner
3462,3462.0,Comparison of Alternative pre-mRNA Splicing and Gene Expression Patterns in Midbrain Lineage Cells Carrying Familial Parkinson’s Disease Mutations,Rio,10.1101/2024.02.28.582420,,1.0,W4392342300,A5089305536,Helen S. Bateup,0000-0002-0135-0972,Co-PI,Team Rio,Helen Bateup
3463,3463.0,Comparison of Alternative pre-mRNA Splicing and Gene Expression Patterns in Midbrain Lineage Cells Carrying Familial Parkinson’s Disease Mutations,Rio,10.1101/2024.02.28.582420,,1.0,W4392342300,A5070152031,Frank Soldner,0000-0002-7102-8655,Co-PI,Team Rio,Frank Soldner
3464,3464.0,Comparison of Alternative pre-mRNA Splicing and Gene Expression Patterns in Midbrain Lineage Cells Carrying Familial Parkinson’s Disease Mutations,Rio,10.1101/2024.02.28.582420,,1.0,W4392342300,A5045835078,Dirk Hockemeyer,0000-0002-5598-5092,Co-PI,Team Rio,Dirk Hockemeyer
3465,3465.0,Comparison of Alternative pre-mRNA Splicing and Gene Expression Patterns in Midbrain Lineage Cells Carrying Familial Parkinson’s Disease Mutations,Rio,10.1101/2024.02.28.582420,,1.0,W4392342300,A5034073565,Donald C. Rio,,Lead-PI,Team Rio,Donald Rio
3472,3472.0,Comparison of Alternative pre-mRNA Splicing and Gene Expression Patterns in Midbrain Lineage Cells Carrying Familial Parkinson’s Disease Mutations,Rio,10.1101/2024.02.28.582420,,1.0,W4392342300,A5089305536,Helen S. Bateup,0000-0002-0135-0972,Co-PI,Team Rio,Helen Bateup
3473,3473.0,Comparison of Alternative pre-mRNA Splicing and Gene Expression Patterns in Midbrain Lineage Cells Carrying Familial Parkinson’s Disease Mutations,Rio,10.1101/2024.02.28.582420,,1.0,W4392342300,A5070152031,Frank Soldner,0000-0002-7102-8655,Co-PI,Team Rio,Frank Soldner
3474,3474.0,Comparison of Alternative pre-mRNA Splicing and Gene Expression Patterns in Midbrain Lineage Cells Carrying Familial Parkinson’s Disease Mutations,Rio,10.1101/2024.02.28.582420,,1.0,W4392342300,A5045835078,Dirk Hockemeyer,0000-0002-5598-5092,Co-PI,Team Rio,Dirk Hockemeyer
3475,3475.0,Comparison of Alternative pre-mRNA Splicing and Gene Expression Patterns in Midbrain Lineage Cells Carrying Familial Parkinson’s Disease Mutations,Rio,10.1101/2024.02.28.582420,,1.0,W4392342300,A5034073565,Donald C. Rio,,Lead-PI,Team Rio,Donald Rio
3477,3477.0,Sex Distribution of GBA1 Variants Carriers with Dementia with Lewy Bodies and Parkinson's Disease - Toffoli - 2023 - Movement Disorders - Wiley Online Library,Schapira,review,10.1002/mds.29609,0.0,W4386945332,A5059770430,Anthony H.V. Schapira,0000-0002-3018-3966,Lead-PI,Team Schapira,Anthony Schapira
3478,3478.0,Sex Distribution of GBA1 Variants Carriers with Dementia with Lewy Bodies and Parkinson's Disease - Toffoli - 2023 - Movement Disorders - Wiley Online Library,Schapira,review,10.1002/mds.29609,0.0,W4386945332,A5012157016,Christos Proukakis,0000-0001-6423-6539,Co-PI,Team Voet,Christos Proukakis
3480,3480.0,"Who is at Risk of Parkinson Disease? Refining the Preclinical Phase of GBA1 and LRRK2 Variant Carriers: a Clinical, Biochemical, and Imaging Approach",Schapira,review,10.1007/s11910-023-01259-1,0.0,W4323348262,A5059770430,Anthony H.V. Schapira,0000-0002-3018-3966,Lead-PI,Team Schapira,Anthony Schapira
3481,3481.0,"Who is at Risk of Parkinson Disease? Refining the Preclinical Phase of GBA1 and LRRK2 Variant Carriers: a Clinical, Biochemical, and Imaging Approach",Schapira,review,10.1007/s11910-023-01259-1,0.0,W4323348262,A5007019878,Fabio Blandini,0000-0002-0178-1289,Co-PI,Team Schapira,Fabio Blandini
3484,3484.0,The Gut Microbiota in Parkinson Disease: Interactions with Drugs and Potential for Therapeutic Applications,Schapira,NA_review,10.1007/s40263-024-01073-4,0.0,W4393901714,A5059770430,Anthony H.V. Schapira,0000-0002-3018-3966,Lead-PI,Team Schapira,Anthony Schapira
3508,3508.0,Phenotypic effect of GBA1 variants in individuals with and without Parkinson's disease: The RAPSODI study - PubMed (nih.gov),Schapira,10.1101/2023.07.25.23291637,10.1016/j.nbd.2023.106343,1.0,W4388304230,A5012157016,Christos Proukakis,0000-0001-6423-6539,Co-PI,Team Voet,Christos Proukakis
3509,3509.0,Phenotypic effect of GBA1 variants in individuals with and without Parkinson's disease: The RAPSODI study - PubMed (nih.gov),Schapira,10.1101/2023.07.25.23291637,10.1016/j.nbd.2023.106343,1.0,W4388304230,A5059770430,Anthony H.V. Schapira,0000-0002-3018-3966,Lead-PI,Team Schapira,Anthony Schapira
3512,3512.0,Bile acids and neurological disease,Schapira,review,10.1016/j.pharmthera.2022.108311,0.0,W4309413381,A5002329761,Jane Macnaughtan,0000-0003-1211-9298,Collaborating PI,Team Schapira,Jane Macnaughtan
3513,3513.0,Bile acids and neurological disease,Schapira,review,10.1016/j.pharmthera.2022.108311,0.0,W4309413381,A5059770430,Anthony H.V. Schapira,0000-0002-3018-3966,Lead-PI,Team Schapira,Anthony Schapira
3516,3516.0,"Targeting the GBA1 pathway to slow Parkinson disease: Insights into clinical aspects, pathogenic mechanisms and new therapeutic avenues",Schapira,review,10.1016/j.pharmthera.2023.108419,0.0,W4366256886,A5059770430,Anthony H.V. Schapira,0000-0002-3018-3966,Lead-PI,Team Schapira,Anthony Schapira
3531,3531.0,Glucocerebrosidase is imported into mitochondria and preserves complex I integrity and energy metabolism,Schapira,10.21203/rs.3.rs-1521848/v1,10.1038/s41467-023-37454-4,1.0,W4362692584,A5059770430,Anthony H.V. Schapira,0000-0002-3018-3966,Lead-PI,Team Schapira,Anthony Schapira
3533,3533.0,Glucocerebrosidase is imported into mitochondria and preserves complex I integrity and energy metabolism,Schapira,10.21203/rs.3.rs-1521848/v1,10.1038/s41467-023-37454-4,1.0,W4362692584,A5056933907,Michela Deleidi,0000-0003-0357-0124,Co-PI,Team Schapira,Michela Deleidi
3547,3547.0,LRRK2 kinase activity regulates GCase level and enzymatic activity differently depending on cell type in Parkinson’s disease,Schapira,10.1101/2021.09.27.461935,10.1038/s41531-022-00354-3,1.0,W4285797163,A5056933907,Michela Deleidi,0000-0003-0357-0124,Co-PI,Team Schapira,Michela Deleidi
3556,3556.0,Sphingolipid changes in Parkinson L444P GBA mutation fibroblasts promote α-synuclein aggregation,Schapira,10.1101/2020.11.09.375048,10.1093/brain/awab371,1.0,W4205299346,A5059770430,Anthony H.V. Schapira,0000-0002-3018-3966,Lead-PI,Team Schapira,Anthony Schapira
3557,3557.0,Sphingolipid changes in Parkinson L444P GBA mutation fibroblasts promote α-synuclein aggregation,Schapira,10.1101/2020.11.09.375048,10.1093/brain/awab371,1.0,W4205299346,A5007019878,Fabio Blandini,0000-0002-0178-1289,Co-PI,Team Schapira,Fabio Blandini
3558,3558.0,Sphingolipid changes in Parkinson L444P GBA mutation fibroblasts promote α-synuclein aggregation,Schapira,10.1101/2020.11.09.375048,10.1093/brain/awab371,1.0,W4205299346,A5035849217,Donato A. Di Monte,0000-0002-8296-836X,Co-PI,Team Schapira,Donato Monte
3565,3565.0,α-synuclein expression in response to bacterial ligands and metabolites in gut enteroendocrine cells,Schapira,10.1101/2023.04.02.535274,10.1093/braincomms/fcad285,1.0,W4387928799,A5081742118,Hervé M. Blottière,0000-0002-8390-0607,Collaborating PI,Team Schapira,Hervé Blottière
3566,3566.0,α-synuclein expression in response to bacterial ligands and metabolites in gut enteroendocrine cells,Schapira,10.1101/2023.04.02.535274,10.1093/braincomms/fcad285,1.0,W4387928799,A5002329761,Jane Macnaughtan,0000-0003-1211-9298,Collaborating PI,Team Schapira,Jane Macnaughtan
3567,3567.0,α-synuclein expression in response to bacterial ligands and metabolites in gut enteroendocrine cells,Schapira,10.1101/2023.04.02.535274,10.1093/braincomms/fcad285,1.0,W4387928799,A5059770430,Anthony H.V. Schapira,0000-0002-3018-3966,Lead-PI,Team Schapira,Anthony Schapira
3572,3572.0,The GBA variant E326K is associated with alpha-synuclein aggregation and lipid droplet accumulation in human cell lines,Schapira,10.1101/2022.06.01.494130,10.1093/hmg/ddac233,1.0,W4296974338,A5059770430,Anthony H.V. Schapira,0000-0002-3018-3966,Lead-PI,Team Schapira,Anthony Schapira
3576,3576.0,Glucocerebrosidase 1 and leucine-rich repeat kinase 2 in Parkinson disease and interplay between the two genes,Schapira,review,10.1111/jnc.15524,0.0,W3204540093,A5059770430,Anthony H.V. Schapira,0000-0002-3018-3966,Lead-PI,Team Schapira,Anthony Schapira
3586,3586.0,Neuronal hyperactivity–induced oxidant stress promotes in vivo α-synuclein brain spreading,Schapira,,10.1126/sciadv.abn0356,0.0,W4293783041,A5035849217,Donato A. Di Monte,0000-0002-8296-836X,Co-PI,Team Schapira,Donato Monte
3593,3593.0,The remote assessment of parkinsonism supporting the ongoing development of interventions in Gaucher disease,Schapira,10.1101/2021.07.21.21260533,10.2217/nmt-2021-0032,0.0,W3206328474,A5007019878,Fabio Blandini,0000-0002-0178-1289,Co-PI,Team Schapira,Fabio Blandini
3594,3594.0,The remote assessment of parkinsonism supporting the ongoing development of interventions in Gaucher disease,Schapira,10.1101/2021.07.21.21260533,10.2217/nmt-2021-0032,0.0,W3206328474,A5059770430,Anthony H.V. Schapira,0000-0002-3018-3966,Lead-PI,Team Schapira,Anthony Schapira
3598,3598.0,Genetic variations in GBA1 and LRRK2 genes: Biochemical and clinical consequences in Parkinson disease,Schapira,review,10.3389/fneur.2022.971252,0.0,W4290830810,A5059770430,Anthony H.V. Schapira,0000-0002-3018-3966,Lead-PI,Team Schapira,Anthony Schapira
3608,3608.0,Evaluation of an adapted semi-automated DNA extraction for human salivary shotgun metagenomics,Schapira,10.21203/rs.3.rs-2762553/v1,10.3390/biom13101505,1.0,W4387531995,A5002329761,Jane Macnaughtan,0000-0003-1211-9298,Collaborating PI,Team Schapira,Jane Macnaughtan
3611,3611.0,Evaluation of an adapted semi-automated DNA extraction for human salivary shotgun metagenomics,Schapira,10.21203/rs.3.rs-2762553/v1,10.3390/biom13101505,1.0,W4387531995,A5059770430,Anthony H.V. Schapira,0000-0002-3018-3966,Lead-PI,Team Schapira,Anthony Schapira
3612,3612.0,Evaluation of an adapted semi-automated DNA extraction for human salivary shotgun metagenomics,Schapira,10.21203/rs.3.rs-2762553/v1,10.3390/biom13101505,1.0,W4387531995,A5067904253,Mathieu Almeida,0000-0003-4971-0049,Co-PI,Team Schapira,Mathieu Almeida
3614,3614.0,GBA Variants and Parkinson Disease: Mechanisms and Treatments,Schapira,review,10.3390/cells11081261,0.0,W4224297855,A5059770430,Anthony H.V. Schapira,0000-0002-3018-3966,Lead-PI,Team Schapira,Anthony Schapira
3622,3622.0,Sex-specific microglial responses to glucocerebrosidase inhibition: relevance to GBA1-linked Parkinson disease,Schapira,10.1101/2022.12.05.519143,10.3390/cells12030343,1.0,W4316690364,A5059770430,Anthony H.V. Schapira,0000-0002-3018-3966,Lead-PI,Team Schapira,Anthony Schapira
3634,3634.0,LRRK2-G2019S Synergizes with Ageing and Low-Grade Inflammation to Promote Gut and Peripheral Immune Cell Activation that Precede Nigrostriatal Degeneration,Schapira,10.1101/2022.09.01.505977,,1.0,W4295067826,A5056933907,Michela Deleidi,0000-0003-0357-0124,Co-PI,Team Schapira,Michela Deleidi
3643,3643.0,Reduction of a-synuclein aggregates by PIKfyve inhibition via TFEB-mediated lysosomal biogenesis in a Parkinson disease model | bioRxiv,Schapira,10.1101/2023.10.23.563557,,1.0,W4387908165,A5059770430,Anthony H.V. Schapira,0000-0002-3018-3966,Lead-PI,Team Schapira,Anthony Schapira
3649,3649.0,Mitochondrial oxidant stress promotes α-synuclein aggregation and spreading in mice with mutated glucocerebrosidase,Schapira,10.1101/2024.06.13.598820,,1.0,W4399693312,A5059770430,Anthony H.V. Schapira,0000-0002-3018-3966,Lead-PI,Team Schapira,Anthony Schapira
3651,3651.0,Mitochondrial oxidant stress promotes α-synuclein aggregation and spreading in mice with mutated glucocerebrosidase,Schapira,10.1101/2024.06.13.598820,,1.0,W4399693312,A5035849217,Donato A. Di Monte,0000-0002-8296-836X,Co-PI,Team Schapira,Donato Monte
3664,3664.0,The mitochondrial unfolded protein response promotes senescence in human microglia by increasing S-adenosylmethionine availability for polyamine synthesis,Schapira,10.1101/2024.09.03.610925,,1.0,W4402178515,A5056933907,Michela Deleidi,0000-0003-0357-0124,Co-PI,Team Schapira,Michela Deleidi
3676,3676.0,Post-fibrillization nitration of alpha-synuclein abolishes its seeding activity and pathology formation in primary neurons and in vivo,Schapira,10.1101/2023.03.24.534149,,1.0,W4360951881,A5035849217,Donato A. Di Monte,0000-0002-8296-836X,Co-PI,Team Schapira,Donato Monte
3680,3680.0,Nicotine-Mediated Rescue of α-Synuclein Toxicity Requires Synaptic Vesicle Glycoprotein 2 in Drosophila,Scherzer,10.1101/2022.07.26.501592,10.1002/mds.29283,1.0,W4309748707,A5002571663,Mel Β. Feany,0000-0003-0315-7970,Co-PI,Team Scherzer,Mel Feany
3692,3692.0,Circular RNAs in the human brain are tailored to neuron identity and neuropsychiatric disease,Scherzer,10.1101/2023.04.01.535194,10.1038/s41467-023-40348-0,1.0,W4386833452,A5053690577,Xianjun Dong,0000-0002-8052-9320,Co-PI,Team Scherzer,Xianjun Dong
3701,3701.0,Circular RNAs in the human brain are tailored to neuron identity and neuropsychiatric disease,Scherzer,10.1101/2023.04.01.535194,10.1038/s41467-023-40348-0,1.0,W4386833452,A5002571663,Mel Β. Feany,0000-0003-0315-7970,Co-PI,Team Scherzer,Mel Feany
3703,3703.0,Circular RNAs in the human brain are tailored to neuron identity and neuropsychiatric disease,Scherzer,10.1101/2023.04.01.535194,10.1038/s41467-023-40348-0,1.0,W4386833452,A5072613176,Thomas G. Beach,0000-0003-3296-6128,Collaborating PI,Team Voet,Thomas Beach
3704,3704.0,Circular RNAs in the human brain are tailored to neuron identity and neuropsychiatric disease,Scherzer,10.1101/2023.04.01.535194,10.1038/s41467-023-40348-0,1.0,W4386833452,A5008377476,Clemens R. Scherzer,0000-0002-0567-9193,Lead-PI,Team Scherzer,Clemens Scherzer
3709,3709.0,Integrative analysis reveals a conserved role for the amyloid precursor protein in proteostasis during aging,Scherzer,10.1101/2023.10.06.560646,10.1038/s41467-023-42822-1,1.0,W4388288214,A5053690577,Xianjun Dong,0000-0002-8052-9320,Co-PI,Team Scherzer,Xianjun Dong
3711,3711.0,Integrative analysis reveals a conserved role for the amyloid precursor protein in proteostasis during aging,Scherzer,10.1101/2023.10.06.560646,10.1038/s41467-023-42822-1,1.0,W4388288214,A5002571663,Mel Β. Feany,0000-0003-0315-7970,Co-PI,Team Scherzer,Mel Feany
3724,3724.0,Disease progression strikingly differs in research and real-world Parkinson’s populations,Scherzer,10.1101/2024.02.17.24302981,10.1038/s41531-024-00667-5,1.0,W4392740577,A5008377476,Clemens R. Scherzer,0000-0002-0567-9193,Lead-PI,Team Scherzer,Clemens Scherzer
3739,3739.0,Generation of locus coeruleus norepinephrine neurons from human pluripotent stem cells | Nature Biotechnology,Scherzer,missing,10.1038/s41587-023-01977-4,1.0,W4388728640,A5030394012,Su‐Chun Zhang,,Co-PI,Team Scherzer,Su‐Chun Zhang
3740,3740.0,powerEQTL: An R package and shiny application for sample size and power calculation of bulk tissue and single-cell eQTL analysis,Scherzer,10.1101/2020.12.15.422954,10.1093/bioinformatics/btab385,1.0,W3162394046,A5053690577,Xianjun Dong,0000-0002-8052-9320,Co-PI,Team Scherzer,Xianjun Dong
3743,3743.0,powerEQTL: An R package and shiny application for sample size and power calculation of bulk tissue and single-cell eQTL analysis,Scherzer,10.1101/2020.12.15.422954,10.1093/bioinformatics/btab385,1.0,W3162394046,A5008377476,Clemens R. Scherzer,0000-0002-0567-9193,Lead-PI,Team Scherzer,Clemens Scherzer
3748,3748.0,Pathways controlling neurotoxicity and proteostasis in mitochondrial complex I deficiency | bioRxiv,Scherzer,10.1101/2024.01.08.574634,10.1093/hmg/ddae018,1.0,W4391592420,A5002571663,Mel Β. Feany,0000-0003-0315-7970,Co-PI,Team Scherzer,Mel Feany
3757,3757.0,Transcriptional programs mediating neuronal toxicity and altered glial-neuronal signaling in a Drosophila knock-in tauopathy model,Scherzer,10.1101/2024.02.02.578624,10.1101/gr.278576.123,1.0,W4394676908,A5053690577,Xianjun Dong,0000-0002-8052-9320,Co-PI,Team Scherzer,Xianjun Dong
3758,3758.0,Transcriptional programs mediating neuronal toxicity and altered glial-neuronal signaling in a Drosophila knock-in tauopathy model,Scherzer,10.1101/2024.02.02.578624,10.1101/gr.278576.123,1.0,W4394676908,A5002571663,Mel Β. Feany,0000-0003-0315-7970,Co-PI,Team Scherzer,Mel Feany
3768,3768.0,Chemically induced senescence in human stem cell‐derived neurons promotes phenotypic presentation of neurodegeneration,Scherzer,10.1101/2021.07.11.451956,10.1111/acel.13541,1.0,W4200380426,A5030394012,Su‐Chun Zhang,,Co-PI,Team Scherzer,Su‐Chun Zhang
3771,3771.0,α-Synuclein Promotes Neuronal Dysfunction and Death by Disrupting the Binding of Ankyrin to β-Spectrin,Scherzer,10.1101/2023.06.02.543481,10.1523/JNEUROSCI.1922-22.2022,1.0,W4317384288,A5002571663,Mel Β. Feany,0000-0003-0315-7970,Co-PI,Team Scherzer,Mel Feany
3784,3784.0,Towards a phenome-wide view of Parkinson’s disease,Scherzer,10.1101/2022.02.01.22270276,,1.0,W4210801458,A5055136563,Vikram Khurana,0000-0002-4018-5527,Co-PI,Team Studer,Vikram Khurana
3791,3791.0,Towards a phenome-wide view of Parkinson’s disease,Scherzer,10.1101/2022.02.01.22270276,,1.0,W4210801458,A5041777746,Michael A. Schwarzschild,0000-0001-6019-8280,Co-PI,Team Chen,Michael Schwarzschild
3794,3794.0,Towards a phenome-wide view of Parkinson’s disease,Scherzer,10.1101/2022.02.01.22270276,,1.0,W4210801458,A5008377476,Clemens R. Scherzer,0000-0002-0567-9193,Lead-PI,Team Scherzer,Clemens Scherzer
3807,3807.0,Genetic screening and metabolomics identify glial adenosine metabolism as a therapeutic target in Parkinson’s disease,Scherzer,10.1101/2024.05.15.594309,,1.0,W4396973832,A5008377476,Clemens R. Scherzer,0000-0002-0567-9193,Lead-PI,Team Scherzer,Clemens Scherzer
3818,3818.0,Transcriptional pathobiology and multi-omics predictors for Parkinson’s disease,Scherzer,10.1101/2024.06.18.599639,,1.0,W4399907545,A5008377476,Clemens R. Scherzer,0000-0002-0567-9193,Lead-PI,Team Scherzer,Clemens Scherzer
3819,3819.0,Transcriptional pathobiology and multi-omics predictors for Parkinson’s disease,Scherzer,10.1101/2024.06.18.599639,,1.0,W4399907545,A5053690577,Xianjun Dong,0000-0002-8052-9320,Co-PI,Team Scherzer,Xianjun Dong
3838,3838.0,Experimental and Computational Methods for Allelic Imbalance Analysis from Single-Nucleus RNA-seq Data,Scherzer,10.1101/2024.08.13.607784,,1.0,W4401669789,A5072613176,Thomas G. Beach,0000-0003-3296-6128,Collaborating PI,Team Voet,Thomas Beach
3842,3842.0,Experimental and Computational Methods for Allelic Imbalance Analysis from Single-Nucleus RNA-seq Data,Scherzer,10.1101/2024.08.13.607784,,1.0,W4401669789,A5053690577,Xianjun Dong,0000-0002-8052-9320,Co-PI,Team Scherzer,Xianjun Dong
3843,3843.0,Experimental and Computational Methods for Allelic Imbalance Analysis from Single-Nucleus RNA-seq Data,Scherzer,10.1101/2024.08.13.607784,,1.0,W4401669789,A5008377476,Clemens R. Scherzer,0000-0002-0567-9193,Lead-PI,Team Scherzer,Clemens Scherzer
3844,3844.0,Experimental and Computational Methods for Allelic Imbalance Analysis from Single-Nucleus RNA-seq Data,Scherzer,10.1101/2024.08.13.607784,,1.0,W4401669789,A5024425176,Joshua Z. Levin,0000-0002-0170-3598,Co-PI,Team Scherzer,Joshua Levin
3857,3857.0,Genetic and pharmacological reduction of CDK14 mitigates synucleinopathy,Schlossmacher,10.1101/2022.05.02.490309,10.1038/s41419-024-06534-8,1.0,W4393941511,A5000268173,Michael G. Schlossmacher,0000-0002-0394-0300,Lead-PI,Team Schlossmacher,Michael Schlossmacher
3862,3862.0,Genetic and pharmacological reduction of CDK14 mitigates synucleinopathy,Schlossmacher,10.1101/2022.05.02.490309,10.1038/s41419-024-06534-8,1.0,W4393941511,A5054577159,Maxime W.C. Rousseaux,0000-0002-2737-6193,Co-PI,Team Schlossmacher,Maxime Rousseaux
3869,3869.0,A topographical atlas of αSyn dosage and cell-type expression in the mouse brain and periphery | bioRxiv,Schlossmacher,10.1101/2023.10.05.559770,10.1038/s41531-024-00672-8,1.0,W4392963971,A5047948555,Benjamin R. Arenkiel,0000-0001-9047-2420,Co-PI,Team Schlossmacher,Benjamin Arenkiel
3870,3870.0,A topographical atlas of αSyn dosage and cell-type expression in the mouse brain and periphery | bioRxiv,Schlossmacher,10.1101/2023.10.05.559770,10.1038/s41531-024-00672-8,1.0,W4392963971,A5082185657,Brit Mollenhauer,0000-0001-8437-3645,Co-PI,Team Schlossmacher,Brit Mollenhauer
3871,3871.0,A topographical atlas of αSyn dosage and cell-type expression in the mouse brain and periphery | bioRxiv,Schlossmacher,10.1101/2023.10.05.559770,10.1038/s41531-024-00672-8,1.0,W4392963971,A5000268173,Michael G. Schlossmacher,0000-0002-0394-0300,Lead-PI,Team Schlossmacher,Michael Schlossmacher
3872,3872.0,A topographical atlas of αSyn dosage and cell-type expression in the mouse brain and periphery | bioRxiv,Schlossmacher,10.1101/2023.10.05.559770,10.1038/s41531-024-00672-8,1.0,W4392963971,A5036052976,Christine Stadelmann,0000-0003-1766-5458,Co-PI,Team Schlossmacher,Christine Stadelmann
3874,3874.0,A topographical atlas of αSyn dosage and cell-type expression in the mouse brain and periphery | bioRxiv,Schlossmacher,10.1101/2023.10.05.559770,10.1038/s41531-024-00672-8,1.0,W4392963971,A5034385515,Michael X. Henderson,0000-0001-9710-0726,Co-PI,Team Biederer,Michael Henderson
3875,3875.0,A topographical atlas of αSyn dosage and cell-type expression in the mouse brain and periphery | bioRxiv,Schlossmacher,10.1101/2023.10.05.559770,10.1038/s41531-024-00672-8,1.0,W4392963971,A5034385515,Michael X. Henderson,0000-0001-9710-0726,Co-PI,Team Lee,Michael Henderson
3876,3876.0,A topographical atlas of αSyn dosage and cell-type expression in the mouse brain and periphery | bioRxiv,Schlossmacher,10.1101/2023.10.05.559770,10.1038/s41531-024-00672-8,1.0,W4392963971,A5054577159,Maxime W.C. Rousseaux,0000-0002-2737-6193,Co-PI,Team Schlossmacher,Maxime Rousseaux
3884,3884.0,"Constitutive nuclear accumulation of endogenous alpha-synuclein in mice causes motor impairment and cortical dysfunction, independent of protein aggregation",Schlossmacher,10.1101/2021.10.13.464123,10.1093/hmg/ddac035,1.0,W4213320742,A5054577159,Maxime W.C. Rousseaux,0000-0002-2737-6193,Co-PI,Team Schlossmacher,Maxime Rousseaux
3892,3892.0,Neuropathological assessment of the olfactory bulb and tract in individuals with COVID-19,Schlossmacher,10.1101/2023.12.18.572180,10.1186/s40478-024-01761-8,1.0,W4396622582,A5114228209,Josef Penninger,,Collaborating PI,Team Schlossmacher,Josef Penninger
3893,3893.0,Neuropathological assessment of the olfactory bulb and tract in individuals with COVID-19,Schlossmacher,10.1101/2023.12.18.572180,10.1186/s40478-024-01761-8,1.0,W4396622582,A5047948555,Benjamin R. Arenkiel,0000-0001-9047-2420,Co-PI,Team Schlossmacher,Benjamin Arenkiel
3894,3894.0,Neuropathological assessment of the olfactory bulb and tract in individuals with COVID-19,Schlossmacher,10.1101/2023.12.18.572180,10.1186/s40478-024-01761-8,1.0,W4396622582,A5004947640,Zhandong Liu,0000-0002-7608-0831,Collaborating PI,Team Schlossmacher,Zhandong Liu
3895,3895.0,Neuropathological assessment of the olfactory bulb and tract in individuals with COVID-19,Schlossmacher,10.1101/2023.12.18.572180,10.1186/s40478-024-01761-8,1.0,W4396622582,A5082185657,Brit Mollenhauer,0000-0001-8437-3645,Co-PI,Team Schlossmacher,Brit Mollenhauer
3896,3896.0,Neuropathological assessment of the olfactory bulb and tract in individuals with COVID-19,Schlossmacher,10.1101/2023.12.18.572180,10.1186/s40478-024-01761-8,1.0,W4396622582,A5059310975,Josef Penninger,0000-0002-8194-3777,Collaborating PI,Team Schlossmacher,Josef Penninger
3897,3897.0,Neuropathological assessment of the olfactory bulb and tract in individuals with COVID-19,Schlossmacher,10.1101/2023.12.18.572180,10.1186/s40478-024-01761-8,1.0,W4396622582,A5054577159,Maxime W.C. Rousseaux,0000-0002-2737-6193,Co-PI,Team Schlossmacher,Maxime Rousseaux
3898,3898.0,Neuropathological assessment of the olfactory bulb and tract in individuals with COVID-19,Schlossmacher,10.1101/2023.12.18.572180,10.1186/s40478-024-01761-8,1.0,W4396622582,A5091123067,Armen Saghatelyan,0000-0003-4962-0465,Collaborating PI,Team Schlossmacher,Armen Saghatelyan
3899,3899.0,Neuropathological assessment of the olfactory bulb and tract in individuals with COVID-19,Schlossmacher,10.1101/2023.12.18.572180,10.1186/s40478-024-01761-8,1.0,W4396622582,A5089514184,Natalina Salmaso,0000-0002-9661-5194,Collaborating PI,Team Schlossmacher,Natalina Salmaso
3900,3900.0,Neuropathological assessment of the olfactory bulb and tract in individuals with COVID-19,Schlossmacher,10.1101/2023.12.18.572180,10.1186/s40478-024-01761-8,1.0,W4396622582,A5036052976,Christine Stadelmann,0000-0003-1766-5458,Co-PI,Team Schlossmacher,Christine Stadelmann
3901,3901.0,Neuropathological assessment of the olfactory bulb and tract in individuals with COVID-19,Schlossmacher,10.1101/2023.12.18.572180,10.1186/s40478-024-01761-8,1.0,W4396622582,A5000268173,Michael G. Schlossmacher,0000-0002-0394-0300,Lead-PI,Team Schlossmacher,Michael Schlossmacher
3903,3903.0,Neuropathological assessment of the olfactory bulb and tract in individuals with COVID-19,Schlossmacher,10.1101/2023.12.18.572180,10.1186/s40478-024-01761-8,1.0,W4396622582,A5090917194,John Woulfe,0000-0002-7382-6343,Collaborating PI,Team Schlossmacher,John Woulfe
3904,3904.0,Neuropathological assessment of the olfactory bulb and tract in individuals with COVID-19,Schlossmacher,10.1101/2023.12.18.572180,10.1186/s40478-024-01761-8,1.0,W4396622582,A5036052976,Christine Stadelmann,0000-0003-1766-5458,Co-PI,Team Schlossmacher,Christine Stadelmann
3905,3905.0,Neuropathological assessment of the olfactory bulb and tract in individuals with COVID-19,Schlossmacher,10.1101/2023.12.18.572180,10.1186/s40478-024-01761-8,1.0,W4396622582,A5090917194,John Woulfe,0000-0002-7382-6343,Collaborating PI,Team Schlossmacher,John Woulfe
3906,3906.0,Neuropathological assessment of the olfactory bulb and tract in individuals with COVID-19,Schlossmacher,10.1101/2023.12.18.572180,10.1186/s40478-024-01761-8,1.0,W4396622582,A5000268173,Michael G. Schlossmacher,0000-0002-0394-0300,Lead-PI,Team Schlossmacher,Michael Schlossmacher
3907,3907.0,Persistent Hyposmia as Surrogate for a-Synuclein-Linked Brain Pathology,Schlossmacher,10.1101/2023.12.19.23300164,,1.0,W4390008521,A5082185657,Brit Mollenhauer,0000-0001-8437-3645,Co-PI,Team Schlossmacher,Brit Mollenhauer
3914,3914.0,Persistent Hyposmia as Surrogate for a-Synuclein-Linked Brain Pathology,Schlossmacher,10.1101/2023.12.19.23300164,,1.0,W4390008521,A5000268173,Michael G. Schlossmacher,0000-0002-0394-0300,Lead-PI,Team Schlossmacher,Michael Schlossmacher
3919,3919.0,3D imaging of neuronal inclusions and protein aggregates in human neurodegeneration by multiscale X-ray phase-contrast tomography,Schlossmacher,10.1101/2024.03.26.24304193,,1.0,W4393214864,A5110690838,Brit Mollenhauer,,Co-PI,Team Schlossmacher,Brit Mollenhauer
3920,3920.0,3D imaging of neuronal inclusions and protein aggregates in human neurodegeneration by multiscale X-ray phase-contrast tomography,Schlossmacher,10.1101/2024.03.26.24304193,,1.0,W4393214864,A5036052976,Christine Stadelmann,0000-0003-1766-5458,Co-PI,Team Schlossmacher,Christine Stadelmann
3933,3933.0,"Development of a Simplified Smell Test to Identify Patients with Typical Parkinson’s as Informed by Multiple Cohorts, Machine Learning and External Validation",Schlossmacher,10.1101/2024.08.09.24311696,,1.0,W4401450240,A5089514184,Natalina Salmaso,0000-0002-9661-5194,Collaborating PI,Team Schlossmacher,Natalina Salmaso
3937,3937.0,"Development of a Simplified Smell Test to Identify Patients with Typical Parkinson’s as Informed by Multiple Cohorts, Machine Learning and External Validation",Schlossmacher,10.1101/2024.08.09.24311696,,1.0,W4401450240,A5082185657,Brit Mollenhauer,0000-0001-8437-3645,Co-PI,Team Schlossmacher,Brit Mollenhauer
3938,3938.0,"Development of a Simplified Smell Test to Identify Patients with Typical Parkinson’s as Informed by Multiple Cohorts, Machine Learning and External Validation",Schlossmacher,10.1101/2024.08.09.24311696,,1.0,W4401450240,A5000268173,Michael G. Schlossmacher,0000-0002-0394-0300,Lead-PI,Team Schlossmacher,Michael Schlossmacher
3941,3941.0,Lessons from inducible pluripotent stem cell models on neuronal senescence in aging and neurodegeneration,"Senescence WG (Studer, Mobley, Lee)",NA_review,10.1038/s43587-024-00586-3,0.0,W4392356353,A5009879178,William C. Mobley,0000-0002-6408-9548,Co-PI,Team Mobley,William Mobley
3942,3942.0,Lessons from inducible pluripotent stem cell models on neuronal senescence in aging and neurodegeneration,"Senescence WG (Studer, Mobley, Lee)",NA_review,10.1038/s43587-024-00586-3,0.0,W4392356353,A5065135570,Lorenz Studer,0000-0003-0741-7987,Lead PI,Team Studer,Lorenz Studer
3953,3953.0,"Scalable, flexible carbon fiber electrode thread arrays for three-dimensional spatial profiling of neurochemical activity in deep brain structures of rodents",Strick,10.1101/2023.04.15.537033,10.1016/j.bios.2023.115625,1.0,W4386034921,A5035254479,Helen N. Schwerdt,,Co-PI,Team Strick,Helen Schwerdt
3960,3960.0,An open-source MRI compatible frame for multimodal presurgical mapping in macaque and capuchin monkeys,Strick,10.1101/2024.02.17.580767,10.1016/j.jneumeth.2024.110133,1.0,W4394014279,A5035254479,Helen N. Schwerdt,,Co-PI,Team Strick,Helen Schwerdt
3961,3961.0,An open-source MRI compatible frame for multimodal presurgical mapping in macaque and capuchin monkeys,Strick,10.1101/2024.02.17.580767,10.1016/j.jneumeth.2024.110133,1.0,W4394014279,A5070330500,William R. Stauffer,0000-0003-1031-8824,Co-PI,Team Strick,William Stauffer
3964,3964.0,An open-source MRI compatible frame for multimodal presurgical mapping in macaque and capuchin monkeys,Strick,10.1101/2024.02.17.580767,10.1016/j.jneumeth.2024.110133,1.0,W4394014279,A5103180866,David J. Schaeffer,0000-0003-2201-7092,Collaborating PI,Team Strick,David Schaeffer
3968,3968.0,Detecting rhythmic spiking through the power spectra of point process model residuals,Strick,10.1101/2023.09.08.556120,10.1088/1741-2552/ad6188,1.0,W4400482301,A5018445297,Robert S. Turner,0000-0002-6074-4365,Co-PI,Team Strick,Robert Turner
3972,3972.0,A neurocomputational view of the effects of Parkinson’s disease on speech production,Strick,NA_Review,10.3389/fnhum.2024.1383714,0.0,W4396934609,A5018445297,Robert S. Turner,0000-0002-6074-4365,Co-PI,Team Strick,Robert Turner
3983,3983.0,Dissociation of novel open loop from ventral putamen to motor areas from classic closed loop in humans II: task-based function,Strick,10.1101/2024.06.18.599622,,1.0,W4399929404,A5021968379,Regina C. Lapate,0000-0002-1835-2309,Collaborating PI,Team Strick,Regina Lapate
3984,3984.0,Dissociation of novel open loop from ventral putamen to motor areas from classic closed loop in humans II: task-based function,Strick,10.1101/2024.06.18.599622,,1.0,W4399929404,A5082140726,Scott T. Grafton,0000-0003-4015-3151,Co-PI,Team Strick,Scott Grafton
3991,3991.0,Dissociation of putative open loop circuit from ventral putamen to motor cortical areas in humans I: high-resolution connectomics,Strick,10.1101/2024.08.28.610129,,1.0,W4402077132,A5021968379,Regina C. Lapate,0000-0002-1835-2309,Collaborating PI,Team Strick,Regina Lapate
3992,3992.0,Dissociation of putative open loop circuit from ventral putamen to motor cortical areas in humans I: high-resolution connectomics,Strick,10.1101/2024.08.28.610129,,1.0,W4402077132,A5082140726,Scott T. Grafton,0000-0003-4015-3151,Co-PI,Team Strick,Scott Grafton
4001,4001.0,Movement-related activity in the internal globus pallidus of the parkinsonian macaque,Strick,10.1101/2024.08.29.610310,,1.0,W4402049473,A5018445297,Robert S. Turner,0000-0002-6074-4365,Co-PI,Team Strick,Robert Turner
4002,4002.0,Dysfunction of Motor Cortices in Parkinson’s disease,"Strick, Wichmann",NA_Review,10.1093/cercor/bhae294,0.0,W4401103245,A5073427053,Hong‐Yuan Chu,0000-0003-0923-683X,Co-PI,Team Wichmann,Hong‐Yuan Chu
4003,4003.0,Dysfunction of Motor Cortices in Parkinson’s disease,"Strick, Wichmann",NA_Review,10.1093/cercor/bhae294,0.0,W4401103245,A5051289855,Yoland Smith,0000-0002-8700-878X,Co-PI,Team Wichmann,Yoland Smith
4005,4005.0,Dysfunction of Motor Cortices in Parkinson’s disease,"Strick, Wichmann",NA_Review,10.1093/cercor/bhae294,0.0,W4401103245,A5082140726,Scott T. Grafton,0000-0003-4015-3151,Co-PI,Team Strick,Scott Grafton
4008,4008.0,Dysfunction of Motor Cortices in Parkinson’s disease,"Strick, Wichmann",NA_Review,10.1093/cercor/bhae294,0.0,W4401103245,A5042569468,Thomas Wichmann,0000-0002-2751-9545,Lead-PI,Team Wichmann,Thomas Wichmann
4017,4017.0,The Parkinson's disease protein alpha-synuclein is a modulator of processing bodies and mRNA stability,Studer,missing,10.1016/j.cell.2022.05.008,1.0,W4281832698,A5053690577,Xianjun Dong,0000-0002-8052-9320,Co-PI,Team Scherzer,Xianjun Dong
4032,4032.0,The Parkinson's disease protein alpha-synuclein is a modulator of processing bodies and mRNA stability,Studer,missing,10.1016/j.cell.2022.05.008,1.0,W4281832698,A5002571663,Mel Β. Feany,0000-0003-0315-7970,Co-PI,Team Scherzer,Mel Feany
4035,4035.0,The Parkinson's disease protein alpha-synuclein is a modulator of processing bodies and mRNA stability,Studer,missing,10.1016/j.cell.2022.05.008,1.0,W4281832698,A5055136563,Vikram Khurana,0000-0002-4018-5527,Co-PI,Team Studer,Vikram Khurana
4047,4047.0,TNF-NF-κB-p53 axis restricts in vivo survival of hPSC-derived dopamine neurons,Studer,10.1101/2023.03.29.534819,10.1016/j.cell.2024.05.030,1.0,W4399538948,A5065135570,Lorenz Studer,0000-0003-0741-7987,Lead PI,Team Studer,Lorenz Studer
4101,4101.0,"Rapid iPSC inclusionopathy models shed light on formation, consequence and molecular subtype of α-synuclein inclusions",Studer,10.1101/2022.11.08.515615,10.1016/j.neuron.2024.06.002,1.0,W4401078278,A5047141421,Glenda M. Halliday,0000-0003-0422-8398,Collaborating PI,Team Edwards,Glenda Halliday
4102,4102.0,"Rapid iPSC inclusionopathy models shed light on formation, consequence and molecular subtype of α-synuclein inclusions",Studer,10.1101/2022.11.08.515615,10.1016/j.neuron.2024.06.002,1.0,W4401078278,A5047141421,Glenda M. Halliday,0000-0003-0422-8398,Co-PI,Team Kirik,Glenda Halliday
4103,4103.0,"Rapid iPSC inclusionopathy models shed light on formation, consequence and molecular subtype of α-synuclein inclusions",Studer,10.1101/2022.11.08.515615,10.1016/j.neuron.2024.06.002,1.0,W4401078278,A5047141421,Glenda M. Halliday,0000-0003-0422-8398,Co-PI,Team Vila,Glenda Halliday
4105,4105.0,"Rapid iPSC inclusionopathy models shed light on formation, consequence and molecular subtype of α-synuclein inclusions",Studer,10.1101/2022.11.08.515615,10.1016/j.neuron.2024.06.002,1.0,W4401078278,A5055136563,Vikram Khurana,0000-0002-4018-5527,Co-PI,Team Studer,Vikram Khurana
4132,4132.0,SARS-CoV-2 infection causes dopaminergic neuron senescence: Cell Stem Cell,Studer,10.21203/rs.3.rs-513461/v1,10.1016/j.stem.2023.12.012,1.0,W4390942359,A5065135570,Lorenz Studer,0000-0003-0741-7987,Lead PI,Team Studer,Lorenz Studer
4143,4143.0,Genome-wide CRISPR screen identifies neddylation as a regulator of neuronal aging and AD neurodegeneration,Studer,,10.1016/j.stem.2024.06.001,1.0,W4399970235,A5065135570,Lorenz Studer,0000-0003-0741-7987,Lead PI,Team Studer,Lorenz Studer
4146,4146.0,Induced pluripotent stem cells: a tool for modeling Parkinson’s disease,Studer,NA Review,10.1016/j.tins.2022.05.001,0.0,W4281977146,A5065135570,Lorenz Studer,0000-0003-0741-7987,Lead PI,Team Studer,Lorenz Studer
4150,4150.0,"Integrating population genetics, stem cell biology and cellular genomics to study complex human diseases",Studer,NA_review,10.1038/s41588-024-01731-9,0.0,W4396870546,A5065135570,Lorenz Studer,0000-0003-0741-7987,Lead PI,Team Studer,Lorenz Studer
4152,4152.0,"Integrating population genetics, stem cell biology and cellular genomics to study complex human diseases",Studer,NA_review,10.1038/s41588-024-01731-9,0.0,W4396870546,A5063458641,Joseph E. Powell,0000-0002-5070-4124,Co-PI,Team Studer,Joseph Powell
4163,4163.0,The SATB1-MIR22-GBA axis mediates glucocerebroside accumulation inducing a cellular senescence-like phenotype in dopaminergic neurons,Studer,10.1101/2023.07.19.549710,10.1111/acel.14077,1.0,W4391483361,A5065135570,Lorenz Studer,0000-0003-0741-7987,Lead PI,Team Studer,Lorenz Studer
4190,4190.0,Deep sequencing of proteotoxicity modifier genes uncovers a Presenilin-2/beta-amyloid-actin genetic risk module shared among alpha-synucleinopathies,Studer,10.1101/2024.03.03.583145,,1.0,W4392449058,A5008377476,Clemens R. Scherzer,0000-0002-0567-9193,Lead-PI,Team Scherzer,Clemens Scherzer
4199,4199.0,Deep sequencing of proteotoxicity modifier genes uncovers a Presenilin-2/beta-amyloid-actin genetic risk module shared among alpha-synucleinopathies,Studer,10.1101/2024.03.03.583145,,1.0,W4392449058,A5063458641,Joseph E. Powell,0000-0002-5070-4124,Co-PI,Team Studer,Joseph Powell
4200,4200.0,Deep sequencing of proteotoxicity modifier genes uncovers a Presenilin-2/beta-amyloid-actin genetic risk module shared among alpha-synucleinopathies,Studer,10.1101/2024.03.03.583145,,1.0,W4392449058,A5065135570,Lorenz Studer,0000-0003-0741-7987,Lead PI,Team Studer,Lorenz Studer
4201,4201.0,Deep sequencing of proteotoxicity modifier genes uncovers a Presenilin-2/beta-amyloid-actin genetic risk module shared among alpha-synucleinopathies,Studer,10.1101/2024.03.03.583145,,1.0,W4392449058,A5002571663,Mel Β. Feany,0000-0003-0315-7970,Co-PI,Team Scherzer,Mel Feany
4203,4203.0,Deep sequencing of proteotoxicity modifier genes uncovers a Presenilin-2/beta-amyloid-actin genetic risk module shared among alpha-synucleinopathies,Studer,10.1101/2024.03.03.583145,,1.0,W4392449058,A5055136563,Vikram Khurana,0000-0002-4018-5527,Co-PI,Team Studer,Vikram Khurana
4208,4208.0,Conserved and cell type-specific transcriptional responses to IFN-γ in the ventral midbrain,Sulzer,10.1101/2022.12.14.520294,10.1016/j.bbi.2023.04.008,1.0,W4366814678,A5004169353,Eugene V. Mosharov,0000-0002-0229-7114,Key Personnel (PI),Team Sulzer,Eugene Mosharov
4209,4209.0,Conserved and cell type-specific transcriptional responses to IFN-γ in the ventral midbrain,Sulzer,10.1101/2022.12.14.520294,10.1016/j.bbi.2023.04.008,1.0,W4366814678,A5066080208,Peter A. Sims,0000-0002-3921-4837,Key Personnel (PI),Team Sulzer,Peter Sims
4210,4210.0,Conserved and cell type-specific transcriptional responses to IFN-γ in the ventral midbrain,Sulzer,10.1101/2022.12.14.520294,10.1016/j.bbi.2023.04.008,1.0,W4366814678,A5026787858,David Sulzer,0000-0001-7632-0439,Lead PI,Team Sulzer,David Sulzer
4215,4215.0,Subcellular and regional localization of mRNA translation in midbrain dopamine neurons,Sulzer,10.1101/2021.07.30.454065,10.1016/j.celrep.2021.110208,1.0,W4226101007,A5004169353,Eugene V. Mosharov,0000-0002-0229-7114,Key Personnel (PI),Team Sulzer,Eugene Mosharov
4217,4217.0,Subcellular and regional localization of mRNA translation in midbrain dopamine neurons,Sulzer,10.1101/2021.07.30.454065,10.1016/j.celrep.2021.110208,1.0,W4226101007,A5026787858,David Sulzer,0000-0001-7632-0439,Lead PI,Team Sulzer,David Sulzer
4218,4218.0,Subcellular and regional localization of mRNA translation in midbrain dopamine neurons,Sulzer,10.1101/2021.07.30.454065,10.1016/j.celrep.2021.110208,1.0,W4226101007,A5066080208,Peter A. Sims,0000-0002-3921-4837,Key Personnel (PI),Team Sulzer,Peter Sims
4236,4236.0,Peripheral neuronal activation shapes the microbiome and alters gut physiology,Sulzer,10.1101/2021.04.12.439539,10.1016/j.celrep.2024.113953,1.0,W4393040330,A5050240445,Viviana Gradinaru,0000-0001-5868-348X,Lead-PI,Team Gradinaru,Viviana Gradinaru
4237,4237.0,Peripheral neuronal activation shapes the microbiome and alters gut physiology,Sulzer,10.1101/2021.04.12.439539,10.1016/j.celrep.2024.113953,1.0,W4393040330,A5053569958,Sarkis K. Mazmanian,0000-0003-2713-1513,Co-PI,Team Gradinaru,Sarkis Mazmanian
4238,4238.0,Peripheral neuronal activation shapes the microbiome and alters gut physiology,Sulzer,10.1101/2021.04.12.439539,10.1016/j.celrep.2024.113953,1.0,W4393040330,A5053569958,Sarkis K. Mazmanian,0000-0003-2713-1513,Co-PI,Team Sulzer,Sarkis Mazmanian
4241,4241.0,Gut microbiome-mediated regulation of neuroinflammation,Sulzer,NA Review,10.1016/j.coi.2022.102177,0.0,W4224232095,A5053569958,Sarkis K. Mazmanian,0000-0003-2713-1513,Co-PI,Team Gradinaru,Sarkis Mazmanian
4242,4242.0,Gut microbiome-mediated regulation of neuroinflammation,Sulzer,NA Review,10.1016/j.coi.2022.102177,0.0,W4224232095,A5053569958,Sarkis K. Mazmanian,0000-0003-2713-1513,Co-PI,Team Sulzer,Sarkis Mazmanian
4251,4251.0,Unaltered T cell responses to common antigens in individuals with Parkinson’s disease,Sulzer,10.1101/2022.04.05.487195,10.1016/j.jns.2022.120510,1.0,W4309938596,A5067845430,Amy W. Amara,0000-0003-0762-9656,Key Personnel (PI),Team Sulzer,Amy Amara
4252,4252.0,Unaltered T cell responses to common antigens in individuals with Parkinson’s disease,Sulzer,10.1101/2022.04.05.487195,10.1016/j.jns.2022.120510,1.0,W4309938596,A5000374325,David G. Standaert,0000-0003-2921-8348,Key Personnel (PI),Team Sulzer,David Standaert
4256,4256.0,Unaltered T cell responses to common antigens in individuals with Parkinson’s disease,Sulzer,10.1101/2022.04.05.487195,10.1016/j.jns.2022.120510,1.0,W4309938596,A5026787858,David Sulzer,0000-0001-7632-0439,Lead PI,Team Sulzer,David Sulzer
4257,4257.0,Unaltered T cell responses to common antigens in individuals with Parkinson’s disease,Sulzer,10.1101/2022.04.05.487195,10.1016/j.jns.2022.120510,1.0,W4309938596,A5066674783,Cecilia S. Lindestam Arlehamn,0000-0001-7302-8002,Co-PI,Team Sulzer,Cecilia Arlehamn
4258,4258.0,Unaltered T cell responses to common antigens in individuals with Parkinson’s disease,Sulzer,10.1101/2022.04.05.487195,10.1016/j.jns.2022.120510,1.0,W4309938596,A5010966529,Alessandro Sette,0000-0001-7013-2250,Key Personnel (PI),Team Sulzer,Alessandro Sette
4263,4263.0,"Interactions of dopamine, iron, and alpha-synuclein linked to dopaminergic neuron vulnerability in Parkinson's disease and Neurodegeneration with Brain Iron Accumulation disorders",Sulzer,NA Review,10.1016/j.nbd.2022.105920,0.0,W4308293006,A5004169353,Eugene V. Mosharov,0000-0002-0229-7114,Key Personnel (PI),Team Sulzer,Eugene Mosharov
4265,4265.0,"Interactions of dopamine, iron, and alpha-synuclein linked to dopaminergic neuron vulnerability in Parkinson's disease and Neurodegeneration with Brain Iron Accumulation disorders",Sulzer,NA Review,10.1016/j.nbd.2022.105920,0.0,W4308293006,A5026787858,David Sulzer,0000-0001-7632-0439,Lead PI,Team Sulzer,David Sulzer
4274,4274.0,Interaction of an α-synuclein epitope with HLA-DRB1*15:01 initiates early enteric features of Parkinson’s disease in humanized mice,Sulzer,10.1101/2022.02.03.479014,10.1016/j.neuron.2023.07.015,1.0,W4385989451,A5010966529,Alessandro Sette,0000-0001-7013-2250,Key Personnel (PI),Team Sulzer,Alessandro Sette
4277,4277.0,Interaction of an α-synuclein epitope with HLA-DRB1*15:01 initiates early enteric features of Parkinson’s disease in humanized mice,Sulzer,10.1101/2022.02.03.479014,10.1016/j.neuron.2023.07.015,1.0,W4385989451,A5103243942,Dritan Agalliu,0000-0002-1365-6450,Key Personnel (PI),Team Sulzer,Dritan Agalliu
4278,4278.0,Interaction of an α-synuclein epitope with HLA-DRB1*15:01 initiates early enteric features of Parkinson’s disease in humanized mice,Sulzer,10.1101/2022.02.03.479014,10.1016/j.neuron.2023.07.015,1.0,W4385989451,A5026787858,David Sulzer,0000-0001-7632-0439,Lead PI,Team Sulzer,David Sulzer
4287,4287.0,Border-associated macrophages mediate the neuroinflammatory response in an alpha-synuclein model of Parkinson disease,Sulzer,10.1101/2022.10.12.511960,10.1038/s41467-023-39060-w,1.0,W4382059965,A5000374325,David G. Standaert,0000-0003-2921-8348,Key Personnel (PI),Team Sulzer,David Standaert
4288,4288.0,Border-associated macrophages mediate the neuroinflammatory response in an alpha-synuclein model of Parkinson disease,Sulzer,10.1101/2022.10.12.511960,10.1038/s41467-023-39060-w,1.0,W4382059965,A5011457832,James E. Goldman,0000-0003-2135-8936,Key Personnel (PI),Team Sulzer,James Goldman
4289,4289.0,Border-associated macrophages mediate the neuroinflammatory response in an alpha-synuclein model of Parkinson disease,Sulzer,10.1101/2022.10.12.511960,10.1038/s41467-023-39060-w,1.0,W4382059965,A5046016738,Ashley S. Harms,0000-0002-7054-2812,Co-PI,Team Kordower,Ashley Harms
4290,4290.0,Border-associated macrophages mediate the neuroinflammatory response in an alpha-synuclein model of Parkinson disease,Sulzer,10.1101/2022.10.12.511960,10.1038/s41467-023-39060-w,1.0,W4382059965,A5046016738,Ashley S. Harms,0000-0002-7054-2812,Co-PI,Team Sulzer,Ashley Harms
4298,4298.0,Transcriptional analysis of peripheral memory T cells reveals Parkinson’s disease-specific gene signatures,Sulzer,10.1101/2021.05.28.446215,10.1038/s41531-022-00282-2,1.0,W4221115508,A5067845430,Amy W. Amara,0000-0003-0762-9656,Key Personnel (PI),Team Sulzer,Amy Amara
4299,4299.0,Transcriptional analysis of peripheral memory T cells reveals Parkinson’s disease-specific gene signatures,Sulzer,10.1101/2021.05.28.446215,10.1038/s41531-022-00282-2,1.0,W4221115508,A5000374325,David G. Standaert,0000-0003-2921-8348,Key Personnel (PI),Team Sulzer,David Standaert
4304,4304.0,Transcriptional analysis of peripheral memory T cells reveals Parkinson’s disease-specific gene signatures,Sulzer,10.1101/2021.05.28.446215,10.1038/s41531-022-00282-2,1.0,W4221115508,A5026787858,David Sulzer,0000-0001-7632-0439,Lead PI,Team Sulzer,David Sulzer
4305,4305.0,Transcriptional analysis of peripheral memory T cells reveals Parkinson’s disease-specific gene signatures,Sulzer,10.1101/2021.05.28.446215,10.1038/s41531-022-00282-2,1.0,W4221115508,A5066674783,Cecilia S. Lindestam Arlehamn,0000-0001-7302-8002,Co-PI,Team Sulzer,Cecilia Arlehamn
4306,4306.0,Transcriptional analysis of peripheral memory T cells reveals Parkinson’s disease-specific gene signatures,Sulzer,10.1101/2021.05.28.446215,10.1038/s41531-022-00282-2,1.0,W4221115508,A5010966529,Alessandro Sette,0000-0001-7013-2250,Key Personnel (PI),Team Sulzer,Alessandro Sette
4309,4309.0,Similarities and differences between nigral and enteric dopaminergic neurons unravel distinctive involvement in Parkinson’s diseas,Sulzer,NA Review,10.1038/s41531-022-00308-9,0.0,W4224305265,A5026787858,David Sulzer,0000-0001-7632-0439,Lead PI,Team Sulzer,David Sulzer
4311,4311.0,Neuronal Presentation of Antigen and Its Possible Role in Parkinson’s Disease,Sulzer,review,10.3233/JPD-223153,0.0,W4214855533,A5026787858,David Sulzer,0000-0001-7632-0439,Lead PI,Team Sulzer,David Sulzer
4314,4314.0,Central and Peripheral Inflammation: Connecting the Immune Responses of Parkinson’s Disease,Sulzer,review,10.3233/JPD-223241,0.0,W4283364966,A5010966529,Alessandro Sette,0000-0001-7013-2250,Key Personnel (PI),Team Sulzer,Alessandro Sette
4315,4315.0,Central and Peripheral Inflammation: Connecting the Immune Responses of Parkinson’s Disease,Sulzer,review,10.3233/JPD-223241,0.0,W4283364966,A5066674783,Cecilia S. Lindestam Arlehamn,0000-0001-7302-8002,Co-PI,Team Sulzer,Cecilia Arlehamn
4318,4318.0,Subcellular proteomics of dopamine neurons in the mouse brain reveals axonal enrichment of proteins encoded by Parkinson’s disease-linked genes,Sulzer,10.1101/2021.06.01.446584,10.7554/eLife.70921,1.0,W4220677882,A5004169353,Eugene V. Mosharov,0000-0002-0229-7114,Key Personnel (PI),Team Sulzer,Eugene Mosharov
4320,4320.0,Subcellular proteomics of dopamine neurons in the mouse brain reveals axonal enrichment of proteins encoded by Parkinson’s disease-linked genes,Sulzer,10.1101/2021.06.01.446584,10.7554/eLife.70921,1.0,W4220677882,A5026787858,David Sulzer,0000-0001-7632-0439,Lead PI,Team Sulzer,David Sulzer
4321,4321.0,Subcellular proteomics of dopamine neurons in the mouse brain reveals axonal enrichment of proteins encoded by Parkinson’s disease-linked genes,Sulzer,10.1101/2021.06.01.446584,10.7554/eLife.70921,1.0,W4220677882,A5066080208,Peter A. Sims,0000-0002-3921-4837,Key Personnel (PI),Team Sulzer,Peter Sims
4337,4337.0,A prebiotic diet modulates microglial states and motor deficits in α-synuclein overexpressing mice,Sulzer,10.1101/2022.06.27.497828,10.7554/eLife.81453,1.0,W4308633748,A5050240445,Viviana Gradinaru,0000-0001-5868-348X,Lead-PI,Team Gradinaru,Viviana Gradinaru
4340,4340.0,A prebiotic diet modulates microglial states and motor deficits in α-synuclein overexpressing mice,Sulzer,10.1101/2022.06.27.497828,10.7554/eLife.81453,1.0,W4308633748,A5053569958,Sarkis K. Mazmanian,0000-0003-2713-1513,Co-PI,Team Gradinaru,Sarkis Mazmanian
4341,4341.0,A prebiotic diet modulates microglial states and motor deficits in α-synuclein overexpressing mice,Sulzer,10.1101/2022.06.27.497828,10.7554/eLife.81453,1.0,W4308633748,A5053569958,Sarkis K. Mazmanian,0000-0003-2713-1513,Co-PI,Team Sulzer,Sarkis Mazmanian
4353,4353.0,The spatial landscape of glial pathology and T-cell response in Parkinson’s disease substantia nigra,Sulzer,10.1101/2024.01.08.574736,,1.0,W4390691959,A5026787858,David Sulzer,0000-0001-7632-0439,Lead PI,Team Sulzer,David Sulzer
4354,4354.0,The spatial landscape of glial pathology and T-cell response in Parkinson’s disease substantia nigra,Sulzer,10.1101/2024.01.08.574736,,1.0,W4390691959,A5011457832,James E. Goldman,0000-0003-2135-8936,Key Personnel (PI),Team Sulzer,James Goldman
4355,4355.0,The spatial landscape of glial pathology and T-cell response in Parkinson’s disease substantia nigra,Sulzer,10.1101/2024.01.08.574736,,1.0,W4390691959,A5066080208,Peter A. Sims,0000-0002-3921-4837,Key Personnel (PI),Team Sulzer,Peter Sims
4368,4368.0,PINK1 is a target of T cell responses in Parkinson's disease,Sulzer,10.1101/2024.02.09.579465,,1.0,W4391744684,A5026787858,David Sulzer,0000-0001-7632-0439,Lead PI,Team Sulzer,David Sulzer
4369,4369.0,PINK1 is a target of T cell responses in Parkinson's disease,Sulzer,10.1101/2024.02.09.579465,,1.0,W4391744684,A5010966529,Alessandro Sette,0000-0001-7013-2250,Key Personnel (PI),Team Sulzer,Alessandro Sette
4370,4370.0,PINK1 is a target of T cell responses in Parkinson's disease,Sulzer,10.1101/2024.02.09.579465,,1.0,W4391744684,A5066674783,Cecilia S. Lindestam Arlehamn,0000-0001-7302-8002,Co-PI,Team Sulzer,Cecilia Arlehamn
4375,4375.0,Dopamine neuron activity encodes the length of upcoming contralateral movement sequences,Surmeier,10.1101/2021.04.20.440527,10.1016/j.cub.2024.01.067,1.0,W4391934167,A5062838955,José Á. Obeso,0000-0002-6996-8613,Co-PI,Team Vila,José Obeso
4376,4376.0,Dopamine neuron activity encodes the length of upcoming contralateral movement sequences,Surmeier,10.1101/2021.04.20.440527,10.1016/j.cub.2024.01.067,1.0,W4391934167,A5060965799,Rui M. Costa,0000-0003-0495-8374,Co-PI,Team Surmeier,Rui Costa
4381,4381.0,Feed-forward metabotropic signaling by Cav1 Ca2+ channels supports pacemaking in pedunculopontine cholinergic neurons,Surmeier,10.1101/2023.08.05.552108,10.1016/j.nbd.2023.106328,1.0,W4387675855,A5033742239,D. James Surmeier,0000-0002-6376-5225,Lead-PI,Team Surmeier,D. Surmeier
4388,4388.0,Motor learning selectively strengthens cortical and striatal synapses of motor engram neurons,Surmeier,10.1101/2021.10.28.466357,10.1016/j.neuron.2022.06.006,1.0,W4284973744,A5070396294,Jun Ding,0000-0003-0690-1312,Co-PI,Team Surmeier,Jun Ding
4390,4390.0,Cortico-basal ganglia plasticity in motor learning,Surmeier,NA_Review,10.1016/j.neuron.2024.06.014,0.0,W4400582704,A5070396294,Jun Ding,0000-0003-0690-1312,Co-PI,Team Surmeier,Jun Ding
4397,4397.0,Disrupted sleep-wake regulation in the MCI-Park mouse model of Parkinson’s disease | bioRxiv,Surmeier,10.1101/2023.11.09.566376,10.1038/s41531-024-00670-w,1.0,W4392639128,A5036365985,Yang Dan,0000-0002-3818-877X,Co-PI,Team Surmeier,Yang Dan
4398,4398.0,Disrupted sleep-wake regulation in the MCI-Park mouse model of Parkinson’s disease | bioRxiv,Surmeier,10.1101/2023.11.09.566376,10.1038/s41531-024-00670-w,1.0,W4392639128,A5033742239,D. James Surmeier,0000-0002-6376-5225,Lead-PI,Team Surmeier,D. Surmeier
4406,4406.0,Dynamic behaviour restructuring mediates dopamine-dependent credit assignment | Nature,Surmeier,10.1101/2022.09.22.507905,10.1038/s41586-023-06941-5,1.0,W4389671970,A5060965799,Rui M. Costa,0000-0003-0495-8374,Co-PI,Team Surmeier,Rui Costa
4409,4409.0,Neural heterogeneity controls computations in spiking neural networks,Surmeier,10.48550/arXiv.2206.08813,10.1073/pnas.2311885121,1.0,W4390691678,A5071419759,Ann Kennedy,0000-0002-3782-0518,Co-PI,Team Surmeier,Ann Kennedy
4412,4412.0,Macroscopic dynamics of neural networks with heterogeneous spiking thresholds,Surmeier,10.48550/arXiv.2209.03501,10.1103/PhysRevE.107.024306,1.0,W4321111295,A5071419759,Ann Kennedy,0000-0002-3782-0518,Co-PI,Team Surmeier,Ann Kennedy
4427,4427.0,Ca2+ channels couple spiking to mitochondrial metabolism in substantia nigra dopainergic neurons,Surmeier,missing,10.1126/sciadv.abp8701,1.0,W4298126240,A5033742239,D. James Surmeier,0000-0002-6376-5225,Lead-PI,Team Surmeier,D. Surmeier
4435,4435.0,GABAergic regulation of striatal spiny projection neurons depends upon their activity state,Surmeier,10.1101/2023.03.14.532627,10.1371/journal.pbio.3002483,1.0,W4391381044,A5033742239,D. James Surmeier,0000-0002-6376-5225,Lead-PI,Team Surmeier,D. Surmeier
4438,4438.0,PyRates—A code-generation tool for modeling dynamical systems in biology and beyond | PLOS Computational Biology,Surmeier,10.48550/arXiv.2302.03763,10.1371/journal.pcbi.1011761,1.0,W4390264077,A5075478892,Ann R. Kennedy,0000-0002-1602-2015,Co-PI,Team Surmeier,Ann Kennedy
4444,4444.0,Synchronous Measurements of Extracellular Action Potentials and Neurochemical Activity with Carbon Fiber Electrodes in Nonhuman Primates | bioRxiv,Surmeier,10.1101/2023.12.23.573130,10.1523/ENEURO.0001-24.2024,1.0,W4400018516,A5035254479,Helen N. Schwerdt,,Co-PI,Team Strick,Helen Schwerdt
4453,4453.0,α-Synuclein pathology disrupts mitochondrial function in dopaminergic and cholinergic neurons at-risk in Parkinson’s disease | bioRxiv,Surmeier,10.1101/2023.12.11.571045,,1.0,W4389580093,A5025568267,Valina L. Dawson,0000-0002-2915-3970,Collaborating PI,Team Kaplitt,Valina Dawson
4454,4454.0,α-Synuclein pathology disrupts mitochondrial function in dopaminergic and cholinergic neurons at-risk in Parkinson’s disease | bioRxiv,Surmeier,10.1101/2023.12.11.571045,,1.0,W4389580093,A5021759485,Ted M. Dawson,0000-0002-6459-0893,Co-PI,Team Kaplitt,Ted Dawson
4457,4457.0,α-Synuclein pathology disrupts mitochondrial function in dopaminergic and cholinergic neurons at-risk in Parkinson’s disease | bioRxiv,Surmeier,10.1101/2023.12.11.571045,,1.0,W4389580093,A5033742239,D. James Surmeier,0000-0002-6376-5225,Lead-PI,Team Surmeier,D. Surmeier
4462,4462.0,Tonic dendritic GABA release by substantia nigra dopaminergic neurons,Surmeier,10.1101/2024.03.27.586699,,1.0,W4393338914,A5070396294,Jun Ding,0000-0003-0690-1312,Co-PI,Team Surmeier,Jun Ding
4463,4463.0,Tonic dendritic GABA release by substantia nigra dopaminergic neurons,Surmeier,10.1101/2024.03.27.586699,,1.0,W4393338914,A5082378596,Rajeshwar Awatramani,0000-0002-0713-2140,Lead-PI,Team Awatramani,Rajeshwar Awatramani
4465,4465.0,Tonic dendritic GABA release by substantia nigra dopaminergic neurons,Surmeier,10.1101/2024.03.27.586699,,1.0,W4393338914,A5033742239,D. James Surmeier,0000-0002-6376-5225,Lead-PI,Team Surmeier,D. Surmeier
4470,4470.0,Refinement of efficient encodings of movement in the dorsolateral striatum throughout learning,Surmeier,10.1101/2024.06.06.596654,,1.0,W4399443539,A5070396294,Jun Ding,0000-0003-0690-1312,Co-PI,Team Surmeier,Jun Ding
4474,4474.0,Activity-Dependent Remodeling of Corticostriatal Axonal Boutons During Motor Learning,Surmeier,10.1101/2024.06.10.598366,,1.0,W4399516825,A5111498304,Jun B. Ding,,Co-PI,Team Surmeier,Jun Ding
4475,4475.0,Frontiers | Rethinking the network determinants of motor disability in Parkinson’s disease (frontiersin.org),Surmerier,review,10.3389/fnsyn.2023.1186484,0.0,W4382399915,A5033742239,D. James Surmeier,0000-0002-6376-5225,Lead-PI,Team Surmeier,D. Surmeier
4482,4482.0,No Evidence That Glucosylsphingosine Is a Biomarker for Parkinson's Disease: Statistical Differences Do Not Necessarily Indicate Biological Significance,Vangheluwe,NA_review,10.1002/mds.28935,0.0,W4210466597,A5009140419,Ellen Sidransky,0000-0002-3019-8500,Co-PI,Team Vangheluwe,Ellen Sidransky
4486,4486.0,CRISPR/Cas9-Based Functional Genomics in Human Induced Pluripotent Stem Cell–Derived Models: Can “the Stars Align” for Neurodegenerative Diseases?,Vangheluwe,review,10.1002/mds.28998,0.0,W4221130945,A5009140419,Ellen Sidransky,0000-0002-3019-8500,Co-PI,Team Vangheluwe,Ellen Sidransky
4495,4495.0,Kufor-Rakeb Syndrome-Associated Psychosis: A Novel Loss-of-Function ATP13A2 Variant and Response to Treatment | medRxiv,Vangheluwe,10.1101/2024.01.12.23300401,10.1007/s10048-024-00767-7,1.0,W4400785253,A5008583951,Peter Vangheluwe,0000-0002-7822-2944,Lead-PI,Team Vangheluwe,Peter Vangheluwe
4501,4501.0,P5B-ATPases in the mammalian polyamine transport system and their role in disease,Vangheluwe,review,10.1016/j.bbamcr.2022.119354,0.0,W4294190937,A5008583951,Peter Vangheluwe,0000-0002-7822-2944,Lead-PI,Team Vangheluwe,Peter Vangheluwe
4505,4505.0,The lipid flippase ATP10B enables cellular lipid uptake under stress conditions,Vangheluwe,10.1101/2023.06.01.543059,10.1016/j.bbamcr.2023.119652,1.0,W4389570670,A5081531120,Veerle Baekelandt,0000-0001-8966-2921,Co-PI,Team Vangheluwe,Veerle Baekelandt
4508,4508.0,The lipid flippase ATP10B enables cellular lipid uptake under stress conditions,Vangheluwe,10.1101/2023.06.01.543059,10.1016/j.bbamcr.2023.119652,1.0,W4389570670,A5008583951,Peter Vangheluwe,0000-0002-7822-2944,Lead-PI,Team Vangheluwe,Peter Vangheluwe
4511,4511.0,Rodent models based on endolysosomal genes involved in Parkinson's disease,Vangheluwe,review,10.1016/j.conb.2021.09.004,0.0,W3204682936,A5081531120,Veerle Baekelandt,0000-0001-8966-2921,Co-PI,Team Vangheluwe,Veerle Baekelandt
4514,4514.0,The lysosome as a master regulator of iron metabolism,Vangheluwe,NA Review,10.1016/j.tibs.2021.07.003,0.0,W3192249208,A5008583951,Peter Vangheluwe,0000-0002-7822-2944,Lead-PI,Team Vangheluwe,Peter Vangheluwe
4518,4518.0,Lysosomal dysfunction in neurodegeneration: emerging concepts and methods,Vangheluwe,NA Review,10.1016/j.tins.2021.12.004,0.0,W4205593204,A5009140419,Ellen Sidransky,0000-0002-3019-8500,Co-PI,Team Vangheluwe,Ellen Sidransky
4531,4531.0,Disruption of lysosomal proteolysis in astrocytes facilitates midbrain organoid proteostasis failure in an early-onset Parkinson’s disease model | Nature Communications,Vangheluwe,10.1101/2022.08.26.505472,10.1038/s41467-024-44732-2,1.0,W4390691315,A5027087812,Joel Blanchard,0000-0003-3142-2970,Co-PI,Team Vangheluwe,Joel Blanchard
4543,4543.0,ATP13A2 -mediated endo-lysosomal polyamine export counters mitochondrial oxidative stress,Vangheluwe,missing,10.1073/pnas.1922342117,1.0,W3110543229,A5081531120,Veerle Baekelandt,0000-0001-8966-2921,Co-PI,Team Vangheluwe,Veerle Baekelandt
4547,4547.0,ATP13A2 -mediated endo-lysosomal polyamine export counters mitochondrial oxidative stress,Vangheluwe,missing,10.1073/pnas.1922342117,1.0,W3110543229,A5008583951,Peter Vangheluwe,0000-0002-7822-2944,Lead-PI,Team Vangheluwe,Peter Vangheluwe
4552,4552.0,Polyamines in Parkinson's Disease: Balancing Between Neurotoxicity and Neuroprotection - PubMed (nih.gov),Vangheluwe,review,10.1146/annurev-biochem-071322-021330,0.0,W4362632568,A5008583951,Peter Vangheluwe,0000-0002-7822-2944,Lead-PI,Team Vangheluwe,Peter Vangheluwe
4559,4559.0,Inter-organellar Communication in Parkinson's and Alzheimer's Disease: Looking Beyond Endoplasmic Reticulum-Mitochondria Contact Sites,Vangheluwe,review,10.3389/fnins.2022.900338,0.0,W4283206225,A5008583951,Peter Vangheluwe,0000-0002-7822-2944,Lead-PI,Team Vangheluwe,Peter Vangheluwe
4562,4562.0,Lyso-IP: Uncovering Pathogenic Mechanisms of Lysosomal Dysfunction - PubMed (nih.gov),Vangheluwe,review,10.3390/biom12050616,0.0,W4224241428,A5009140419,Ellen Sidransky,0000-0002-3019-8500,Co-PI,Team Vangheluwe,Ellen Sidransky
4573,4573.0,Novel green fluorescent polyamines to analyze ATP13A2 and ATP13A3 activity in the mammalian polyamine transport system,Vangheluwe,10.1101/2022.12.15.520427,10.3390/biom13020337,1.0,W4319971674,A5008583951,Peter Vangheluwe,0000-0002-7822-2944,Lead-PI,Team Vangheluwe,Peter Vangheluwe
4579,4579.0,"ATP13A2 regulates cellular α-synuclein multimerization, membrane association, and externalization",Vangheluwe,missing,10.3390/ijms22052689,1.0,W3135554717,A5008583951,Peter Vangheluwe,0000-0002-7822-2944,Lead-PI,Team Vangheluwe,Peter Vangheluwe
4580,4580.0,"ATP13A2 regulates cellular α-synuclein multimerization, membrane association, and externalization",Vangheluwe,missing,10.3390/ijms22052689,1.0,W3135554717,A5081531120,Veerle Baekelandt,0000-0001-8966-2921,Co-PI,Team Vangheluwe,Veerle Baekelandt
4584,4584.0,Neuropathological Features of Gaucher Disease and Gaucher Disease with Parkinsonism,Vangheluwe,review,10.3390/ijms23105842,0.0,W4281390096,A5009140419,Ellen Sidransky,0000-0002-3019-8500,Co-PI,Team Vangheluwe,Ellen Sidransky
4591,4591.0,A Comparative Biochemical and Pathological Evaluation of Brain Samples from Knock-In Murine Models of Gaucher Disease,Vangheluwe,,10.3390/ijms25031827,1.0,W4391472513,A5009140419,Ellen Sidransky,0000-0002-3019-8500,Co-PI,Team Vangheluwe,Ellen Sidransky
4597,4597.0,Functional characterization of ATP13A2 variants associated with distinct neurodegenerative disorders,Vangheluwe,10.1101/2023.08.21.552829,,1.0,W4386050476,A5081531120,Veerle Baekelandt,0000-0001-8966-2921,Co-PI,Team Vangheluwe,Veerle Baekelandt
4598,4598.0,Functional characterization of ATP13A2 variants associated with distinct neurodegenerative disorders,Vangheluwe,10.1101/2023.08.21.552829,,1.0,W4386050476,A5086345439,Joseph A. Lyons,0000-0003-0218-4862,Co-PI,Team Vangheluwe,Joseph Lyons
4600,4600.0,Functional characterization of ATP13A2 variants associated with distinct neurodegenerative disorders,Vangheluwe,10.1101/2023.08.21.552829,,1.0,W4386050476,A5008583951,Peter Vangheluwe,0000-0002-7822-2944,Lead-PI,Team Vangheluwe,Peter Vangheluwe
4604,4604.0,Is Gauchian genotyping of GBA1 variants reliable? | medRxiv,Vangheluwe,10.1101/2023.10.26.23297627,,1.0,W4387973789,A5009140419,Ellen Sidransky,0000-0002-3019-8500,Co-PI,Team Vangheluwe,Ellen Sidransky
4615,4615.0,Comparative study of enriched dopaminergic neurons from siblings with Gaucher disease discordant for parkinsonism,Vangheluwe,10.1101/2024.02.25.581985,,1.0,W4392243974,A5027087812,Joel Blanchard,0000-0003-3142-2970,Co-PI,Team Vangheluwe,Joel Blanchard
4619,4619.0,Comparative study of enriched dopaminergic neurons from siblings with Gaucher disease discordant for parkinsonism,Vangheluwe,10.1101/2024.02.25.581985,,1.0,W4392243974,A5009140419,Ellen Sidransky,0000-0002-3019-8500,Co-PI,Team Vangheluwe,Ellen Sidransky
4627,4627.0,Genetically Encoded and Modular SubCellular Organelle Probes (GEM-SCOPe) reveal lysosomal and mitochondrial dysfunction driven by PRKN knockout,Vangheluwe,10.1101/2024.05.21.594886,,1.0,W4398160425,A5027087812,Joel Blanchard,0000-0003-3142-2970,Co-PI,Team Vangheluwe,Joel Blanchard
4638,4638.0,Loss of the lysosomal lipid flippase ATP10B leads to progressive dopaminergic neurodegeneration and Parkinsonian motor deficits,Vangheluwe,10.1101/2024.07.09.602700,,1.0,W4400665181,A5008583951,Peter Vangheluwe,0000-0002-7822-2944,Lead-PI,Team Vangheluwe,Peter Vangheluwe
4639,4639.0,Loss of the lysosomal lipid flippase ATP10B leads to progressive dopaminergic neurodegeneration and Parkinsonian motor deficits,Vangheluwe,10.1101/2024.07.09.602700,,1.0,W4400665181,A5027087812,Joel Blanchard,0000-0003-3142-2970,Co-PI,Team Vangheluwe,Joel Blanchard
4641,4641.0,Loss of the lysosomal lipid flippase ATP10B leads to progressive dopaminergic neurodegeneration and Parkinsonian motor deficits,Vangheluwe,10.1101/2024.07.09.602700,,1.0,W4400665181,A5081531120,Veerle Baekelandt,0000-0001-8966-2921,Co-PI,Team Vangheluwe,Veerle Baekelandt
4648,4648.0,The VEGFs/VEGFRs system in Alzheimer’s and Parkinson’s diseases: Pathophysiological roles and therapeutic implications,Vila,NA_review,10.1016/j.phrs.2024.107101,0.0,W4391605343,A5082528797,Nicola Biagio Mercuri,0000-0001-6700-7491,Co-PI,Team Vila,Nicola Mercuri
4657,4657.0,Dopaminergic denervation and associated MRI microstructural changes in the nigrostriatal projection in early Parkinson’s disease patients | npj Parkinson's Disease (nature.com),Vila,missing,10.1038/s41531-023-00586-x,1.0,W4387765831,A5062838955,José Á. Obeso,0000-0002-6996-8613,Co-PI,Team Vila,José Obeso
4665,4665.0,Neurovascular and immune factors of vulnerability of substantia nigra dopaminergic neurons in non-human primates,Vila,,10.1038/s41531-024-00735-w,1.0,W4399754101,A5062838955,José Á. Obeso,0000-0002-6996-8613,Co-PI,Team Vila,José Obeso
4678,4678.0,In vivo reduction of age-dependent neuromelanin accumulation mitigates features of Parkinson's disease,Vila,10.1101/2022.08.08.503142,10.1093/brain/awac445,1.0,W4318592048,A5059189782,Miquel Vila,0000-0002-1352-989X,Lead-PI,Team Vila,Miquel Vila
4689,4689.0,Neuromelanin accumulation drives endogenous synucleinopathy in non-human primates,Vila,10.1101/2023.08.04.551615,10.1093/brain/awad331,1.0,W4387125046,A5059189782,Miquel Vila,0000-0002-1352-989X,Lead-PI,Team Vila,Miquel Vila
4709,4709.0,Adult-specific Reelin expression alters striatal neuronal organization: implications for neuropsychiatric disorders,Vila,10.1101/2023.01.21.525025,10.3389/fncel.2023.1143319,1.0,W4366547833,A5059189782,Miquel Vila,0000-0002-1352-989X,Lead-PI,Team Vila,Miquel Vila
4718,4718.0,Frontiers | Neuronal dysfunction and gene modulation by non-coding RNA in Parkinson’s disease and synucleinopathies (frontiersin.org),Vila,review,10.3389/fncel.2023.1328269,0.0,W4390611441,A5082528797,Nicola Biagio Mercuri,0000-0001-6700-7491,Co-PI,Team Vila,Nicola Mercuri
4743,4743.0,Modelling human brain-wide pigmentation in rodents recapitulates age-related multisystem neurodegenerative deficits,Vila,10.1101/2023.08.08.552400,,1.0,W4385649180,A5059189782,Miquel Vila,0000-0002-1352-989X,Lead-PI,Team Vila,Miquel Vila
4755,4755.0,Non-ablative disease-modifying effects of magnetic resonance-guided focused ultrasound in neuromelanin-producing parkinsonian rodents,Vila,10.1101/2023.08.08.552410,,1.0,W4385782167,A5059189782,Miquel Vila,0000-0002-1352-989X,Lead-PI,Team Vila,Miquel Vila
4772,4772.0,Systemic inflammation triggers long-lasting neuroinflammation and accelerates neurodegeneration in a rat model of Parkinson’s disease overexpressing human α-synuclein,Vila,10.1101/2024.01.30.577912,,1.0,W4391400026,A5082528797,Nicola Biagio Mercuri,0000-0001-6700-7491,Co-PI,Team Vila,Nicola Mercuri
4778,4778.0,Functional efficacy of the MAO-B inhibitor safinamide in murine substantia nigra pars compacta dopaminergic neurons in vitro: a comparative study with tranylcypromine,Vila,10.1101/2024.05.28.596142,,1.0,W4399255251,A5082528797,Nicola Biagio Mercuri,0000-0001-6700-7491,Co-PI,Team Vila,Nicola Mercuri
4786,4786.0,Nova-ST: Nano-Patterned Ultra-Dense platform for spatial transcriptomics,Voet,10.1101/2024.02.22.581576,10.1016/j.crmeth.2024.100831,1.0,W4401364144,A5002137087,Stein Aerts,0000-0002-8006-0315,Co-PI,Team Voet,Stein Aerts
4788,4788.0,More of less: Novel multi-ome profiling of single human neurons,Voet,NA Review,10.1016/j.xgen.2022.100110,0.0,W4221026466,A5081498592,Bernard Thienpont,0000-0002-8772-6845,Co-PI,Team Voet,Bernard Thienpont
4790,4790.0,Methods and applications for single-cell and spatial multi-omics,Voet,NA Review,10.1038/s41576-023-00580-2,0.0,W4322768301,A5045411063,Alejandro Sifrim,0000-0001-8247-4020,Collaborating PI,Team Voet,Alejandro Sifrim
4791,4791.0,Methods and applications for single-cell and spatial multi-omics,Voet,NA Review,10.1038/s41576-023-00580-2,0.0,W4322768301,A5081498592,Bernard Thienpont,0000-0002-8772-6845,Co-PI,Team Voet,Bernard Thienpont
4792,4792.0,Methods and applications for single-cell and spatial multi-omics,Voet,NA Review,10.1038/s41576-023-00580-2,0.0,W4322768301,A5033632636,Thierry Voet,0000-0003-1204-9963,Lead-PI,Team Voet,Thierry Voet
4805,4805.0,Cell-type-directed design of synthetic enhancers,Voet,10.1101/2022.07.26.501466,10.1038/s41586-023-06936-2,1.0,W4389613138,A5002137087,Stein Aerts,0000-0002-8006-0315,Co-PI,Team Voet,Stein Aerts
4818,4818.0,Comprehensive structural variant detection: From mosaic to population-level,Voet,10.1101/2022.04.04.487055,10.1038/s41587-023-02024-y,1.0,W4390500910,A5012157016,Christos Proukakis,0000-0001-6423-6539,Co-PI,Team Voet,Christos Proukakis
4819,4819.0,Comprehensive structural variant detection: From mosaic to population-level,Voet,10.1101/2022.04.04.487055,10.1038/s41587-023-02024-y,1.0,W4390500910,A5037440162,Fritz J. Sedlazeck,0000-0001-6040-2691,Collaborating PI,Team Voet,Fritz Sedlazeck
4822,4822.0,Multiple genome alignment in the telomere-to-telomere assembly era | Genome Biology | Full Text (biomedcentral.com),Voet,review,10.1186/s13059-022-02735-6,0.0,W4293680421,A5037440162,Fritz J. Sedlazeck,0000-0001-6040-2691,Collaborating PI,Team Voet,Fritz Sedlazeck
4837,4837.0,Hydrop enables droplet-based single-cell ATAC-seq and single-cell RNA-seq using dissolvable hydrogel beads,Voet,10.1101/2021.06.04.447104,10.7554/eLife.73971,1.0,W4212780233,A5002137087,Stein Aerts,0000-0002-8006-0315,Co-PI,Team Voet,Stein Aerts
4845,4845.0,Single-cell somatic copy number variants in brain using different amplification methods and reference genomes | bioRxiv,Voet,10.1101/2023.08.07.552289,,1.0,W4385667615,A5063134863,Zane Jaunmuktane,0000-0001-7738-8881,Co-PI,Team Hardy,Zane Jaunmuktane
4846,4846.0,Single-cell somatic copy number variants in brain using different amplification methods and reference genomes | bioRxiv,Voet,10.1101/2023.08.07.552289,,1.0,W4385667615,A5063134863,Zane Jaunmuktane,0000-0001-7738-8881,Collaborating PI,Team Voet,Zane Jaunmuktane
4847,4847.0,Single-cell somatic copy number variants in brain using different amplification methods and reference genomes | bioRxiv,Voet,10.1101/2023.08.07.552289,,1.0,W4385667615,A5021604609,Jonas Demeulemeester,0000-0002-2660-2478,Collaborating PI,Team Voet,Jonas Demeulemeester
4848,4848.0,Single-cell somatic copy number variants in brain using different amplification methods and reference genomes | bioRxiv,Voet,10.1101/2023.08.07.552289,,1.0,W4385667615,A5037440162,Fritz J. Sedlazeck,0000-0001-6040-2691,Collaborating PI,Team Voet,Fritz Sedlazeck
4849,4849.0,Single-cell somatic copy number variants in brain using different amplification methods and reference genomes | bioRxiv,Voet,10.1101/2023.08.07.552289,,1.0,W4385667615,A5012157016,Christos Proukakis,0000-0001-6423-6539,Co-PI,Team Voet,Christos Proukakis
4865,4865.0,Behavioral screening defines three molecular Parkinsonism subgroups in Drosophila | bioRxiv,Voet,10.1101/2024.08.27.609924,,1.0,W4401933640,A5040983698,Patrik Verstreken,0000-0002-5073-5393,Collaborating PI,Team Voet,Patrik Verstreken
4878,4878.0,Open-Source Platform for Kinematic Analysis of Mouse Forelimb Movement,Wichmann,10.1101/2024.01.31.578239,10.1016/j.xpro.2024.103140,1.0,W4399857718,A5073427053,Hong‐Yuan Chu,0000-0003-0923-683X,Co-PI,Team Wichmann,Hong‐Yuan Chu
4882,4882.0,Reduced Thalamic Excitation to Motor Cortical Pyramidal Tract Neurons in Parkinsonism,Wichmann,10.1101/2022.09.24.509340,10.1126/sciadv.adg3038,1.0,W4386090431,A5073427053,Hong‐Yuan Chu,0000-0003-0923-683X,Co-PI,Team Wichmann,Hong‐Yuan Chu
4888,4888.0,Basal ganglia neurons in healthy and parkinsonian primates generate recurring sequences of spikes,Wichmann,10.1101/2022.05.25.493476,10.1152/jn.00265.2022,1.0,W4362602509,A5056482545,Adriana Galván,0000-0001-9939-0130,Co-PI,Team Wichmann,Adriana Galván
4889,4889.0,Basal ganglia neurons in healthy and parkinsonian primates generate recurring sequences of spikes,Wichmann,10.1101/2022.05.25.493476,10.1152/jn.00265.2022,1.0,W4362602509,A5042569468,Thomas Wichmann,0000-0002-2751-9545,Lead-PI,Team Wichmann,Thomas Wichmann
4895,4895.0,Motor cortical circuit adaptations in parkinsonism,Wichmann,NA_review,10.4103/1673-5374.392884,0.0,W4390730026,A5073427053,Hong‐Yuan Chu,0000-0003-0923-683X,Co-PI,Team Wichmann,Hong‐Yuan Chu
4904,4904.0,Synaptic location is a determinant of the detrimental effects of α-synuclein pathology to glutamatergic transmission in the basolateral amygdala,Wichmann,10.1101/2022.02.20.481207,10.7554/eLife.78055,1.0,W4283741897,A5034385515,Michael X. Henderson,0000-0001-9710-0726,Co-PI,Team Biederer,Michael Henderson
4905,4905.0,Synaptic location is a determinant of the detrimental effects of α-synuclein pathology to glutamatergic transmission in the basolateral amygdala,Wichmann,10.1101/2022.02.20.481207,10.7554/eLife.78055,1.0,W4283741897,A5034385515,Michael X. Henderson,0000-0001-9710-0726,Co-PI,Team Lee,Michael Henderson
4906,4906.0,Synaptic location is a determinant of the detrimental effects of α-synuclein pathology to glutamatergic transmission in the basolateral amygdala,Wichmann,10.1101/2022.02.20.481207,10.7554/eLife.78055,1.0,W4283741897,A5054577159,Maxime W.C. Rousseaux,0000-0002-2737-6193,Co-PI,Team Schlossmacher,Maxime Rousseaux
4908,4908.0,Synaptic location is a determinant of the detrimental effects of α-synuclein pathology to glutamatergic transmission in the basolateral amygdala,Wichmann,10.1101/2022.02.20.481207,10.7554/eLife.78055,1.0,W4283741897,A5073427053,Hong‐Yuan Chu,0000-0003-0923-683X,Co-PI,Team Wichmann,Hong‐Yuan Chu
4914,4914.0,Impaired Functional Connectivity of Cortico-Amygdala Pathway Can Drive Social Behavior Deficits in Synucleinopathies,Wichmann,10.1101/2024.05.20.594995,,1.0,W4398181948,A5073427053,Hong‐Yuan Chu,0000-0003-0923-683X,Co-PI,Team Wichmann,Hong‐Yuan Chu
4915,4915.0,Decreased cellular excitability of pyramidal tract neurons in primary motor cortex leads to paradoxically increased network activity in simulated parkinsonian motor cortex,Wichmann,10.1101/2024.05.23.595566,,1.0,W4398778789,A5053818945,Donald Doherty,0000-0002-4973-6225,Collaborating PI,Team Wichmann,Donald Doherty
4918,4918.0,Decreased cellular excitability of pyramidal tract neurons in primary motor cortex leads to paradoxically increased network activity in simulated parkinsonian motor cortex,Wichmann,10.1101/2024.05.23.595566,,1.0,W4398778789,A5051289855,Yoland Smith,0000-0002-8700-878X,Co-PI,Team Wichmann,Yoland Smith
4919,4919.0,Decreased cellular excitability of pyramidal tract neurons in primary motor cortex leads to paradoxically increased network activity in simulated parkinsonian motor cortex,Wichmann,10.1101/2024.05.23.595566,,1.0,W4398778789,A5042569468,Thomas Wichmann,0000-0002-2751-9545,Lead-PI,Team Wichmann,Thomas Wichmann
4920,4920.0,Decreased cellular excitability of pyramidal tract neurons in primary motor cortex leads to paradoxically increased network activity in simulated parkinsonian motor cortex,Wichmann,10.1101/2024.05.23.595566,,1.0,W4398778789,A5073427053,Hong‐Yuan Chu,0000-0003-0923-683X,Co-PI,Team Wichmann,Hong‐Yuan Chu
4924,4924.0,Microendoscopic Calcium Imaging In Supplementary Motor Area And Primary Motor Cortex Of Rhesus Macaques At Rest And During Arm Movement,Wichmann,10.1101/2024.06.20.599918,,1.0,W4399992138,A5013254201,Annaelle Devergnas,0000-0002-0461-6422,Collaborating PI,Team Wichmann,Annaelle Devergnas
4925,4925.0,Microendoscopic Calcium Imaging In Supplementary Motor Area And Primary Motor Cortex Of Rhesus Macaques At Rest And During Arm Movement,Wichmann,10.1101/2024.06.20.599918,,1.0,W4399992138,A5035960168,Benjamin B. Risk,0000-0003-1090-0777,Collaborating PI,Team Wichmann,Benjamin Risk
4929,4929.0,Microendoscopic Calcium Imaging In Supplementary Motor Area And Primary Motor Cortex Of Rhesus Macaques At Rest And During Arm Movement,Wichmann,10.1101/2024.06.20.599918,,1.0,W4399992138,A5042569468,Thomas Wichmann,0000-0002-2751-9545,Lead-PI,Team Wichmann,Thomas Wichmann
4930,4930.0,Microendoscopic Calcium Imaging In Supplementary Motor Area And Primary Motor Cortex Of Rhesus Macaques At Rest And During Arm Movement,Wichmann,10.1101/2024.06.20.599918,,1.0,W4399992138,A5056482545,Adriana Galván,0000-0001-9939-0130,Co-PI,Team Wichmann,Adriana Galván
4933,4933.0,Motor Cortical Neuronal Hyperexcitability Associated with α-Synuclein Aggregation,Wichmann,10.1101/2024.07.24.604995,,1.0,W4400995943,A5073427053,Hong‐Yuan Chu,0000-0003-0923-683X,Co-PI,Team Wichmann,Hong‐Yuan Chu
4941,4941.0,RASP: Optimal single fluorescent puncta detection in complex cellular backgrounds,Wood,10.1101/2023.12.18.572148,10.1021/acs.jpcb.4c00174,1.0,W4394622590,A5050946548,Tammaryn Lashley,0000-0001-7389-0348,Collaborating PI,Team Wood,Tammaryn Lashley
4942,4942.0,RASP: Optimal single fluorescent puncta detection in complex cellular backgrounds,Wood,10.1101/2023.12.18.572148,10.1021/acs.jpcb.4c00174,1.0,W4394622590,A5042439287,Mina Ryten,0000-0001-9520-6957,Co-PI,Team Hardy,Mina Ryten
4943,4943.0,RASP: Optimal single fluorescent puncta detection in complex cellular backgrounds,Wood,10.1101/2023.12.18.572148,10.1021/acs.jpcb.4c00174,1.0,W4394622590,A5042439287,Mina Ryten,0000-0001-9520-6957,Co-PI,Team Wood,Mina Ryten
4944,4944.0,RASP: Optimal single fluorescent puncta detection in complex cellular backgrounds,Wood,10.1101/2023.12.18.572148,10.1021/acs.jpcb.4c00174,1.0,W4394622590,A5064529704,Nicholas Wood,0000-0002-9500-3348,Lead-PI,Team Wood,Nicholas Wood
4945,4945.0,RASP: Optimal single fluorescent puncta detection in complex cellular backgrounds,Wood,10.1101/2023.12.18.572148,10.1021/acs.jpcb.4c00174,1.0,W4394622590,A5038452125,Michele Vendruscolo,0000-0002-3616-1610,Co-PI,Team Wood,Michele Vendruscolo
4946,4946.0,RASP: Optimal single fluorescent puncta detection in complex cellular backgrounds,Wood,10.1101/2023.12.18.572148,10.1021/acs.jpcb.4c00174,1.0,W4394622590,A5101470156,Sonia Gandhi,0000-0003-4395-2661,Co-PI,Team Wood,Sonia Gandhi
4949,4949.0,RASP: Optimal single fluorescent puncta detection in complex cellular backgrounds,Wood,10.1101/2023.12.18.572148,10.1021/acs.jpcb.4c00174,1.0,W4394622590,A5061407972,Steven F. Lee,0000-0003-4492-5139,Co-PI,Team Wood,Steven Lee
4970,4970.0,Protein aggregation and calcium dysregulation are hallmarks of familial Parkinson’s disease in midbrain dopaminergic neurons,Wood,10.1101/2022.10.28.514238,10.1038/s41531-022-00423-7,1.0,W4309907185,A5054181982,Dario R. Alessi,0000-0002-2140-9185,Lead-PI,Team Alessi,Dario Alessi
4972,4972.0,Protein aggregation and calcium dysregulation are hallmarks of familial Parkinson’s disease in midbrain dopaminergic neurons,Wood,10.1101/2022.10.28.514238,10.1038/s41531-022-00423-7,1.0,W4309907185,A5041913324,Mathew H. Horrocks,0000-0001-5495-5492,Collaborating PI,Team Wood,Mathew Horrocks
4975,4975.0,Protein aggregation and calcium dysregulation are hallmarks of familial Parkinson’s disease in midbrain dopaminergic neurons,Wood,10.1101/2022.10.28.514238,10.1038/s41531-022-00423-7,1.0,W4309907185,A5101470156,Sonia Gandhi,0000-0003-4395-2661,Co-PI,Team Wood,Sonia Gandhi
5004,5004.0,Pathological structural conversion of α-synuclein at the mitochondria induces neuronal toxicity,Wood,10.1101/2022.06.07.494932,10.1038/s41593-022-01140-3,1.0,W4293581901,A5041913324,Mathew H. Horrocks,0000-0001-5495-5492,Collaborating PI,Team Wood,Mathew Horrocks
5005,5005.0,Pathological structural conversion of α-synuclein at the mitochondria induces neuronal toxicity,Wood,10.1101/2022.06.07.494932,10.1038/s41593-022-01140-3,1.0,W4293581901,A5101470156,Sonia Gandhi,0000-0003-4395-2661,Co-PI,Team Wood,Sonia Gandhi
5009,5009.0,Modulation of α-synuclein in vitro aggregation kinetics by its alternative splice isoforms,Wood,,10.1073/pnas.2313465121,1.0,W4391594219,A5038452125,Michele Vendruscolo,0000-0002-3616-1610,Co-PI,Team Wood,Michele Vendruscolo
5028,5028.0,Integrated single cell and unsupervised spatial transcriptomic analysis defines molecular anatomy of the human dorsolateral prefrontal cortex,Wood,10.1101/2023.02.15.528722,10.1126/science.adh1938,1.0,W4398250232,A5042439287,Mina Ryten,0000-0001-9520-6957,Co-PI,Team Hardy,Mina Ryten
5029,5029.0,Integrated single cell and unsupervised spatial transcriptomic analysis defines molecular anatomy of the human dorsolateral prefrontal cortex,Wood,10.1101/2023.02.15.528722,10.1126/science.adh1938,1.0,W4398250232,A5042439287,Mina Ryten,0000-0001-9520-6957,Co-PI,Team Wood,Mina Ryten
5260,5260.0,POLCAM: Instant molecular orientation microscopy for the life sciences,Wood,10.1101/2023.02.07.527479,,1.0,W4319593954,A5061407972,Steven F. Lee,0000-0003-4492-5139,Co-PI,Team Wood,Steven Lee
5292,5292.0,Large-scale visualisation of α-synuclein oligomers in Parkinson’s disease brain tissue,Wood,10.1101/2024.02.17.580698,,1.0,W4391947555,A5015406158,Peter J. Magill,0000-0001-7141-7071,Co-PI,Team Cragg,Peter Magill
5293,5293.0,Large-scale visualisation of α-synuclein oligomers in Parkinson’s disease brain tissue,Wood,10.1101/2024.02.17.580698,,1.0,W4391947555,A5063134863,Zane Jaunmuktane,0000-0001-7738-8881,Co-PI,Team Hardy,Zane Jaunmuktane
5294,5294.0,Large-scale visualisation of α-synuclein oligomers in Parkinson’s disease brain tissue,Wood,10.1101/2024.02.17.580698,,1.0,W4391947555,A5063134863,Zane Jaunmuktane,0000-0001-7738-8881,Collaborating PI,Team Voet,Zane Jaunmuktane
5297,5297.0,Large-scale visualisation of α-synuclein oligomers in Parkinson’s disease brain tissue,Wood,10.1101/2024.02.17.580698,,1.0,W4391947555,A5020514779,John Hardy,0000-0002-3122-0423,Lead-PI,Team Hardy,John Hardy
5298,5298.0,Large-scale visualisation of α-synuclein oligomers in Parkinson’s disease brain tissue,Wood,10.1101/2024.02.17.580698,,1.0,W4391947555,A5050946548,Tammaryn Lashley,0000-0001-7389-0348,Collaborating PI,Team Wood,Tammaryn Lashley
5299,5299.0,Large-scale visualisation of α-synuclein oligomers in Parkinson’s disease brain tissue,Wood,10.1101/2024.02.17.580698,,1.0,W4391947555,A5042439287,Mina Ryten,0000-0001-9520-6957,Co-PI,Team Hardy,Mina Ryten
5300,5300.0,Large-scale visualisation of α-synuclein oligomers in Parkinson’s disease brain tissue,Wood,10.1101/2024.02.17.580698,,1.0,W4391947555,A5042439287,Mina Ryten,0000-0001-9520-6957,Co-PI,Team Wood,Mina Ryten
5301,5301.0,Large-scale visualisation of α-synuclein oligomers in Parkinson’s disease brain tissue,Wood,10.1101/2024.02.17.580698,,1.0,W4391947555,A5038452125,Michele Vendruscolo,0000-0002-3616-1610,Co-PI,Team Wood,Michele Vendruscolo
5302,5302.0,Large-scale visualisation of α-synuclein oligomers in Parkinson’s disease brain tissue,Wood,10.1101/2024.02.17.580698,,1.0,W4391947555,A5064529704,Nicholas Wood,0000-0002-9500-3348,Lead-PI,Team Wood,Nicholas Wood
5304,5304.0,Large-scale visualisation of α-synuclein oligomers in Parkinson’s disease brain tissue,Wood,10.1101/2024.02.17.580698,,1.0,W4391947555,A5101470156,Sonia Gandhi,0000-0003-4395-2661,Co-PI,Team Wood,Sonia Gandhi
5305,5305.0,Large-scale visualisation of α-synuclein oligomers in Parkinson’s disease brain tissue,Wood,10.1101/2024.02.17.580698,,1.0,W4391947555,A5061407972,Steven F. Lee,0000-0003-4492-5139,Co-PI,Team Wood,Steven Lee
5330,5330.0,Alpha-synuclein aggregates trigger anti-viral immune pathways and RNA editing in human astrocytes,Wood,10.1101/2024.02.26.582055,,1.0,W4392272337,A5011838243,Thomas T. Warner,0000-0001-6195-6995,Collaborating PI,Team Voet,Thomas Warner
5335,5335.0,Alpha-synuclein aggregates trigger anti-viral immune pathways and RNA editing in human astrocytes,Wood,10.1101/2024.02.26.582055,,1.0,W4392272337,A5101470156,Sonia Gandhi,0000-0003-4395-2661,Co-PI,Team Wood,Sonia Gandhi
5336,5336.0,Alpha-synuclein aggregates trigger anti-viral immune pathways and RNA editing in human astrocytes,Wood,10.1101/2024.02.26.582055,,1.0,W4392272337,A5042439287,Mina Ryten,0000-0001-9520-6957,Co-PI,Team Hardy,Mina Ryten
5337,5337.0,Alpha-synuclein aggregates trigger anti-viral immune pathways and RNA editing in human astrocytes,Wood,10.1101/2024.02.26.582055,,1.0,W4392272337,A5042439287,Mina Ryten,0000-0001-9520-6957,Co-PI,Team Wood,Mina Ryten
5361,5361.0,GLP1 receptor agonism ameliorates Parkinson’s disease through modulation of neuronal insulin signalling and glial suppression,Wood,10.1101/2024.02.28.582460,,1.0,W4392291460,A5042439287,Mina Ryten,0000-0001-9520-6957,Co-PI,Team Hardy,Mina Ryten
5362,5362.0,GLP1 receptor agonism ameliorates Parkinson’s disease through modulation of neuronal insulin signalling and glial suppression,Wood,10.1101/2024.02.28.582460,,1.0,W4392291460,A5042439287,Mina Ryten,0000-0001-9520-6957,Co-PI,Team Wood,Mina Ryten
5363,5363.0,GLP1 receptor agonism ameliorates Parkinson’s disease through modulation of neuronal insulin signalling and glial suppression,Wood,10.1101/2024.02.28.582460,,1.0,W4392291460,A5041913324,Mathew H. Horrocks,0000-0001-5495-5492,Collaborating PI,Team Wood,Mathew Horrocks
5366,5366.0,GLP1 receptor agonism ameliorates Parkinson’s disease through modulation of neuronal insulin signalling and glial suppression,Wood,10.1101/2024.02.28.582460,,1.0,W4392291460,A5101470156,Sonia Gandhi,0000-0003-4395-2661,Co-PI,Team Wood,Sonia Gandhi
5382,5382.0,"The diversity of SNCA transcripts in neurons, and its impact on antisense oligonucleotide therapeutics",Wood,10.1101/2024.05.30.596437,,1.0,W4399213038,A5020514779,John Hardy,0000-0002-3122-0423,Lead-PI,Team Hardy,John Hardy
5383,5383.0,"The diversity of SNCA transcripts in neurons, and its impact on antisense oligonucleotide therapeutics",Wood,10.1101/2024.05.30.596437,,1.0,W4399213038,A5064529704,Nicholas Wood,0000-0002-9500-3348,Lead-PI,Team Wood,Nicholas Wood
5384,5384.0,"The diversity of SNCA transcripts in neurons, and its impact on antisense oligonucleotide therapeutics",Wood,10.1101/2024.05.30.596437,,1.0,W4399213038,A5038452125,Michele Vendruscolo,0000-0002-3616-1610,Co-PI,Team Wood,Michele Vendruscolo
5387,5387.0,"The diversity of SNCA transcripts in neurons, and its impact on antisense oligonucleotide therapeutics",Wood,10.1101/2024.05.30.596437,,1.0,W4399213038,A5042439287,Mina Ryten,0000-0001-9520-6957,Co-PI,Team Hardy,Mina Ryten
5388,5388.0,"The diversity of SNCA transcripts in neurons, and its impact on antisense oligonucleotide therapeutics",Wood,10.1101/2024.05.30.596437,,1.0,W4399213038,A5042439287,Mina Ryten,0000-0001-9520-6957,Co-PI,Team Wood,Mina Ryten
5389,5389.0,"The diversity of SNCA transcripts in neurons, and its impact on antisense oligonucleotide therapeutics",Wood,10.1101/2024.05.30.596437,,1.0,W4399213038,A5101470156,Sonia Gandhi,0000-0003-4395-2661,Co-PI,Team Wood,Sonia Gandhi
5400,5400.0,Network nature of ligand-receptor interactions underlies disease comorbidity in the brain,Wood,10.1101/2024.06.15.599140,,1.0,W4399716922,A5064529704,Nicholas Wood,0000-0002-9500-3348,Lead-PI,Team Wood,Nicholas Wood
5401,5401.0,Network nature of ligand-receptor interactions underlies disease comorbidity in the brain,Wood,10.1101/2024.06.15.599140,,1.0,W4399716922,A5101470156,Sonia Gandhi,0000-0003-4395-2661,Co-PI,Team Wood,Sonia Gandhi
5405,5405.0,Network nature of ligand-receptor interactions underlies disease comorbidity in the brain,Wood,10.1101/2024.06.15.599140,,1.0,W4399716922,A5042439287,Mina Ryten,0000-0001-9520-6957,Co-PI,Team Hardy,Mina Ryten
5406,5406.0,Network nature of ligand-receptor interactions underlies disease comorbidity in the brain,Wood,10.1101/2024.06.15.599140,,1.0,W4399716922,A5042439287,Mina Ryten,0000-0001-9520-6957,Co-PI,Team Wood,Mina Ryten
5426,,,Awatramani,,,,,A5013611528,,,Co-PI,Team Awatramani,Tom Hnasko
5439,,,Awatramani,,,,,A5050070314,,,Collaborating PI,Team Awatramani,Åsa Wallén-Mackenzie
5450,,,Awatramani,,,,,A5064391371,,,Collaborating PI,Team Awatramani,David Gate
5456,,,Biederer,,,,,A5076555389,,,Lead-PI,Team Biederer,Thomas Biederer
5457,,,Biederer,,,,,A5022502578,,,Co-PI,Team Biederer,Elena Gracheva
5458,,,Biederer,,,,,A5031151569,,,Co-PI,Team Biederer,Michael Higley
5462,,,Biederer,,,,,A5040525760,,,Collaborating PI,Team Biederer,Terrance Kummer
5464,,,Biederer,,,,,A5006321623,,,Collaborating PI,Team Biederer,Ed Boyden
5489,,,Biederer,,,,,A5040122670,,,Collaborating PI,Team Biederer,Robert E Kennedy
5491,,,Calakos,,,,,A5017962710,,,Co-PI,Team Calakos,Cagla Eroglu
5492,,,Calakos,,,,,A5088379859,,,Co-PI,Team Calakos,Sergiu Pasca
5493,,,Calakos,,,,,A5047661140,,,Collaborating PI,Team Calakos,Laurie Sanders
5494,,,Calakos,,,,,A5004078699,,,Collaborating PI,Team Calakos,Simon Gregory
5523,,,Calakos,,,,,A5033015769,,,Collaborating PI,Team Calakos,Evans Chantell
5527,,,Chen,,,,,A5080223712,,,Co-PI,Team Chen,Timothy Chan
5528,,,Chen,,,,,A5000768609,,,Collaborating PI,Team Chen,Hussein Tawbi
5539,,,Chen,,,,,A5028161783,,,Collaborating PI,Team Chen,Cassian Yee
5552,,,Cragg,,,,,A5004457607,,,Co-PI,Team Cragg,Dinos (Konstantinos) Meletis
5553,,,Cragg,,,,,A5028723665,,,Co-PI,Team Cragg,Richard Wade-Martins
5589,,,De Camilli,,,,,A5037459294,,,Lead PI,Team De Camilli,Pietro De Camilli
5611,,,Desjardins,,,,,A5074478086,,,Collaborating PI,Team Desjardins,Jo Anne Stratton
5612,,,Desjardins,,,,,A5024580674,,,Co-PI,Team Desjardins,Louis-Eric Trudeau
5614,,,Desjardins,,,,,A5078393119,,,Co-PI,Team Desjardins,Janelle Drouin-Ouellet
5633,,,Edwards,,,,,A5042504580,,,Co-PI,Team Edwards,Lerner Talia
5634,,,Edwards,,,,,A5029464086,,,Collaborating PI,Team Edwards,Chris Ford
5666,,,Gradinaru,,,,,A5063109286,,,Co-PI,Team Gradinaru,Ashley Seifert
5667,,,Gradinaru,,,,,A5045170248,,,Co-PI,Team Gradinaru,David Van Valen
5668,,,Gradinaru,,,,,A5088379859,,,Collaborating PI,Team Gradinaru,Sergiu Pasca
5700,,,Hafler,,,,,A5017619994,,,Co-PI,Team Hafler,Rui Chang
5701,,,Hafler,,,,,A5056408708,,,Co-PI,Team Hafler,Ramnik Xavier
5733,,,Hardy,,,,,A5037609259,,,Co-PI,Team Hardy,Maria Grazia Spillantini
5749,,,Hardy,,,,,A5045997682,,,Collaborating PI,Team Hardy,Helene Plun-Favreau
5775,,,Harper,,,,,A5061030857,,,Co-PI,Team Harper,Ruben Fernandez-Busnadiego
5780,,,Harper,,,,,A5047746208,,,Lead PI,Team Harper,J. Wade Harper
5781,,,Harper,,,,,A5086048712,,,Co-PI,Team Harper,Franz-Ulrich Hartl
5827,,,Jakobsson,,,,,A5032075946,,,Co-PI,Team Jakobsson,Molly Gale Hammell
5828,,,Jakobsson,,,,,A5071467664,,,Co-PI,Team Jakobsson,Agnete Kirkeby
5851,,,Kaplitt,,,,,A5079387074,,,Collaborating PI,Team Kaplitt,Tae-In Kam
5852,,,Kaplitt,,,,,A5030425534,,,Collaborating PI,Team Kaplitt,Hanseok Ko
5855,,,Kaplitt,,,,,A5035672227,,,Collaborating PI,Team Kaplitt,Xiaobo Mao
5862,,,Kaplitt,,,,,A5054618323,,,Collaborating PI,Team Kaplitt,Nozomi Nishimura
5863,,,Kaplitt,,,,,A5066785148,,,Collaborating PI,Team Kaplitt,Chris Schaffer
5871,,,Kirik,,,,,A5016649904,,,Co-PI,Team Kirik,Jennifer Johnston
5896,,,Kordower,,,,,A5056072835,,,Collaborating PI,Team Kordower,Frederic Manfredsson
5933,,,Lee,,,,,A5034385515,,,Co-PI,Team Lee,Mike Henderson
5946,,,Liddle,,,,,A5008036209,,,Co-PI,Team Liddle,Malu Tansey
5971,,,MAC,,,,,A5068576885,,,Lead PI,Team MAC,Nicola Segata
5972,,,MAC,,,,,A5052283192,,,Co-PI,Team MAC,Levi Waldron
5975,,,Mobley,,,,,A5103144746,,,Lead-PI,Team Mobley,Xiang-Dong Fu
5976,,,Mobley,,,,,A5048054072,,,Co-PI,Team Mobley,Steve Dowdy
5977,,,Mobley,,,,,A5086086716,,,Co-PI,Team Mobley,Yuanchao Xue
5979,,,Mobley,,,,,A5052581222,,,Co-PI,Team Mobley,Allen Wang
5980,,,Mobley,,,,,A5073855965,,,Collaborating PI,Team Mobley,Bing Ren
5981,,,Mobley,,,,,A5101625376,,,Collaborating PI,Team Mobley,Xiaoqun Wang
5982,,,Mobley,,,,,A5045770248,,,Collaborating PI,Team Mobley,Miranda Orr
5983,,,Mobley,,,,,A5033998542,,,Collaborating PI,Team Mobley,Don Cleveland
5984,,,Reck-Peterson,,,,,A5021023250,,,Lead-PI,Team Reck-Peterson,Samara Reck-Peterson
5986,,,Reck-Peterson,,,,,A5040750259,,,Collaborating PI,Team Reck-Peterson,Peter Heid
5987,,,Reck-Peterson,,,,,A5070482927,,,Collaborating PI,Team Reck-Peterson,Jasmin Jansen
5992,,,Reck-Peterson,,,,,A5111717449,,,Collaborating PI,Team Reck-Peterson,Tom Kraus
5997,,,Reck-Peterson,,,,,A5015060333,,,Collaborating PI,Team Reck-Peterson,Marcel Wendel
6017,,,Schapira,,,,,A5035849217,,,Co-PI,Team Schapira,Donato Di Monte
6018,,,Schapira,,,,,A5078857122,,,Collaborating PI,Team Schapira,Stanislav Ehrlich
6019,,,Schapira,,,,,A5081742118,,,Collaborating PI,Team Schapira,Hervé Blottiere
6056,,,Scherzer,,,,,A5030394012,,,Co-PI,Team Scherzer,Su-Chun Zhang
6100,,,Schlossmacher,,,,,A5067278835,,,Collaborating PI,Team Schlossmacher,Jacob Reimer
6109,,,Schlossmacher,,,,,A5037473598,,,Collaborating PI,Team Schlossmacher,Gianfilippo Coppola
6118,,,Strick,,,,,A5084138592,,,Lead-PI,Team Strick,Peter Strick
6119,,,Strick,,,,,A5041774892,,,Collaborating PI,Team Strick,Afonso Silva
6120,,,Strick,,,,,A5008550747,,,Collaborating PI,Team Strick,Andreas Pfenning
6163,,,Studer,,,,,A5086052373,,,Collaborating PI,Team Studer,Marinka Zitnik
6166,,,Studer,,,,,A5086724086,,,Co-PI,Team Studer,Gist Croft
6177,,,Sulzer,,,,,A5075231025,,,Key Personnel (PI),Team Sulzer,Natividad Stover
6181,,,Surmeier,,,,,A5033742239,,,Lead-PI,Team Surmeier,D. James (Jim) Surmeier
6182,,,Surmeier,,,,,A5020694621,,,Co-PI,Team Surmeier,Silvia Arber
6234,,,Vangheluwe,,,,,A5032467961,,,Collaborating PI,Team Vangheluwe,Paul Saftig
6236,,,Vila,,,,,A5062838955,,,Co-PI,Team Vila,Jose Obeso
6237,,,Vila,,,,,A5065389586,,,Co-PI,Team Vila,Matthias Prigge
6239,,,Vila,,,,,A5013471636,,,"Collaborator, PI",Team Vila,Ernest Arenas
6283,,,Voet,,,,,A5051093942,,,Co-PI,Team Voet,Guy Boeckxstaens
6284,,,Voet,,,,,A5044812020,,,Collaborating PI,Team Voet,Pieter Vanden Berghe
6285,,,Voet,,,,,A5037440162,,,Collaborating PI,Team Voet,Fritz J Sedlazeck
6314,,,Wichmann,,,,,A5073427053,,,Co-PI,Team Wichmann,Hong-Yuan Chu
6315,,,Wichmann,,,,,A5056482545,,,Co-PI,Team Wichmann,Adriana Galvan
6318,,,Wichmann,,,,,A5053818945,,,Collaborating PI,Team Wichmann,Bill Lytton
